993 genotypes with 2028 annotations displayed
of selected term and subterms
|
Searched Term: abnormal pancreas morphology
|
4933430I17Riktm1a(EUCOMM)Wtsi/4933430I17Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933430I17Riktm1a(EUCOMM)Wtsi/Ics)
|
abnormal pancreas morphology
|
J:211773
|
Ay/a
(involves: KK)
|
abnormal pancreatic islet morphology
|
J:26460
|
degranulated pancreatic beta cells
|
J:26460
|
Abcc8tm1.1Fmas/Abcc8+
(B6.129S2(Cg)-Abcc8tm1.1Fmas)
|
abnormal pancreatic beta cell morphology
|
J:208932
|
Abcc8tm1.1Fmas/Abcc8tm1.1Fmas
(B6.129S2(Cg)-Abcc8tm1.1Fmas)
|
abnormal pancreatic beta cell morphology
|
J:208932
|
Adipor2tm2Dgen/Adipor2tm2Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased pancreatic beta cell number
|
J:129554
|
Afmidtm1b(EUCOMM)Wtsi/Afmidtm1b(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H)
|
abnormal pancreatic islet morphology
|
J:226537
|
decreased pancreatic islet number
|
J:226537
|
Ago2tm1.1Tara/Ago2tm1.1Tara Lepob/Lepob Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
increased pancreatic beta cell mass
|
J:210552
|
increased pancreatic beta cell number
|
J:210552
|
Ago2tm1.1Tara/Ago2tm1.1Tara Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
abnormal pancreatic beta cell morphology
|
J:210552
|
decreased pancreatic beta cell mass
|
J:210552
|
decreased pancreatic beta cell number
|
J:210552
|
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
enlarged pancreatic islets
|
J:186035
|
increased pancreatic beta cell number
|
J:186035
|
Agpat2tm1Garg/Agpat2tm1Garg
(involves: 129S6/SvEvTac)
|
enlarged pancreatic islets
|
J:146649
|
increased pancreatic beta cell mass
|
J:146649
|
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreas morphology
|
J:146326
|
decreased pancreas weight
|
J:146326
|
pancreas fibrosis
|
J:146326
|
pancreatic acinar cell atrophy
|
J:146326
|
Agtr2tm1Tin/Agtr2tm1Tin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreas morphology
|
J:146326
|
decreased pancreas weight
|
J:146326
|
pancreas fibrosis
|
J:146326
|
pancreatic acinar cell atrophy
|
J:146326
|
Akap5tm1.1Jsco/Akap5tm1.1Jsco
(involves: 129S * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:190017
|
Akt1tm1Nhy/Akt1+ Akt2tm1Rsg/Akt2tm1Rsg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ)
|
decreased pancreatic beta cell number
|
J:149156
|
enlarged pancreatic islets
|
J:149156
|
Akt1tm1Nhy/Akt1+ Akt2tm1Rsg/Akt2tm1Rsg Ptentm1Ppp/Pten+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ)
|
enlarged pancreatic islets
|
J:149156
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pancreatic islet number
|
J:71491
|
Akt2tm1Rsg/Akt2tm1Rsg
(DBA/1LacJ-Akt2tm1Rsg)
|
decreased pancreatic beta cell number
|
J:84606
|
Akt2tm1Rsg/Akt2tm1Rsg
(involves: C57BL/6 * DBA/1LacJ)
|
enlarged pancreatic islets
|
J:149156
|
Aldh1b1tm1.1(KOMP)Vlcg/Aldh1b1tm1.1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac * CBA)
|
abnormal pancreas development
|
J:232360
|
abnormal pancreatic beta cell differentiation
|
J:232360
|
abnormal pancreatic islet morphology
|
J:232360
|
increased pancreatic alpha cell number
|
J:232360
|
increased pancreatic beta cell mass
|
J:232360
|
increased pancreatic delta cell number
|
J:232360
|
pancreatic islet hyperplasia
|
J:232360
|
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
degranulated pancreatic beta cells
|
J:100403
|
pancreatic islet hyperplasia
|
J:100403
|
Alox15tm1.1Nadl/Alox15tm1.1Nadl Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA)
|
increased pancreatic beta cell mass
|
J:224344
|
pancreatic islet hyperplasia
|
J:224344
|
Alx3tm1Hubr/Alx3tm1Hubr
(involves: 129P2/OlaHsd)
|
decreased pancreatic beta cell mass
|
J:166436
|
small pancreatic islets
|
J:166436
|
Ankrd13cem1(IMPC)Tcp/Ankrd13cem1(IMPC)Tcp
(C57BL/6NCrl-Ankrd13cem1(IMPC)Tcp/Cmmr)
|
abnormal pancreas morphology
|
J:211773
|
Anxa7tm1Pll/Anxa7+
(Not Specified)
|
abnormal pancreatic beta cell morphology
|
J:58572
|
enlarged pancreatic islets
|
J:58572
|
pancreatic islet hyperplasia
|
J:58572
|
ApcMin/Apc+ Trp53tm1Mlh/Trp53tm1Mlh
(involves: 129P2/OlaHsd * C57BL/6 * SWR)
|
abnormal exocrine pancreas morphology
|
J:29664
|
increased pancreatic acinar cell carcinoma incidence
|
J:29664
|
Apctm1Mmt/Apc+ Smad4tm1Mmt/Smad4+
(involves: 129S2/SvPas * C57BL/6)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:46242
|
Apctm1Tno/Apc+ Brf1tm1Arte/Brf1tm1Arte Tg(Cyp1a1-cre)1Dwi/0
(involves: C57BL/6 * CBA)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:285667
|
Apctm2Rak/Apc+ Trp53tm1Brn/Trp53tm1Brn Tg(Pdx1-cre)6Tuv/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)
|
increased pancreas tumor incidence
|
J:234310
|
Apctm2Rak/Apctm2Rak Tg(Pdx1-cre)6Tuv/0
(involves: 129/Sv * C57BL/6J * FVB/N * SJL)
|
abnormal pancreas development
|
J:234310
|
decreased pancreatic beta cell mass
|
J:234310
|
decreased pancreatic islet number
|
J:234310
|
Aqp7tm1Chan/Aqp7tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:125011
|
decreased pancreatic alpha cell number
|
J:125011
|
decreased pancreatic beta cell number
|
J:125011
|
decreased PP cell number
|
J:125011
|
small pancreatic islets
|
J:125011
|
Aqp12tm1Rai/Aqp12tm1Rai
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic acinar cell zymogen granule morphology
|
J:155920
|
Arfgef3tm1Hong/Arfgef3tm1Hong
(129.129P2(B6)-Arfgef3tm1Hong)
|
abnormal pancreatic beta cell morphology
|
J:216529
|
Arl3Gt(OST263303)Lex/Arl3Gt(OST263303)Lex
(involves: 129S5/SvEvBrd)
|
abnormal pancreas morphology
|
J:107331
|
pancreas cyst
|
J:107331
|
small pancreas
|
J:107331
|
Arxtm1Gldn/Arxtm1Gldn Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss Tg(Ins2-cre)23Herr/0
(involves: 129 * Black Swiss * C57BL/6 * CBA/J * SJL)
|
decreased pancreatic beta cell number
|
J:177838
|
Arxtm1Pgr/Y
(involves: 129/Sv * NMRI)
|
abnormal pancreatic delta cell morphology
|
J:86206
|
absent pancreatic alpha cells
|
J:86206
|
increased pancreatic beta cell number
|
J:86206
|
increased pancreatic delta cell number
|
J:86206
|
Ate1em1(IMPC)Ccpcz/Ate1+
(C57BL/6NCrl-Ate1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal pancreas morphology
|
J:211773
|
Atf3tm1Dron/Atf3tm1Dron
(B6.129X1-Atf3tm1Hai)
|
abnormal pancreatic islet morphology
|
J:91595
|
Atf4tm1Tow/Atf4tm1Tow
(either: (involves: 129P2/OlaHsd * NIH Black Swiss) or (involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss))
|
abnormal pancreas morphology
|
J:129974
|
abnormal pancreatic acinar cell morphology
|
J:129974
|
abnormal pancreatic acinar cell zymogen granule morphology
|
J:129974
|
abnormal pancreatic acinus morphology
|
J:129974
|
exocrine pancreas hypoplasia
|
J:89403
|
Atf4tm1Tow/Atf4tm1Tow
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss))
|
increased pancreatic beta cell mass
|
J:152695
|
Atp8a2agil-3J/Atp8a2agil-3J
(CBA/J-Atp8a2agil-3J/GrsrJ)
|
pancreas necrosis
|
J:176491
|
Atp8b1em1(IMPC)Tcp/Atp8b1em1(IMPC)Tcp
(C57BL/6NCrl-Atp8b1em1(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Atxn2tm1.1Aub/Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pancreatic beta cell number
|
J:135320
|
pancreatic islet hyperplasia
|
J:135320
|
Awat2em1(IMPC)Mbp/Awat2em1(IMPC)Mbp
(C57BL/6NCrl-Awat2em1(IMPC)Mbp/Mmucd)
|
abnormal pancreas morphology
|
J:211773
|
B2mtm1Unc/B2mtm1Unc
(NOD.129P2-B2mtm1Unc)
|
abnormal pancreatic beta cell morphology
|
J:17000
|
B2mtm1Unc/B2mtm1Unc
(B6.129P2-B2mtm1Unc/DcrJ)
|
abnormal pancreas morphology
|
J:135214
|
B9d2tm1a(EUCOMM)Wtsi/B9d2tm1a(EUCOMM)Wtsi
(C57BL/6N-B9d2tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal pancreas morphology
|
J:239583
|
small pancreas
|
J:239583
|
Badtm1Meg/Badtm1Meg
(involves: 129S4/SvJae)
|
small pancreatic islets
|
J:133563
|
Badtm1Sjk/Badtm1Sjk
(involves: 129X1/SvJ)
|
increased pancreatic islet number
|
J:133563
|
Bap1em2Test/Bap1+
(involves: FVB)
|
increased pancreatic islet cell carcinoma incidence
|
J:231692
|
Bbip1em1(IMPC)Ccpcz/Bbip1+
(C57BL/6N-Bbip1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal pancreas morphology
|
J:211773
|
Bcl2l1tm1.1Mam/Bcl2l1tm1.1Mam Tg(Ins2-cre)25Mgn/0 Tg(RIP1-Tag)2Dh/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
increased pancreas tumor incidence
|
J:146436
|
Bcl2l1tm1.1Mam/Bcl2l1tm1.1Mam Tg(RIP1-Tag)2Dh/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
increased pancreas tumor incidence
|
J:146436
|
Betalinc1tm1Suss/Betalinc1tm1Suss
(involves: 129 * C57BL/6)
|
abnormal endocrine pancreas development
|
J:231585
|
decreased pancreatic alpha cell number
|
J:231585
|
decreased pancreatic beta cell number
|
J:231585
|
decreased pancreatic epsilon cell number
|
J:231585
|
increased pancreatic delta cell number
|
J:231585
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
|
abnormal pancreatic islet morphology
|
J:126780
|
decreased pancreatic beta cell mass
|
J:126780
|
decreased pancreatic islet number
|
J:126780
|
small pancreatic islets
|
J:126780
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
|
abnormal pancreatic islet morphology
|
J:126780
|
decreased pancreatic beta cell mass
|
J:126780
|
decreased pancreatic islet number
|
J:126780
|
small pancreatic islets
|
J:126780
|
Bhlha15tm1Skz/Bhlha15tm1Skz
(B6.129S6-Bhlha15tm1Skz)
|
abnormal pancreatic acinar cell zymogen granule morphology
|
J:90459
|
Bhlha15tm1Skz/Bhlha15tm1Skz
(involves: 129S6/SvEvTac)
|
abnormal exocrine pancreas morphology
|
J:72798
|
abnormal pancreas morphology
|
J:72798
|
abnormal pancreatic acinar cell morphology
|
J:72798
|
abnormal pancreatic acinar cell zymogen granule morphology
|
J:72798
|
pancreas fibrosis
|
J:72798
|
Bhlha15tm1Skz/Bhlha15tm1Skz
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal pancreatic acinar cell morphology
|
J:85104
|
Bhlha15tm2(Kras)Skz/Bhlha15+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal exocrine pancreas morphology
|
J:105076
|
increased pancreas adenoma incidence
|
J:105076
|
increased pancreatic acinar cell carcinoma incidence
|
J:105076
|
pancreatic acinar hyperplasia
|
J:105076
|
Bhlha15tm3(cre/ERT2)Skz/Bhlha15tm3(cre/ERT2)Skz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic acinar cell morphology
|
J:239144
|
abnormal pancreatic acinar cell zymogen granule morphology
|
J:239144
|
Bicc1jcpk/Bicc1jcpk
(involves: 101 * C3H * T STOCK)
|
dilated pancreatic duct
|
J:23047
|
Bicc1tm1Emdr/Bicc1tm1Emdr
(B6SJL-Bicc1tm1Emdr/J)
|
pancreas cyst
|
J:158678
|
Bidtm1Sjk/Bidtm1Sjk
(involves: 129X1/Sv * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:116520
|
Bmal1tm1.2Shbi/Bmal1tm1.2Shbi
(involves: C57BL/6J)
|
enlarged pancreatic islets
|
J:177865
|
Bmal1tm1Bra/Bmal1tm1Bra
(involves: 129/Sv * C57BL/6)
|
decreased pancreatic islet number
|
J:162641
|
Bmp6em1(IMPC)Ccpcz/Bmp6em1(IMPC)Ccpcz
(C57BL/6N-Bmp6em1(IMPC)Ccpcz/Ccpcz)
|
abnormal pancreas morphology
|
J:211773
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal pancreatic acinar cell morphology
|
J:170095
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)
|
abnormal pancreatic acinar cell morphology
|
J:170095
|
Braftm1Bbd/Braf+
(B6.129-Braftm1Bbd)
|
abnormal pancreatic acinar cell morphology
|
J:170095
|
Brca2tm1Brn/Brca2tm1Cam Krastm4Tyj/Kras+ Trp53tm3Tyj/Trp53+ Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N)
|
increased pancreatic acinar cell carcinoma incidence
|
J:166678
|
increased pancreatic ductal adenocarcinoma incidence
|
J:166678
|
Brca2tm1Cam/Brca2+ Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:166678
|
Brca2tm1Cam/Brca2+ Krastm4Tyj/Kras+ Trp53tm3Tyj/Trp53+ Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:166678
|
Brca2tm1Cam/Brca2tm1Brn Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:166678
|
Brd2Gt(RRT234)Byg/Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg)
|
abnormal pancreatic islet morphology
|
J:159964
|
increased pancreatic beta cell number
|
J:159964
|
increased pancreatic islet number
|
J:159964
|
pancreatic islet hyperplasia
|
J:159964
|
Brf1tm1Arte/Brf1tm1Arte Krastm4Tyj/Kras+ Trp53tm2Tyj/Trp53+ Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * 129S7/SvEvBrd * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:285667
|
Cacna1dtm1Hssh/Cacna1dtm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal pancreatic beta cell differentiation
|
J:72316
|
abnormal pancreatic islet morphology
|
J:72316
|
decreased pancreatic beta cell mass
|
J:72316
|
decreased pancreatic beta cell number
|
J:72316
|
decreased pancreatic islet number
|
J:72316
|
increased pancreatic alpha cell number
|
J:72316
|
Cacna1etm1.1Tsch/Cacna1etm1.1Tsch
(involves: C57BL/6)
|
decreased pancreatic alpha cell number
|
J:95377
|
Cacna1itm1b(KOMP)Wtsi/Cacna1itm1b(KOMP)Wtsi
(C57BL/6N-Cacna1itm1b(KOMP)Wtsi/Bay)
|
abnormal pancreas morphology
|
J:211773
|
Cadm1tm1.2Brd/Cadm1tm1.2Brd
(involves: 129S7/SvEvBrd)
|
increased pancreatic beta cell mass
|
J:210552
|
increased pancreatic beta cell number
|
J:210552
|
Cadps2em1(IMPC)Rbrc/Cadps2em1(IMPC)Rbrc
(C57BL/6NJcl-Cadps2em1(IMPC)Rbrc/Rbrc)
|
abnormal pancreas morphology
|
J:211773
|
Cadpstm1Bros/Cadps+ Cadps2tm1Bros/Cadps2tm1Bros
(Not Specified)
|
abnormal pancreatic beta cell morphology
|
J:131014
|
Calcbtm1.1(KOMP)Vlcg/Calcbtm1.1(KOMP)Vlcg
(C57BL/6N-Calcbtm1.1(KOMP)Vlcg/Ucd)
|
abnormal pancreas morphology
|
J:211773
|
Calhm2tm1b(KOMP)Mbp/Calhm2tm1b(KOMP)Mbp
(C57BL/6N-Calhm2tm1b(KOMP)Mbp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
enlarged pancreas
|
J:211773
|
Camk1dem1(IMPC)Mbp/Camk1dem1(IMPC)Mbp
(C57BL/6NCrl-Camk1dem1(IMPC)Mbp/Mmucd)
|
enlarged pancreas
|
J:211773
|
Casrtm1b(KOMP)Mbp/Casr+
(C57BL/6N-Casrtm1b(KOMP)Mbp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Ccdc80tm1Ftrm/Ccdc80tm1Ftrm
(C57BL/6-Ccdc80tm1Ftrm)
|
pancreatic islet hyperplasia
|
J:189183
|
Cckartm1Kym/Cckartm1Kym Cckbrtm1Tom/Cckbrtm1Tom
(involves: 129S4/SvJae)
|
increased pancreas weight
|
J:96087
|
Cckbrtm1Kpn/Cckbrtm1Kpn
(involves: 129S2/SvPas)
|
abnormal pancreatic delta cell morphology
|
J:49320
|
Ccpg1tm1a(EUCOMM)Hmgu/Ccpg1tm1a(EUCOMM)Hmgu
(C57BL/6N-Ccpg1tm1a(EUCOMM)Hmgu)
|
abnormal pancreas morphology
|
J:256708
|
abnormal pancreatic acinar cell morphology
|
J:256708
|
pancreas necrosis
|
J:256708
|
Ccpg1tm1b(EUCOMM)Hmgu/Ccpg1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ccpg1tm1b(EUCOMM)Hmgu/Ieg)
|
abnormal pancreas morphology
|
J:211773
|
Cd9tm1c(EUCOMM)Hmgu/Cd9+ Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0 Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:280854
|
Cd9tm1c(EUCOMM)Hmgu/Cd9tm1c(EUCOMM)Hmgu Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0 Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:280854
|
Cd38tm1Lnd/Cd38tm1Lnd
(B6.129P2-Cd38tm1Lnd)
|
decreased pancreatic beta cell mass
|
J:116576
|
disorganized pancreatic islets
|
J:116576
|
Cd83tm1b(KOMP)Wtsi/Cd83tm1b(KOMP)Wtsi
(C57BL/6N-Cd83tm1b(KOMP)Wtsi/Ucd)
|
abnormal pancreas morphology
|
J:211773
|
Cdh1tm2Kem/Cdh1tm2Kem Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal pancreatic islet morphology
|
J:196410
|
increased pancreatic beta cell mass
|
J:196410
|
Cdk4tm1.1Bbd/Cdk4+
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
increased pancreatic beta cell number
|
J:54534
|
Cdk4tm1.1Bbd/Cdk4+ Krastm1Bbd/Kras+ Tg(CMV-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)
|
abnormal pancreatic duct morphology
|
J:86101
|
Cdk4tm1.1Bbd/Cdk4tm1.1Bbd
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
increased pancreatic beta cell number
|
J:54534
|
Cdk4tm1Bbd/Cdk4tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
abnormal pancreatic islet morphology
|
J:54534
|
small pancreatic islets
|
J:54534
|
Cdk4tm1Kiyo/Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:57854
|
Cdk8tm1a(EUCOMM)Hmgu/Cdk8tm1a(EUCOMM)Hmgu Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased pancreatic beta cell mass
|
J:281075
|
Cdkal1tm1.1Tomik/Cdkal1tm1.1Tomik Tg(Ins2-cre)25Mgn/0
(B6.Cg-Cdkal1tm1.1Tomik Tg(Ins2-cre)25Mgn)
|
abnormal pancreatic islet morphology
|
J:178248
|
Cdkn1btm1Ako/Cdkn1btm1Ako Men1tm1.1Ctre/Men1+
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)
|
increased pancreas tumor incidence
|
J:120835
|
Cdkn1btm1Kin/Cdkn1b+ Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
enlarged pancreatic islets
|
J:96047
|
increased pancreatic beta cell number
|
J:96047
|
Cdkn1btm1Kin/Cdkn1b+ Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J)
|
abnormal pancreatic islet morphology
|
J:96047
|
increased pancreatic beta cell number
|
J:96047
|
Cdkn1btm1Kin/Cdkn1btm1Kin Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
enlarged pancreatic islets
|
J:96047
|
increased pancreatic beta cell number
|
J:96047
|
Cdkn1btm1Kin/Cdkn1btm1Kin Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J)
|
abnormal pancreatic islet morphology
|
J:96047
|
increased pancreatic beta cell number
|
J:96047
|
Cdkn2atm1.1Gsu/Cdkn2atm1.1Gsu Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N)
|
increased pancreas adenoma incidence
|
J:198619
|
increased pancreas tumor incidence
|
J:198619
|
increased pancreatic intraepithelial neoplasia incidence
|
J:198619
|
Cdkn2atm1Rdp/Cdkn2a+ Tg(CAG-Bgeo,-tTA,-EGFP)2A11Kuw/0 Tg(Pdx1-cre)6Tuv/0 Tg(tetO-MYC)36Bop/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)
|
increased pancreas tumor incidence
|
J:197052
|
increased pancreatic ductal adenocarcinoma incidence
|
J:197052
|
Cdkn2atm2.1Rdp/Cdkn2a+ Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N)
|
increased pancreas tumor incidence
|
J:108298
|
increased pancreatic ductal adenocarcinoma incidence
|
J:108298
|
Cdkn2atm2.1Rdp/Cdkn2a+ Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53tm1Brn Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N)
|
increased pancreas tumor incidence
|
J:108298
|
increased pancreatic ductal adenocarcinoma incidence
|
J:108298
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N)
|
increased pancreas adenoma incidence
|
J:198619
|
increased pancreas tumor incidence
|
J:198619
|
increased pancreatic intraepithelial neoplasia incidence
|
J:198619
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp Krastm4Tyj/Kras+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N)
|
increased pancreas tumor incidence
|
J:108298
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N)
|
increased pancreas tumor incidence
|
J:108298
|
increased pancreatic ductal adenocarcinoma incidence
|
J:108298
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53tm1Brn Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N)
|
increased pancreas tumor incidence
|
J:108298
|
increased pancreatic ductal adenocarcinoma incidence
|
J:108298
|
Cdkn2atm2Brn/Cdkn2atm2Brn Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S4/SvJae * FVB/N)
|
abnormal pancreas development
|
J:195229
|
Cdkn2atm4Rdp/Cdkn2a+ Krastm4Tyj/Kras+ Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:116130
|
Cdkn2atm4Rdp/Cdkn2a+ Krastm4Tyj/Kras+ Smad4tm1Rdp/Smad4tm1Rdp Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:116130
|
Cdkn2atm4Rdp/Cdkn2a+ Krastm4Tyj/Kras+ Smad4tm1Rdp/Smad4tm1Rdp Tg(Pdx1-cre)89.1Dam/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:116130
|
Cdkn2atm4Rdp/Cdkn2a+ Krastm4Tyj/Kras+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:116130
|
Cdkn2atm4Rdp/Cdkn2a+ Krastm4Tyj/Kras+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N)
|
increased pancreas tumor incidence
|
J:108298
|
increased pancreatic ductal adenocarcinoma incidence
|
J:108298
|
Cdkn2atm4Rdp/Cdkn2atm4Rdp Krastm4Tyj/Kras+ Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:116130
|
Cdkn2atm4Rdp/Cdkn2atm4Rdp Krastm4Tyj/Kras+ Smad4tm1Rdp/Smad4tm1Rdp Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:116130
|
Cdkn2atm4Rdp/Cdkn2atm4Rdp Krastm4Tyj/Kras+ Smad4tm1Rdp/Smad4tm1Rdp Tg(Pdx1-cre)89.1Dam/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:116130
|
Cdkn2atm4Rdp/Cdkn2atm4Rdp Krastm4Tyj/Kras+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N)
|
increased pancreas tumor incidence
|
J:108298,
J:87196
|
increased pancreatic ductal adenocarcinoma incidence
|
J:116130,
J:108298,
J:87196
|
increased pancreatic intraepithelial neoplasia incidence
|
J:87196
|
Cdkn2atm4Rdp/Cdkn2atm4Rdp Krastm4Tyj/Kras+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:187012
|
Cdkn2atm4Rdp/Cdkn2atm4Rdp Krastm4Tyj/Krastm4Tyj Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
increased pancreas tumor incidence
|
J:151781
|
pancreas cyst
|
J:151781
|
Cdkn2btm1Bbd/Cdkn2btm1Bbd Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
pancreas cyst
|
J:63299
|
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi Men1tm1.1Ctre/Men1+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6)
|
increased pancreas tumor incidence
|
J:120835
|
Cebpbtm1.1Maka/Cebpbtm1.1Maka Ins2Akita/Ins2Akita Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NSlc * CBA/J)
|
abnormal pancreatic beta cell mass
|
J:156725
|
Cebpbtm1.1Maka/Cebpbtm1.1Maka Leprdb/Leprdb Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BLKS/J * CBA/J)
|
increased pancreatic beta cell mass
|
J:156725
|
Ces1dtm1Reli/Ces1dtm1Reli
(involves: 129S6/SvEvTac)
|
small pancreatic islets
|
J:158743
|
Cfap53em1(IMPC)Wtsi/Cfap53em1(IMPC)Wtsi
(C57BL/6N-Cfap53em1(IMPC)Wtsi/Wtsi)
|
abnormal ventral pancreas topology
|
J:239583
|
Cftrtm1Bay/Cftrtm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
pancreatic acinar cell atrophy
|
J:15244
|
Cftrtm1Cam/Cftrtm1Cam
(involves: 129S/SvEv)
|
dilated pancreatic duct
|
J:23850
|
Cftrtm1Unc/Cftrtm1Unc
(B6.129P2-Cftrtm1Unc/J)
|
dilated pancreatic acinus
|
J:58571
|
pancreatic acinar cell zymogen granule accumulation
|
J:58571
|
Cftrtm1Unc/Cftrtm1Unc
(involves: 129P2/OlaHsd)
|
abnormal pancreas morphology
|
J:2079
|
small pancreas
|
J:2079
|
Cftrtm3Bay/Cftrtm3Bay
(involves: 129S7/SvEvBrd)
|
abnormal pancreas morphology
|
J:29656
|
Chtoptm1a(EUCOMM)Wtsi/Chtoptm1a(EUCOMM)Wtsi
(C57BL/6N-Chtoptm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal dorsal pancreas topology
|
J:239583
|
abnormal pancreas topology
|
J:239583
|
Clcnkbem1(IMPC)Mbp/Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd)
|
abnormal pancreas morphology
|
J:211773
|
Clec16atm1.1Hhak/Clec16atm1.1Hhak Tg(Pdx1-cre)1Herr/0
(involves: C57BL/6 * C57BL/6J * CBA/J * SJL)
|
abnormal pancreatic alpha cell morphology
|
J:214528
|
abnormal pancreatic beta cell morphology
|
J:214528
|
Clockm1Jt/Clockm1Jt
(involves: C57BL/6J)
|
abnormal pancreatic islet morphology
|
J:162641
|
small pancreatic islets
|
J:162641
|
Cndp2em1(IMPC)Mbp/Cndp2em1(IMPC)Mbp
(C57BL/6NCrl-Cndp2em1(IMPC)Mbp/Mmucd)
|
abnormal pancreas morphology
|
J:211773
|
Col1a1tm1(tetO-Lin28a)Gqda/Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
small pancreatic islets
|
J:166568
|
Col1a1tm1(tetO-YAP1*)Fcam/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
enlarged pancreas
|
J:141457
|
increased pancreatic acinar cell number
|
J:141457
|
pancreatic acinar-to-ductal metaplasia
|
J:141457
|
Col4a2em1(IMPC)Wtsi/Col4a2em1(IMPC)Wtsi
(C57BL/6N-Col4a2em1(IMPC)Wtsi/WtsiOulu)
|
abnormal ventral pancreas morphology
|
J:239583
|
Col5a3tm1Dgr/Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased pancreas weight
|
J:171817
|
decreased pancreatic beta cell mass
|
J:171817
|
decreased pancreatic beta cell number
|
J:171817
|
Cpa1tm1.1Satom/Cpa1tm1.1Satom
(involves: C57BL/6NCrl * FVB/N)
|
abnormal pancreatic acinar cell morphology
|
J:300042
|
decreased pancreas weight
|
J:300042
|
decreased pancreatic acinar cell number
|
J:300042
|
pancreas atrophy
|
J:300042
|
pancreatic acinar-to-ductal metaplasia
|
J:300042
|
small pancreas
|
J:300042
|
Cpefat/Cpefat
(involves: HRS/J)
|
abnormal pancreatic beta cell morphology
|
J:10872
|
degranulated pancreatic beta cells
|
J:13651
|
increased pancreatic islet number
|
J:13651
|
pancreatic islet hyperplasia
|
J:10872
|
Cpefat/Cpefat
(BKSChpLt.HRS-Cpefat/J)
|
abnormal pancreatic beta cell morphology
|
J:24436
|
degranulated pancreatic beta cells
|
J:10872
|
pancreatic islet hyperplasia
|
J:10872
|
Crebbptm1Few/Crebbp+
(Not Specified)
|
abnormal pancreatic beta cell morphology
|
J:91133
|
Crebbptm1Few/Crebbptm1Few
(Not Specified)
|
abnormal pancreatic beta cell morphology
|
J:91133
|
Crygctm1.1(KOMP)Vlcg/Crygctm1.1(KOMP)Vlcg
(C57BL/6N-Crygctm1.1(KOMP)Vlcg/Ucd)
|
abnormal pancreas morphology
|
J:211773
|
Csf2tm1Mlg/Csf2tm1Mlg
(B6.129S2-Csf2tm1Mlg)
|
abnormal pancreatic islet morphology
|
J:145518
|
Csf2tm1Mlg/Csf2tm1Mlg Il3tm1Glli/Il3tm1Glli
(B6.129S2-Csf2tm1Mlg Il3tm1Glli)
|
abnormal pancreatic islet morphology
|
J:145518
|
decreased pancreatic beta cell number
|
J:145518
|
Ctf1tm1Msd/Ctf1tm1Msd
(B6.Cg-Ctf1tm1Msd)
|
enlarged pancreatic islets
|
J:176727
|
increased pancreatic islet number
|
J:176727
|
Ctnnb1tm4Wbm/Ctnnb1tm4Wbm Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal exocrine pancreas morphology
|
J:119908
|
abnormal pancreas morphology
|
J:119908
|
decreased pancreas weight
|
J:119908
|
pancreas fibrosis
|
J:119908
|
pancreatic acinar hypoplasia
|
J:119908
|
Ctrb1em1Toth/Ctrb1em1Toth
(C57BL/6N-Ctrb1em1Toth)
|
enlarged pancreas
|
J:294171
|
increased pancreas weight
|
J:294171
|
Cul9tm1.2Yxi/Cul9+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased insulinoma incidence
|
J:170976
|
Cxadrtm1.1Ics/Cxadrtm1.1Ics Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)
|
abnormal exocrine pancreas morphology
|
J:174138
|
abnormal pancreas morphology
|
J:174138
|
decreased pancreatic acinar cell number
|
J:174138
|
exocrine pancreas atrophy
|
J:174138
|
pancreatic acinar-to-ductal metaplasia
|
J:174138
|
small pancreas
|
J:174138
|
Cyb5r4tm1Hfb/Cyb5r4tm1Hfb
(involves: 129S4/SvJae * BALB/cAnN)
|
abnormal pancreatic islet morphology
|
J:91486
|
decreased pancreatic beta cell number
|
J:91486
|
Cys1cpk/Cys1cpk
(involves: C57BL/6J * CD-1)
|
pancreas cyst
|
J:33739
|
Cys1cpk/Cys1cpk
(C.B6(Cg)-Cys1cpk)
|
absent pancreatic islets
|
J:99616
|
dilated pancreatic duct
|
J:99616
|
pancreas fibrosis
|
J:99616
|
Cys1cpk/Cys1cpk
(D2J.B6(Cg)-Cys1cpk)
|
abnormal pancreatic acinus morphology
|
J:99620
|
absent pancreatic islets
|
J:99620
|
dilated pancreatic duct
|
J:99620
|
ectopic pancreatic acinar cells
|
J:99620
|
pancreas fibrosis
|
J:99620
|
Cys1cpk/Cys1cpk
(129.B6-Cys1cpk)
|
pancreas cyst
|
J:116210
|
Dach1tm1Krs/Dach1tm1Krs
(involves: 129P2/OlaHsd)
|
decreased pancreatic alpha cell number
|
J:166952
|
decreased pancreatic beta cell number
|
J:166952
|
small pancreatic islets
|
J:166952
|
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6J * CBA)
|
increased pancreatic alpha cell number
|
J:92536
|
increased pancreatic beta cell number
|
J:92536
|
pancreatic islet hyperplasia
|
J:92536
|
Dhtkd1tm1Zgwg/Dhtkd1tm1Zgwg
(involves: C57BL/6)
|
abnormal pancreatic islet morphology
|
J:267178
|
Diras2em1Gpt/Diras2em1Gpt Krastm4Tyj/Kras+ Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129S4/SvJae * C57BL/6J * C57BL/6JGpt)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:348744
|
Diras2em1Gpt/Diras2em1Gpt Krastm4Tyj/Kras+ Ptf1atm1(cre)Hnak/Ptf1a+ Ube2ftm1c(EUCOMM)Hmgu/Ube2ftm1c(EUCOMM)Hmgu
(involves: 129S4/SvJae * C57BL/6)
|
increased pancreas tumor incidence
|
J:348744
|
Dll1tm1.1Hri/Dll1tm1.1Hri Foxa2tm3.1(icre)Heli/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal pancreas development
|
J:184814
|
Dll1tm1Gos/Dll1tm1Gos
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal pancreas development
|
J:57072
|
Dnaaf4b2b811.1Clo/Dnaaf4b2b811.1Clo
(C57BL/6J-Dnaaf4b2b811.1Clo)
|
abnormal pancreas morphology
|
J:205312
|
Dnah5b2b2451Clo/Dnah5b2b2451Clo
(C57BL/6J-Dnah5b2b2451Clo)
|
abnormal pancreas morphology
|
J:175213
|
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(B6.129P2-Dnajb9Gt(KST256)Byg)
|
abnormal pancreatic alpha cell morphology
|
J:226674
|
abnormal pancreatic beta cell morphology
|
J:226674
|
increased pancreatic alpha cell number
|
J:226674
|
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg Tg(CAG-XBP1*/Venus)#Miur/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreatic acinar cell morphology
|
J:226674
|
abnormal pancreatic acinar cell zymogen granule morphology
|
J:226674
|
abnormal pancreatic alpha cell morphology
|
J:226674
|
abnormal pancreatic beta cell morphology
|
J:226674
|
decreased pancreatic beta cell number
|
J:226674
|
Dnajc3tm8663Wcl/Dnajc3tm8663Wcl
(C57BL/6-Dnajc3tm8663Wcl/Mmmh)
|
abnormal pancreatic beta cell morphology
|
J:98194
|
decreased pancreatic beta cell mass
|
J:98194
|
decreased pancreatic beta cell number
|
J:98194
|
Dnmt3atm1Jae/Dnmt3atm1Jae Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+ Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss Tg(Ins2-cre)23Herr/0
(involves: 129S/Sv * Black Swiss * C57BL/6 * CBA/J * SJL)
|
abnormal pancreatic beta cell differentiation
|
J:177838
|
Dnmt3atm1Jae/Dnmt3atm1Jae Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss Tg(Ins2-cre)23Herr/0
(involves: Black Swiss * C57BL/6 * CBA/J * SJL)
|
decreased pancreatic beta cell number
|
J:177838
|
increased pancreatic alpha cell number
|
J:177838
|
Dp(16Lipi-Zbtb21)1Yey/0
(involves: 129S7/SvEvBrd)
|
annular pancreas
|
J:121790
|
E2f1tm1Meg/E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg)
|
abnormal pancreatic islet morphology
|
J:93708
|
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6)
|
abnormal exocrine pancreas morphology
|
J:33099
|
abnormal pancreas morphology
|
J:89720
|
abnormal pancreatic beta cell morphology
|
J:89720
|
abnormal pancreatic islet morphology
|
J:89720
|
decreased pancreas weight
|
J:89720
|
decreased pancreatic islet number
|
J:89720
|
small pancreatic islets
|
J:89720
|
Egfrtm1Rdk/Egfrtm1Rdk
(involves: 129X1/SvJ * Black Swiss)
|
abnormal exocrine pancreas morphology
|
J:62160
|
abnormal pancreas morphology
|
J:62160
|
abnormal pancreatic beta cell morphology
|
J:62160
|
disorganized pancreatic islets
|
J:62160
|
small pancreas
|
J:62160
|
Ehd4tm1.1Haba/Ehd4tm1.1Haba
(involves: C57BL/6 * C57BL/6J * FVB/N)
|
abnormal pancreatic islet morphology
|
J:160188
|
pancreatic islet hyperplasia
|
J:160188
|
Eif2ak3tm1.1Drc/Eif2ak3tm1.1Drc Tg(Ela1-cre)16Eps/0
(involves: 129S6/SvEvTac)
|
abnormal exocrine pancreas morphology
|
J:129974
|
abnormal pancreatic acinar cell morphology
|
J:129974
|
abnormal pancreatic acinus morphology
|
J:129974
|
exocrine pancreas atrophy
|
J:129974
|
small pancreas
|
J:129974
|
Eif2ak3tm1Drc/Eif2ak3tm1Drc
(involves: 129S6/SvEvTac)
|
abnormal exocrine pancreas morphology
|
J:129974
|
abnormal pancreatic acinar cell morphology
|
J:76661
|
abnormal pancreatic alpha cell morphology
|
J:76661
|
absent pancreatic alpha cells
|
J:76661
|
absent pancreatic beta cells
|
J:76661
|
decreased pancreatic beta cell number
|
J:76661,
J:129974
|
small pancreatic islets
|
J:76661
|
Eif2ak3tm1Dron/Eif2ak3tm1Dron
(involves: 129S6/SvEvTac * Swiss Webster)
|
abnormal exocrine pancreas morphology
|
J:70005
|
abnormal pancreatic islet morphology
|
J:70005
|
decreased pancreatic beta cell number
|
J:70005
|
increased pancreatic alpha cell number
|
J:70005
|
Elovl6Gt(OST222498)Lex/Elovl6Gt(OST222498)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:130031
|
Epgntm1.1Msdr/Epgntm1.1Msdr
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased pancreas weight
|
J:194427
|
epi/?
(involves: CBA/J)
|
abnormal exocrine pancreas morphology
|
J:27487
|
exocrine pancreas hypoplasia
|
J:5421
|
pancreatic acinar hypoplasia
|
J:5752
|
Epm2aTg(TcraK,TcrbK)TG-BFlv/Epm2a+ Tg(Ela1-TAg)18Bri/0
(involves: C57BL/6 * CBA/J * SJL)
|
abnormal exocrine pancreas morphology
|
J:107545
|
abnormal pancreas morphology
|
J:107545
|
Erbb3tm1Gne/Erbb3tm1Gne
(involves: 129S2/SvPas * C57BL/6)
|
abnormal pancreas morphology
|
J:45302
|
Ero1bGt(P077G11)Wrst/Ero1b+ Ins2Akita/Ins2+
(involves: 129S2/SvPas * C57BL/6NSlc)
|
small pancreatic islets
|
J:158805
|
Ero1bGt(P077G11)Wrst/Ero1bGt(P077G11)Wrst
(involves: 129S2/SvPas * C57BL/6)
|
disorganized pancreatic islets
|
J:158805
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd)
|
enlarged pancreatic islets
|
J:151012
|
Etn2Sd/Etn2+ Ptf1a/Ptf1aostm1Kymm/Ptf1aos+
(involves: C57BL/6)
|
absent pancreas
|
J:195133
|
Etn2Sd/Etn2+ Ptf1a/Ptf1aostm1Kymm/Ptf1a+
(involves: C57BL/6)
|
absent pancreas
|
J:195133
|
Extl3tm1.1Okam/Extl3tm1Okam Tg(Ins2-cre)#Okam/0
(involves: 129P2/OlaHsd * ICR)
|
decreased pancreatic beta cell mass
|
J:148348
|
decreased pancreatic beta cell number
|
J:148348
|
disorganized pancreatic islets
|
J:148348
|
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL)
|
increased pancreatic alpha cell number
|
J:27735
|
pancreas hyperplasia
|
J:27735
|
Fblim1em5(IMPC)Tcp/Fblim1em5(IMPC)Tcp
(C57BL/6NCrl-Fblim1em5(IMPC)Tcp/Tcp)
|
enlarged pancreas
|
J:211773
|
Fbxl20tm1Seto/Fbxl20tm1Seto
(involves: 129P2/OlaHsd * C57BL/6J)
|
small pancreas
|
J:127941
|
Ffar4tm1Gdds/Ffar4tm1Gdds
(involves: 129 * C57BL/6)
|
enlarged pancreatic islets
|
J:182599
|
Fgatm1Jld/Fgatm1Jld
(involves: 129P2/OlaHsd * CF-1)
|
pancreas cyst
|
J:36591
|
Fgf10tm1Ska/Fgf10tm1Ska
(involves: C57BL/6 * CBA)
|
decreased pancreatic beta cell number
|
J:114183
|
pancreas fibrosis
|
J:114183
|
small pancreas
|
J:114183
|
Fgfr2m1Sgg/Fgfr2m1Sgg
(involves: C3H/HeJ * C57BL/6J)
|
small pancreas
|
J:160674
|
Fgfr2tm1.1Dsn/Fgfr2tm1.1Dsn
(involves: 129P2/OlaHsd)
|
abnormal pancreas development
|
J:82083
|
small pancreas
|
J:82083
|
Fgfr2tm3Dsn/Fgfr2tm3Dsn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreas development
|
J:67731
|
Fhip1bem1(IMPC)Tcp/Fhip1bem1(IMPC)Tcp
(C57BL/6NCrl-Fhip1bem1(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Fnip1em1(IMPC)Ccpcz/Fnip1em1(IMPC)Ccpcz
(C57BL/6NCrl-Fnip1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal pancreas morphology
|
J:211773
|
Foxa1tm1Khk/Foxa1+ Foxa2tm1Khk/Foxa2tm1Khk Tg(Pdx1-cre)6Cvw/0
(involves: 129 * C57BL/6 * CBA * SJL)
|
decreased pancreatic beta cell number
|
J:143476
|
exocrine pancreas hypoplasia
|
J:143476
|
pancreas hypoplasia
|
J:143476
|
pancreatic islet hypoplasia
|
J:143476
|
Foxa1tm1Khk/Foxa1tm1Khk Foxa2tm1Khk/Foxa2tm1Khk Tg(Pdx1-cre)6Cvw/0
(involves: 129 * C57BL/6 * CBA * SJL)
|
abnormal pancreas development
|
J:143476
|
abnormal pancreas morphology
|
J:143476
|
decreased pancreatic beta cell number
|
J:143476
|
exocrine pancreas hypoplasia
|
J:143476
|
pancreas hypoplasia
|
J:143476
|
pancreatic islet hypoplasia
|
J:143476
|
Foxa2tm1Khk/Foxa2tm1Khk
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA)
|
abnormal pancreatic beta cell morphology
|
J:70409
|
disorganized pancreatic islets
|
J:70409
|
Foxa2tm1Khk/Foxa2tm1Khk Tg(Foxa3-cre)1Khk/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA)
|
decreased pancreatic alpha cell number
|
J:96332
|
disorganized pancreatic islets
|
J:96332
|
Foxm1tm1Rhc/Foxm1tm1Rhc Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal exocrine pancreas morphology
|
J:111026
|
abnormal pancreatic beta cell morphology
|
J:111026
|
abnormal pancreatic islet morphology
|
J:111026
|
decreased pancreas weight
|
J:111026
|
decreased pancreatic beta cell mass
|
J:111026
|
decreased pancreatic beta cell number
|
J:111026
|
increased pancreatic alpha cell number
|
J:111026
|
pancreas cyst
|
J:111026
|
pancreas necrosis
|
J:111026
|
small pancreatic islets
|
J:111026
|
Foxo1tm1Rdp/Foxo1tm1Rdp Foxo3tm1Rdp/Foxo3tm1Rdp Foxo4tm1Rdp/Foxo4tm1Rdp Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA/J)
|
abnormal pancreatic beta cell differentiation
|
J:215526
|
Foxo1tm1Whb/Foxo1+ Pdpk1tm1Maka/Pdpk1tm1Maka Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
increased pancreatic beta cell number
|
J:109010
|
Foxp3tm2.1(EGFP/cre)Shori/Y Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129 * 129S2/SvPas * C57BL/6)
|
pancreas atrophy
|
J:234397
|
Fstl3tm1Alsc/Fstl3tm1Alsc
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal pancreatic beta cell morphology
|
J:119526
|
abnormal pancreatic islet morphology
|
J:119526
|
enlarged pancreatic islets
|
J:119526
|
increased pancreatic beta cell number
|
J:119526
|
Ftotm1Urt/Ftotm1Urt Lepob/Lepob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
enlarged pancreatic islets
|
J:219118
|
G2e3em1(IMPC)Tcp/G2e3em1(IMPC)Tcp
(C57BL/6NCrl-G2e3em1(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
G6pc3tm1Rmob/G6pc3tm1Rmob
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased pancreatic alpha cell number
|
J:117664
|
Gadd45gip1tm2Kong/Gadd45gip1tm2Kong Tg(Ins2-cre)25Mgn/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
abnormal pancreatic beta cell morphology
|
J:220742
|
abnormal pancreatic islet morphology
|
J:220742
|
decreased pancreatic beta cell mass
|
J:220742
|
decreased pancreatic beta cell number
|
J:220742
|
Gcgtm1Yhys/Gcgtm1Yhys
(B6.129S6-Gcgtm1Yhys)
|
abnormal pancreatic alpha cell morphology
|
J:154694
|
increased pancreas weight
|
J:154694
|
increased pancreatic islet number
|
J:154694
|
Gcgrem2Smoc/Gcgrem2Smoc
(C57BL/6J-Gcgrem2Smoc)
|
abnormal pancreatic alpha cell morphology
|
J:300368
|
increased pancreas weight
|
J:300368
|
Gcgrtm1Jcp/Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp)
|
abnormal pancreatic acinar cell morphology
|
J:176507
|
abnormal pancreatic alpha cell differentiation
|
J:176507
|
abnormal pancreatic alpha cell morphology
|
J:176507
|
abnormal pancreatic islet morphology
|
J:176507
|
enlarged pancreas
|
J:176507
|
enlarged pancreatic islets
|
J:176507
|
increased glucagonoma incidence
|
J:176507
|
increased pancreas tumor incidence
|
J:176507
|
pancreatic islet hyperplasia
|
J:176507
|
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal pancreatic alpha cell morphology
|
J:251829
|
increased pancreatic alpha cell number
|
J:251829
|
pancreatic islet hyperplasia
|
J:251829,
J:81772
|
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129 * C57BL/6J * SJL)
|
increased pancreas weight
|
J:208604
|
increased pancreatic alpha cell mass
|
J:208604
|
increased pancreatic alpha cell number
|
J:208604
|
increased pancreatic beta cell mass
|
J:208604
|
Gcgrtm1Mjch/Gcgrtm1Mjch Slc38a5tm1(KOMP)Vlcg/Slc38a5tm1(KOMP)Vlcg
(involves: 129/Sv * C57BL/6 * C57BL/6J * C57BL/6NTac * SJL)
|
abnormal pancreatic alpha cell morphology
|
J:251829
|
pancreatic islet hyperplasia
|
J:251829
|
Gcgrtm2.1Mjch/Gcgrtm2.1Mjch Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA * SJL)
|
increased pancreas weight
|
J:208604
|
increased pancreatic alpha cell number
|
J:208604
|
increased pancreatic beta cell mass
|
J:208604
|
GckGls006/Gck+
(C3HeB/FeJ-GckGls006)
|
decreased pancreatic beta cell mass
|
J:189544
|
small pancreatic islets
|
J:189544
|
GckGls006/GckGls006
(C3HeB/FeJ-GckGls006)
|
abnormal pancreatic beta cell morphology
|
J:189544
|
abnormal pancreatic islet morphology
|
J:189544
|
decreased pancreatic beta cell mass
|
J:189544
|
small pancreatic islets
|
J:189544
|
Gckm1Rge/Gck+
(involves: C3HeB/FeJ)
|
decreased pancreatic beta cell mass
|
J:162903
|
small pancreatic islets
|
J:162903
|
Gcktm1Tka/Gck+ Irs1tm1Tka/Irs1tm1Tka
(involves: 129X1/SvJ * C57BL/6 * CBA * ICR)
|
increased pancreatic beta cell mass
|
J:38899
|
pancreatic islet hyperplasia
|
J:38899
|
Gcktm1Ydor/Gck+ Tg(Ins1-cre/ERT)1Lphi/0
(involves: C57BL/6 * C57BL/6J * CD-1)
|
increased pancreatic beta cell mass
|
J:302600
|
Gcktm1Ydor/Gck+ Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA)
|
decreased pancreatic beta cell mass
|
J:302600
|
increased pancreatic beta cell mass
|
J:302600
|
Gdf1tm1Sjl/Gdf1tm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
annular pancreas
|
J:60755
|
Gdf11tm1Sjl/Gdf11+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased pancreatic alpha cell mass
|
J:94455
|
increased pancreatic islet number
|
J:94455
|
small pancreatic islets
|
J:94455
|
Gdf11tm1Sjl/Gdf11tm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal exocrine pancreas morphology
|
J:94455
|
abnormal pancreas morphology
|
J:94455
|
abnormal pancreatic beta cell differentiation
|
J:94455
|
decreased pancreatic acinar cell number
|
J:94455
|
decreased pancreatic beta cell mass
|
J:94455
|
increased pancreatic alpha cell mass
|
J:94455
|
pancreatic islet hyperplasia
|
J:94455
|
small pancreatic islets
|
J:94455
|
Ghrtm1.1Dlr/Ghrtm1.1Dlr Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell mass
|
J:284574
|
Ghrtm1.1Dlr/Ghrtm1.1Dlr Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C3H * C57BL/6 * DBA)
|
decreased pancreatic beta cell mass
|
J:173909
|
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased pancreatic beta cell mass
|
J:107763
|
small pancreatic islets
|
J:107763
|
Glis3tm1.2Chan/Glis3tm1.2Chan
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
absent pancreatic alpha cells
|
J:177082
|
absent pancreatic beta cells
|
J:177082
|
decreased pancreatic alpha cell number
|
J:177082
|
decreased pancreatic beta cell number
|
J:177082
|
decreased pancreatic delta cell number
|
J:177082
|
decreased pancreatic epsilon cell number
|
J:177082
|
disorganized pancreatic islets
|
J:177082
|
small pancreatic islets
|
J:177082
|
Glis3tm1Hiha/Glis3tm1Hiha
(involves: C57BL/6 * CBA)
|
abnormal pancreatic islet morphology
|
J:150077
|
decreased pancreatic alpha cell number
|
J:150077
|
decreased pancreatic beta cell number
|
J:150077
|
decreased pancreatic delta cell number
|
J:150077
|
small pancreatic islets
|
J:150077
|
Gls2em1Xen/Gls2em1Xen
(involves: C57BL/6NTac)
|
increased pancreatic alpha cell number
|
J:271619
|
Glud1tm1.1Pma/Glud1tm1.1Pma Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/J * SJL)
|
disorganized pancreatic islets
|
J:145558
|
Gm26330em1Liuq/Gm26330em1Liuq
(C57BL/6-Gm26330em1Liuq)
|
enlarged pancreatic islets
|
J:341056
|
Gnao1tm4Lbi/Gnao1tm4Lbi Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA)
|
abnormal pancreas morphology
|
J:169627
|
decreased pancreatic beta cell mass
|
J:169627
|
Gnastm5.1Lsw/Gnastm5.1Lsw Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * Black Swiss * FVB/N)
|
increased pancreas weight
|
J:102504
|
pancreatic islet hyperplasia
|
J:102504
|
GnptabGt(OST97730)Lex/GnptabGt(OST97730)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal exocrine pancreas morphology
|
J:127156
|
abnormal pancreatic acinar cell zymogen granule morphology
|
J:127156
|
Gnptabnym/Gnptabnym
(involves: BALB/cAnNHsd * C3H/HeNHsd)
|
abnormal pancreas morphology
|
J:218156
|
abnormal pancreatic acinar cell morphology
|
J:218156
|
Gpr39tm1Dgen/Gpr39tm1Dgen
(B6.129P2-Gpr39tm1Dgen)
|
abnormal pancreatic islet morphology
|
J:151806
|
Gramd2aem1(IMPC)Tcp/Gramd2aem1(IMPC)Tcp
(C57BL/6NCrl-Gramd2aem1(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Grb10Gt(XC302)Byg/Grb10Gt(XC302)Byg
(involves: 129P2/OlaHsd * Black Swiss * C57BL/6)
|
increased pancreas weight
|
J:125128
|
Grb10tm1.1Fliu/Grb10tm1.1Fliu Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
abnormal pancreatic beta cell morphology
|
J:208498
|
increased pancreas weight
|
J:208498
|
increased pancreatic beta cell mass
|
J:208498
|
Gsk3btm1Jrw/Gsk3b+ Insrtm1Dac/Insr+
(involves: 129 * C57BL/6J)
|
decreased pancreatic beta cell mass
|
J:135659
|
Gt(ROSA)26Sortm1(CAG-Kcnj11*,-GFP)Nich/Gt(ROSA)26Sor+ Tg(Ins2-cre)23Herr/0
(involves: C57BL/6 * CBA/J)
|
abnormal pancreas morphology
|
J:146650
|
abnormal pancreatic alpha cell morphology
|
J:146650
|
abnormal pancreatic islet morphology
|
J:146650
|
decreased pancreas weight
|
J:146650
|
decreased pancreatic alpha cell number
|
J:146650
|
decreased pancreatic beta cell number
|
J:146650
|
decreased pancreatic islet number
|
J:146650
|
small pancreatic islets
|
J:146650
|
Gt(ROSA)26Sortm1(DTA)Kio/Gt(ROSA)26Sor+ Tg(Tnfrsf4-cre)1Nik/0
(B6.129-Tnfrsf4tm2(cre)Nik Gt(ROSA)26Sortm1(DTA)Kio)
|
exocrine pancreas atrophy
|
J:203905
|
Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+ Chrna7tm2.1(cre)Swr/Chrna7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
enlarged pancreas
|
J:223063
|
Gt(ROSA)26Sortm1(DTA)Vlcg/Gt(ROSA)26Sortm1(DTA)Vlcg Tg(BGLAP-cre/ERT2)#Stko/0
(involves: 129S1/Sv * FVB/N)
|
decreased pancreatic beta cell mass
|
J:201507
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Hprt1tm1(Ins2-HBEGF)Herr/Y Tg(Gcg-rtTA)#Herr/0 Tg(tetO-cre)1Jaw/0
(involves: 129X1/SvJ * C57BL/6)
|
abnormal pancreatic alpha cell differentiation
|
J:159291
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Hprt1tm1(Ins2-HBEGF)Herr/Y Tg(Ins2-cre/ERT)1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal pancreatic islet morphology
|
J:159291
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0 Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:280854
|
increased pancreatic intraepithelial neoplasia incidence
|
J:280854
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Krastm4Tyj/Kras+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA)
|
pancreatic acinar-to-ductal metaplasia
|
J:289183
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Krastm4Tyj/Kras+ Tg(Pdx1-cre)89.1Dam/0 Trp53tm1Brn/Trp53+
(involves: 129 * C57BL/6 * CBA)
|
increased pancreas tumor incidence
|
J:289183
|
increased pancreatic ductal adenocarcinoma incidence
|
J:289183
|
increased pancreatic intraepithelial neoplasia incidence
|
J:289183
|
pancreatic acinar-to-ductal metaplasia
|
J:289183
|
Gt(ROSA)26Sortm1(Gck)Ydor/Gt(ROSA)26Sor+ Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA)
|
decreased pancreatic beta cell mass
|
J:210493
|
Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas/Gt(ROSA)26Sor+ Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal pancreatic alpha cell morphology
|
J:144715
|
abnormal pancreatic beta cell morphology
|
J:144715
|
abnormal pancreatic islet morphology
|
J:144715
|
decreased pancreatic beta cell number
|
J:144715
|
increased pancreatic alpha cell number
|
J:144715
|
Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe/? Krt19tm1(cre/ERT)Ggu/?
(B6.Cg-Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe Krt19tm1(cre/ERT)Ggu)
|
increased pancreatic beta cell number
|
J:215154
|
Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe/? Tg(Pdx1-cre)6Tuv/?
(B6.Cg-Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe Tg(Pdx1-cre)6Tuv)
|
increased pancreatic beta cell number
|
J:215154
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Hes1tm1(cre/ERT2)Lcm/Hes1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
abnormal pancreas development
|
J:169830
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Krastm4Tyj/Krastm4Tyj Tg(Cela1-cre/ERT)1Dam/0
(involves: 129S4/SvJae * 129S4/SvJaeSor)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:142188
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Krastm4Tyj/Krastm4Tyj Tg(Pdx1-cre/Esr1*)35.10Dam/0
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * CBA)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:142188
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Tg(Neurod1-cre)1Able/0
(involves: 129S4/SvJaeSor * C57BL/6 * DBA/2)
|
abnormal pancreas morphology
|
J:190530
|
abnormal pancreatic islet morphology
|
J:190530
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Tg(Neurog3-cre)C1Able/0
(involves: 129S4/SvJaeSor)
|
abnormal pancreas development
|
J:190530
|
abnormal pancreatic duct morphology
|
J:190530
|
absent pancreatic islets
|
J:190530
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Tg(Neurog3-cre/Esr1*)1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
absent pancreatic alpha cells
|
J:86975
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * ICR)
|
abnormal endocrine pancreas morphology
|
J:86975
|
abnormal exocrine pancreas morphology
|
J:86975
|
abnormal pancreas development
|
J:86975
|
decreased pancreatic alpha cell number
|
J:86975
|
decreased pancreatic beta cell number
|
J:86975
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
abnormal pancreas development
|
J:169830
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Tg(Pdx1-cre/Esr1*)35.10Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal pancreas development
|
J:86975
|
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+ Ptf1atm1.1(cre)Cvw/Ptf1a+ Tg(tetO-Kras2)12Hev/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
increased pancreas tumor incidence
|
J:184378
|
increased pancreatic intraepithelial neoplasia incidence
|
J:184378
|
pancreatic acinar-to-ductal metaplasia
|
J:184378
|
small pancreas
|
J:184378
|
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+ Ptf1atm1.1(cre)Cvw/Ptf1a+ Tg(tetO-Kras2)12Hev/0 Trp53tm1Tyj/Trp53+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:184378
|
increased pancreatic intraepithelial neoplasia incidence
|
J:184378
|
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+ Ptf1atm1.1(cre)Cvw/Ptf1a+ Tg(tetO-Kras*G12D)#Rdp/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:186194
|
increased pancreatic intraepithelial neoplasia incidence
|
J:186194
|
pancreatic acinar-to-ductal metaplasia
|
J:186194
|
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+ Ptf1atm1.1(cre)Cvw/Ptf1a+ Tg(tetO-Kras*G12D)#Rdp/0 Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:186194
|
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+ Ptf1atm1.1(cre)Cvw/Ptf1a+ Tg(tetO-Kras*G12D)#Rdp/0 Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:186194
|
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/? Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal pancreas morphology
|
J:114992
|
Gt(ROSA)26Sortm1(Tva)Dsa/Gt(ROSA)26Sor+ Krastm4Tyj/Kras+ Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:140423
|
Gt(ROSA)26Sortm1(Tva)Dsa/Gt(ROSA)26Sor+ Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:140423
|
increased pancreatic intraepithelial neoplasia incidence
|
J:140423
|
Gt(ROSA)26Sortm1.1(Maml1/EGFP)Hri/? Foxa2tm3.1(icre)Heli/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal pancreas development
|
J:184814
|
abnormal pancreatic beta cell differentiation
|
J:184814
|
Gt(ROSA)26Sortm1.1(Mir26a-1)Coh/?
(involves: 129 * C57BL/6)
|
abnormal endocrine pancreas development
|
J:201964
|
increased pancreatic islet number
|
J:201964
|
Gt(ROSA)26Sortm1.1(Mir26a-1)Coh/Gt(ROSA)26Sor+ Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA)
|
decreased pancreatic beta cell mass
|
J:286108
|
small pancreatic islets
|
J:286108
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+ Ptf1atm1(cre)Cvw/Ptf1atm2Macd
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
abnormal pancreas development
|
J:125691
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1Sor Ptf1atm1.1(cre)Cvw/Ptf1atm1.1(cre)Cvw
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * Black Swiss)
|
abnormal pancreas development
|
J:78710
|
absent pancreatic acini
|
J:78710
|
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+ Ptentm2Mak/Ptentm2Mak Tg(RasE)290Biat/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased pancreas tumor incidence
|
J:226601
|
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+ Tg(RasE)290Biat/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased pancreas tumor incidence
|
J:226601
|
increased pancreatic ductal adenocarcinoma incidence
|
J:226601
|
increased pancreatic intraepithelial neoplasia incidence
|
J:226601
|
Gt(ROSA)26Sortm2(Pik3ca*)Dsa/Gt(ROSA)26Sor+ Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129S6/SvEvTac)
|
enlarged pancreas
|
J:197054
|
increased pancreas weight
|
J:197054
|
increased pancreatic ductal adenocarcinoma incidence
|
J:197054
|
increased pancreatic intraepithelial neoplasia incidence
|
J:197054
|
pancreatic acinar-to-ductal metaplasia
|
J:197054
|
Gt(ROSA)26Sortm2(Pik3ca*)Dsa/Gt(ROSA)26Sor+ Tg(Cela1-cre/ERT)1Dam/0
(involves: 129S6/SvEvTac)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:197054
|
pancreatic acinar-to-ductal metaplasia
|
J:197054
|
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+ Hmga2tm1.1Mmw/Hmga2+ Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0 Trp53tm2Tyj/Trp53+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:245611
|
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+ Krastm4Tyj/Kras+ Prdm1tm1Clme/Prdm1tm1Clme Tg(Pdx1-cre)6Tuv/0 Trp53tm2Tyj/Trp53+
(involves: 129 * C57BL/6NCrl * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:245611
|
increased pancreatic intraepithelial neoplasia incidence
|
J:245611
|
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+ Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0 Trp53tm2Tyj/Trp53+
(involves: 129 * C57BL/6NCrl * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:245611
|
increased pancreatic intraepithelial neoplasia incidence
|
J:245611
|
H4c16em1(IMPC)Mbp/H4c16em1(IMPC)Mbp
(C57BL/6N-H4c16em1(IMPC)Mbp/MbpMmucd)
|
abnormal pancreas morphology
|
J:211773
|
H13tm1b(KOMP)Wtsi/H13tm1b(KOMP)Wtsi
(C57BL/6N-H13tm1b(KOMP)Wtsi/Wtsi)
|
abnormal pancreas topology
|
J:239583
|
Hadhtm1Csta/Hadhtm1Csta
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss)
|
abnormal pancreatic alpha cell morphology
|
J:166803
|
Hddc3tm1.1(KOMP)Vlcg/Hddc3tm1.1(KOMP)Vlcg
(C57BL/6N-Hddc3tm1.1(KOMP)Vlcg/Ucd)
|
abnormal pancreas morphology
|
J:211773
|
Hes1tm1Fgu/Hes1tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal exocrine pancreas morphology
|
J:59312
|
abnormal pancreas development
|
J:59312
|
abnormal pancreas morphology
|
J:87397,
J:59312
|
Hes1tm1Fgu/Hes1tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreas development
|
J:151981
|
Hes1tm1Kag/Hes1tm1Kag Foxa2tm3.1(icre)Heli/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pancreas development
|
J:184814
|
abnormal pancreatic beta cell differentiation
|
J:184814
|
Hhiptm1Amc/Hhiptm1Amc
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreas development
|
J:85472
|
abnormal pancreatic islet morphology
|
J:85472
|
disorganized pancreatic islets
|
J:85472
|
ectopic pancreas
|
J:85472
|
small pancreatic islets
|
J:85472
|
Hhiptm1Amc/Hhiptm1Amc Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal branching involved in pancreas development
|
J:85472
|
abnormal pancreas development
|
J:85472
|
Hic1tm1Sbb/Hic1+
(involves: 129S4/SvJae * C57BL/6)
|
increased pancreatic islet cell carcinoma incidence
|
J:81448
|
Hipk3Gt(OST51087)Lex/Hipk3Gt(OST51087)Lex
(involves: 129S5/SvEvBrd)
|
abnormal pancreatic islet morphology
|
J:194563
|
small pancreatic islets
|
J:194563
|
Hjvtm1Arbr/Hjvtm1Arbr
(involves: 129S4/SvJae * 129X1/SvJ)
|
increased pancreas iron level
|
J:100173
|
Hjvtm1Nca/Hjv+ Tmprss6tm1Dgen/Tmprss6tm1Dgen
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
decreased pancreas iron level
|
J:160248
|
Hlxtm1Rph/Hlxtm1Rph
(involves: 129P2/OlaHsd)
|
small pancreas
|
J:31553
|
Hmga1tm1Brun/Hmga1tm1Brun
(Not Specified)
|
abnormal pancreatic islet morphology
|
J:99652
|
small pancreatic islets
|
J:99652
|
Hmgb1tm1.1Dltg/Hmgb1tm1.1Dltg Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6 * FVB/N)
|
pancreas necrosis
|
J:225260
|
Hnf1atm1.1Ylee/Hnf1atm1.1Ylee
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal pancreatic islet morphology
|
J:47008
|
decreased pancreatic beta cell number
|
J:47008
|
Hnf1atm1Mya/Hnf1atm1Mya
(involves: 129S2/SvPas)
|
decreased pancreas weight
|
J:48230
|
decreased pancreatic beta cell mass
|
J:48230
|
small pancreatic islets
|
J:48230
|
Hnf1btm2Ics/Hnf1b+
(involves: 129 * C57BL/6N)
|
abnormal pancreatic duct morphology
|
J:306082
|
decreased pancreatic acinar cell number
|
J:306082
|
decreased pancreatic islet number
|
J:306082
|
pancreas fibrosis
|
J:306082
|
pancreas lipomatosis
|
J:306082
|
pancreatic acinar hypoplasia
|
J:306082
|
pancreatic acinar-to-ductal metaplasia
|
J:306082
|
small pancreatic islets
|
J:306082
|
Hprt1tm1(CAG-BRF1)Gu/Hprt1+ Krastm4Tyj/Kras+ Trp53tm2Tyj/Trp53+ Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:285667
|
Hprt1tm1(Ins2-HBEGF)Herr/Y
(involves: 129 * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:159291
|
decreased pancreatic beta cell mass
|
J:159291
|
decreased pancreatic beta cell number
|
J:159291
|
increased pancreatic beta cell mass
|
J:159291
|
Htr2btm1Kry/Htr2btm1Kry Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * CBA/J)
|
decreased pancreatic beta cell mass
|
J:284574
|
Huwe1tm1Wgu/Y Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * CBA/J)
|
decreased pancreatic beta cell number
|
J:182446
|
disorganized pancreatic islets
|
J:182446
|
Icostm1Flv/Icos+
(NOD.129S1-Icostm1Flv)
|
decreased pancreatic islet number
|
J:131529
|
Ier3ip1tm1Arvn/Ier3ip1tm1Arvn Tg(Ins1-cre/ERT)1Lphi/0
(involves: 129S4/SvJaeSor * C57BL/6J * CD-1)
|
abnormal pancreatic beta cell differentiation
|
J:336782
|
abnormal pancreatic beta cell morphology
|
J:336782
|
Ier3ip1tm1Arvn/Ier3ip1tm1Arvn Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA)
|
abnormal pancreatic beta cell differentiation
|
J:336782
|
abnormal pancreatic beta cell morphology
|
J:336782
|
decreased pancreatic beta cell mass
|
J:336782
|
small pancreatic islets
|
J:336782
|
Ift88Tg737Rpw/Ift88Tg737Rpw
(involves: FVB/N)
|
abnormal pancreas morphology
|
J:90990
|
abnormal pancreatic acinar cell morphology
|
J:90990
|
abnormal pancreatic duct morphology
|
J:90990
|
decreased pancreatic primary cilium length
|
J:90990
|
decreased pancreatic primary cilium number
|
J:90990
|
pancreas cyst
|
J:90990
|
small pancreas
|
J:90990
|
Ift88Tg737Rpw/Ift88Tg737Rpw
(FVB/N-Ift88Tg737Rpw)
|
abnormal pancreatic acinus morphology
|
J:95813
|
abnormal pancreatic duct morphology
|
J:73583
|
decreased pancreatic acinar cell number
|
J:73583
|
decreased pancreatic primary cilium length
|
J:95813
|
decreased pancreatic primary cilium number
|
J:95813
|
pancreas cyst
|
J:73583,
J:95813
|
small pancreas
|
J:95813
|
Ift88Tg737Rpw/Ift88Tg737Rpw
(C3.FVB-Ift88Tg737Rpw)
|
abnormal pancreatic duct morphology
|
J:73583
|
Ift88Tg737Rpw/Ift88Tg737Rpw
(involves: C3H * FVB/N)
|
abnormal pancreas morphology
|
J:73583
|
Ift88Tg737Rpw/Ift88Tg737Rpw
(involves: 129/Sv * FVB/N)
|
abnormal pancreatic duct morphology
|
J:62025
|
pancreatic acinar cell atrophy
|
J:62025
|
Ift88Tg737Rpw/Ift88tm1Rpw
(involves: 129/Sv * FVB/N)
|
abnormal pancreatic duct morphology
|
J:62025
|
pancreatic acinar cell atrophy
|
J:62025
|
Igfbp3tm1Jep/Igfbp3tm1Jep Igfbp4tm1Jep/Igfbp4tm1Jep Igfbp5tm1Jep/Igfbp5tm1Jep
(involves: 129S/SvEv * C57BL/6J)
|
abnormal pancreatic beta cell morphology
|
J:112029
|
Ighmtm1Cgn/Ighmtm1Cgn Tg(Ins2-Cxcl13)1Cys/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:110548
|
Igs2em5(CAG-Mir802)Gpt/Igs2em5(CAG-Mir802)Gpt Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6JGpt * DBA)
|
abnormal pancreatic beta cell differentiation
|
J:287584
|
decreased pancreatic beta cell mass
|
J:287584
|
decreased pancreatic beta cell number
|
J:287584
|
Ihhtm1Amc/Ihhtm1Amc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
annular pancreas
|
J:62158
|
Il3tm1Glli/Il3tm1Glli
(B6.129S2-Il3tm1Glli)
|
abnormal pancreatic islet morphology
|
J:145518
|
Il6tm1Kopf/Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J)
|
abnormal pancreatic alpha cell mass
|
J:139138
|
Ildr2Dbsm1-DBA/2J/Ildr2Dbsm1-DBA/2J Lepob/Lepob
(B6.Cg-Ildr2Dbsm1-DBA/2J Lepob)
|
decreased pancreatic beta cell mass
|
J:138216
|
Ildr2W87*/Ildr2W87*
(involves: C3HeB/FeJ)
|
abnormal pancreatic beta cell differentiation
|
J:138216
|
decreased pancreatic beta cell mass
|
J:138216
|
decreased pancreatic beta cell number
|
J:138216
|
Ins1tm1Jja/Ins1tm1Jja
(involves: 129S2/SvPas)
|
increased pancreatic beta cell mass
|
J:77595
|
increased pancreatic beta cell number
|
J:77595
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Jja/Ins2+
(involves: 129S2/SvPas * C57BL/6)
|
increased pancreatic alpha cell mass
|
J:106827
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas)
|
enlarged pancreatic islets
|
J:40377
|
increased pancreatic beta cell number
|
J:77595
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas * C57BL/6)
|
enlarged pancreatic islets
|
J:106827
|
increased pancreatic alpha cell mass
|
J:106827
|
increased pancreatic beta cell mass
|
J:106827
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Mnt/Ins2tm1Mnt Tg(Aire-cre)1Mnt/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased pancreatic beta cell number
|
J:152798
|
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita)
|
abnormal pancreatic beta cell morphology
|
J:47883
|
degranulated pancreatic beta cells
|
J:47883
|
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita/J)
|
abnormal pancreatic islet morphology
|
J:321591
|
decreased pancreatic beta cell number
|
J:321591
|
Ins2Akita/Ins2+
(involves: C57BL/6NSlc)
|
abnormal pancreatic islet morphology
|
J:200802
|
Ins2Akita/Ins2+ Or12d17em1Cya/Or12d17em1Cya
(C57BL/6-Ins2Akita Or12d17em1Cya)
|
abnormal pancreatic islet morphology
|
J:321591
|
Ins2Akita/Ins2+ Prf1tm1Sdz/Prf1tm1Sdz Rag1tm1Mom/Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Ins2Akita Prf1tm1Sdz)
|
abnormal pancreatic islet morphology
|
J:138005
|
Ins2Akita/Ins2+ Rnf213tm1.1Akoi/Rnf213tm1.1Akoi
(involves: C57BL/6N * C57BL/6NSlc)
|
abnormal pancreatic islet morphology
|
J:200802
|
decreased pancreatic beta cell number
|
J:200802
|
Ins2Akita/Ins2Akita
(C57BL/6-Ins2Akita)
|
abnormal pancreatic alpha cell morphology
|
J:47883
|
abnormal pancreatic beta cell morphology
|
J:47883
|
small pancreatic islets
|
J:47883
|
Ins2Akita/Ins2Akita
(involves: C57BL/6NSlc)
|
decreased pancreatic beta cell mass
|
J:156725
|
Ins2Akita/Ins2Akita Jazf1tm1c(EUCOMM)Wtsi/Jazf1tm1c(EUCOMM)Wtsi Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJaeSor * C57BL/6N * C57BL/6NSlc * CBA/J)
|
decreased pancreatic beta cell mass
|
J:303318
|
Ins2C95S/Ins2+
(C3HeB/FeJ-Ins2C95S)
|
abnormal pancreatic beta cell morphology
|
J:122098
|
abnormal pancreatic islet morphology
|
J:122098
|
decreased pancreatic beta cell number
|
J:122098
|
disorganized pancreatic islets
|
J:122098
|
increased pancreatic alpha cell number
|
J:122098
|
Ins2em#Arak/Ins2+
(C.129-Rag2tm1Fwa Ins2em#Arak Jak3tm1Tks/Arak)
|
abnormal pancreatic beta cell morphology
|
J:294041
|
abnormal pancreatic islet morphology
|
J:294041
|
small pancreatic islets
|
J:294041
|
Ins2tm1Delt/Ins2+
(involves: 129S2/SvPas * Black Swiss)
|
absent pancreatic beta cells
|
J:94589
|
decreased pancreatic alpha cell number
|
J:94589
|
small pancreatic islets
|
J:94589
|
Ins2tm1Delt/Ins2tm1Jja
(involves: 129S2/SvPas)
|
decreased pancreatic beta cell number
|
J:94589
|
Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas)
|
increased pancreatic beta cell mass
|
J:77595
|
increased pancreatic beta cell number
|
J:77595
|
Insl5tm1Imad/Insl5tm1Imad
(129(B6)-Insl5tm1Imad)
|
decreased pancreatic beta cell number
|
J:189146
|
small pancreatic islets
|
J:189146
|
Insm1tm1.1(GFP/cre)Mgn/Insm1tm1.1(GFP/cre)Mgn
(involves: 129S6/SvEvTac * CD-1 * SJL)
|
abnormal endocrine pancreas development
|
J:214095
|
abnormal endocrine pancreas morphology
|
J:214095
|
Insm1tm1Cbm/Insm1tm1Cbm
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
abnormal endocrine pancreas development
|
J:112173
|
absent PP cells
|
J:112173
|
decreased pancreatic alpha cell number
|
J:112173
|
decreased pancreatic beta cell number
|
J:112173
|
decreased pancreatic delta cell number
|
J:112173
|
decreased pancreatic epsilon cell number
|
J:112173
|
increased PP cell number
|
J:112173
|
pancreatic islet hypoplasia
|
J:112173
|
Insm1tm1Cbm/Insm1tm1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased pancreatic beta cell number
|
J:112173
|
Insrtm1Dac/Insr+
(involves: 129 * C57BL/6J)
|
increased pancreatic beta cell mass
|
J:135659
|
Insrtm1Dac/Insr+
(B6.129S4-Insrtm1Dac/J)
|
increased pancreatic beta cell mass
|
J:246319
|
Insrtm1Dac/Insr+ Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
absent pancreatic beta cells
|
J:80826
|
Insrtm1Dac/Insr+ Ppp2r2aigt10/Ppp2r2a+
(involves: 129S4/SvJae * C3H/HeH * C57BL/6J)
|
increased pancreatic beta cell mass
|
J:246319
|
Insrtm1Dac/Insrtm1Dac Tg(TTR-INSR)L1Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
decreased pancreatic beta cell mass
|
J:91350
|
Insrtm1Dac/Insrtm1Dac Tg(TTR-INSR)L2Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
abnormal pancreatic islet morphology
|
J:91350
|
increased pancreatic beta cell mass
|
J:91350
|
Insrtm1Dac/Insrtm1Dac Tg(TTR-INSR)L3Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
abnormal pancreatic islet morphology
|
J:91350
|
increased pancreatic beta cell mass
|
J:91350
|
Insrtm1Khn/Insrtm1Khn Pdx1tm1Ted/Pdx1+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased pancreatic beta cell mass
|
J:92861
|
Insrtm1Khn/Insrtm1Khn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6J * DBA/2 * FVB)
|
increased pancreatic beta cell mass
|
J:63878,
J:92861
|
pancreatic islet hyperplasia
|
J:92861
|
Insrtm1Khn/Insrtm1Khn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
increased pancreatic beta cell mass
|
J:121640
|
Insrtm1Khn/Insrtm1Khn Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased pancreatic beta cell mass
|
J:121640
|
Insrtm1Khn/Insrtm1Khn Tg(Slc2a4-cre)546Dac/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB)
|
abnormal pancreatic beta cell morphology
|
J:169404
|
abnormal pancreatic islet morphology
|
J:169404
|
decreased pancreatic beta cell number
|
J:169404
|
Invsinv/Invsinv
(involves: FVB/N)
|
abnormal pancreatic acinar cell morphology
|
J:50117
|
abnormal pancreatic acinus morphology
|
J:50117
|
abnormal pancreatic islet morphology
|
J:50117
|
decreased pancreatic acinar cell number
|
J:50117
|
dilated pancreatic duct
|
J:50117
|
disorganized pancreatic islets
|
J:50117
|
pancreatic islet hyperplasia
|
J:50117
|
Invsinv/Invsinv
(FVB/N-Invsinv)
|
abnormal pancreas morphology
|
J:48533
|
Irs1tm1Jos/Irs1+ Irs2tm2Mfw/Irs2tm2Mfw Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:93415
|
Irs1tm1Jos/Irs1tm1Jos Irs3tm1Lhd/Irs3tm1Lhd
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased pancreatic beta cell mass
|
J:80976
|
pancreatic islet hyperplasia
|
J:80976
|
Irs1tm2.1Mfw/Irs1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal pancreatic beta cell morphology
|
J:156999
|
Irs1tm2.1Mfw/Irs1tm2.1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal pancreatic beta cell morphology
|
J:156999
|
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal pancreatic beta cell morphology
|
J:96047
|
decreased pancreatic beta cell mass
|
J:135659,
J:46134
|
decreased pancreatic beta cell number
|
J:94000
|
small pancreatic islets
|
J:96047
|
Irs2tm1Mfw/Irs2tm1Mfw Ptpn1tm1Bbk/Ptpn1tm1Bbk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:87249
|
pancreatic islet hyperplasia
|
J:87249
|
Irs2tm1Mfw/Irs2tm1Mfw Tg(Ins2-Irs2)13Mfw/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:94000
|
Irs2tm1Tka/Irs2tm1Tka
(involves: C57BL/6 * CBA)
|
abnormal pancreatic beta cell morphology
|
J:65485
|
decreased pancreatic beta cell mass
|
J:65485
|
Irs2tm1With/Irs2tm1With Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased pancreatic beta cell number
|
J:97406
|
Irs2tm1With/Irs2tm1With Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased pancreatic beta cell mass
|
J:97406
|
Irs2tm2Mfw/Irs2tm2Mfw Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:93415
|
Irs2tm2Tka/Irs2tm2Tka Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6)
|
decreased pancreatic beta cell mass
|
J:93416
|
Isl1tm1Tmj/Isl1tm1Tmj
(involves: 129S1/Sv)
|
abnormal pancreas mesenchyme morphology
|
J:37641
|
abnormal pancreas morphology
|
J:37641
|
abnormal pancreatic acinar cell morphology
|
J:37641
|
abnormal pancreatic islet morphology
|
J:37641
|
absent pancreatic alpha cells
|
J:37641
|
Itga3tm1Jak/Itga3tm1Jak Itga6tm1Egl/Itga6tm1Egl
(involves: 129S2/SvPas * 129S4/SvJae)
|
pancreas hypoplasia
|
J:56564
|
Itgb1tm1Ref/Itgb1tm1Ref Tg(Ins2-cre)1Heed/?
(involves: 129 * C57BL/6 * CBA)
|
disorganized pancreatic islets
|
J:122649
|
increased pancreatic alpha cell number
|
J:122649
|
Itpr2tm1Kmik/Itpr2tm1Kmik Itpr3tm1Kmik/Itpr3tm1Kmik
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal pancreatic acinar cell morphology
|
J:101380
|
pancreatic acinar cell zymogen granule accumulation
|
J:101380
|
Jazf1tm1c(EUCOMM)Wtsi/Jazf1tm1c(EUCOMM)Wtsi Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJaeSor * C57BL/6N * CBA/J)
|
decreased pancreatic beta cell mass
|
J:303318
|
Katnal2em1(IMPC)Tcp/Katnal2em1(IMPC)Tcp
(C57BL/6N-Katnal2em1(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Kcmf1Gt(XE080)Byg/Kcmf1Gt(XE080)Byg Tg(Mt1-Tgfa)149Bri/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
abnormal pancreas morphology
|
J:162125
|
decreased pancreas weight
|
J:162125
|
Kcnh6em1Jkya/Kcnh6em1Jkya
(involves: C57BL/6N)
|
decreased pancreatic beta cell mass
|
J:271003
|
decreased pancreatic beta cell number
|
J:271003
|
increased pancreatic alpha cell number
|
J:271003
|
pancreas necrosis
|
J:271003
|
Kdm5atm1Kael/Kdm5atm1Kael Men1tm2.1Mmey/Men1tm2.1Mmey Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA/J * FVB/N)
|
abnormal pancreatic islet morphology
|
J:175625
|
increased insulinoma incidence
|
J:175625
|
pancreatic islet hyperplasia
|
J:175625
|
Kif5btm1Njen/Kif5btm1.1Njen Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6N * DBA * SJL)
|
abnormal pancreatic beta cell morphology
|
J:170198
|
increased pancreatic beta cell number
|
J:170198
|
small pancreatic islets
|
J:170198
|
Klkl/Klkl
(involves: C3H/J * C57BL/6J)
|
abnormal pancreatic beta cell morphology
|
J:66078
|
small pancreatic islets
|
J:66078
|
Klhl6em1(IMPC)Ccpcz/Klhl6em1(IMPC)Ccpcz
(C57BL/6NCrl-Klhl6em1(IMPC)Ccpcz/Ccpcz)
|
abnormal pancreas morphology
|
J:211773
|
enlarged pancreas
|
J:211773
|
Kmt2bGena263/Kmt2b+
(involves: BALB/c * C3H/HeH)
|
enlarged pancreatic islets
|
J:203736
|
Krastm1.1Khai/Kras+ Tg(Pdx1-cre)6Tuv/0 Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:276349
|
Krastm1Bbd/Kras+ Trp53tm1Brd/Trp53+ Tg(Cela1-tTA)#Eps/? Tg(tetO-cre)3Jig/?
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:119988
|
Krastm1Bbd/Krastm1Bbd Tg(Cela1-tTA)#Eps/? Tg(tetO-cre)3Jig/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:119988
|
Krastm4Tyj/Kras+ Gt(ROSA)26Sortm1(sb13)Tuv/Gt(ROSA)26Sor+ Tg(Pdx1-cre)6Tuv/0 TgTn(sb-T2/Onc)#Dla/0
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N)
|
increased pancreas tumor incidence
|
J:186717
|
increased pancreatic ductal adenocarcinoma incidence
|
J:186717
|
increased pancreatic intraepithelial neoplasia incidence
|
J:186717
|
Krastm4Tyj/Kras+ Krt19tm1(cre/ERT)Ggu/Krt19+ Ptentm2Mak/Ptentm2Mak
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:254370
|
Krastm4Tyj/Kras+ Pdpk1tm1Mlw/Pdpk1tm1Mlw Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129S4/SvJae)
|
abnormal pancreas morphology
|
J:197054
|
Krastm4Tyj/Kras+ Ptentm1Hwu/Pten+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
increased pancreas tumor incidence
|
J:164210
|
increased pancreatic ductal adenocarcinoma incidence
|
J:164210
|
increased pancreatic intraepithelial neoplasia incidence
|
J:164210
|
pancreatic acinar-to-ductal metaplasia
|
J:164210
|
Krastm4Tyj/Kras+ Ptentm1Hwu/Ptentm1Hwu Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA)
|
abnormal exocrine pancreas morphology
|
J:164210
|
exocrine pancreas atrophy
|
J:164210
|
increased pancreatic ductal adenocarcinoma incidence
|
J:164210
|
increased pancreatic intraepithelial neoplasia incidence
|
J:164210
|
pancreatic acinar-to-ductal metaplasia
|
J:164210
|
Krastm4Tyj/Kras+ Ptf1atm1(cre)Hnak/Ptf1a+ Ube2ftm1c(EUCOMM)Hmgu/Ube2ftm1c(EUCOMM)Hmgu
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
small pancreas
|
J:348744
|
Krastm4Tyj/Kras+ Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal pancreatic acinar cell morphology
|
J:262746
|
enlarged pancreas
|
J:87973
|
increased pancreatic ductal adenocarcinoma incidence
|
J:116130,
J:87973
|
increased pancreatic intraepithelial neoplasia incidence
|
J:262746
|
Krastm4Tyj/Kras+ Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:116129
|
Krastm4Tyj/Kras+ Ptf1atm1.1(cre)Cvw/Ptf1a+
(B6.129(Cg)-Krastm4Tyj Ptf1atm1.1(cre)Cvw)
|
increased pancreas tumor incidence
|
J:138959
|
increased pancreas weight
|
J:138959
|
increased pancreatic ductal adenocarcinoma incidence
|
J:138959
|
increased pancreatic intraepithelial neoplasia incidence
|
J:138959
|
Krastm4Tyj/Kras+ Ptf1atm1.1(cre)Cvw/Ptf1a+ Tg(MUC1)79.24Gend/0
(B6.Cg-Krastm4Tyj Ptf1atm1.1(cre)Cvw Tg(MUC1)79.24Gend)
|
increased pancreas tumor incidence
|
J:138959,
J:234412
|
increased pancreatic ductal adenocarcinoma incidence
|
J:138959
|
increased pancreatic intraepithelial neoplasia incidence
|
J:138959,
J:234412
|
Krastm4Tyj/Kras+ Raf1tm2Bacc/Raf1tm2Bacc Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:197054
|
Krastm4Tyj/Kras+ Smad4tm1Rdp/Smad4tm1Rdp Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:116130
|
pancreas cyst
|
J:116130
|
Krastm4Tyj/Kras+ Smad4tm1Rdp/Smad4tm1Rdp Tg(Pdx1-cre)89.1Dam/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA * FVB/N)
|
pancreas cyst
|
J:116130
|
Krastm4Tyj/Kras+ Stk11tm1.1Gne/Stk11tm1.1Gne
(involves: 129S4/SvJae * C57BL/6N)
|
pancreas cyst
|
J:195229
|
Krastm4Tyj/Kras+ Tg(CAG-Bgeo,-tsA58T)T26Ichi/0 Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:214846
|
increased pancreatic intraepithelial neoplasia incidence
|
J:214846
|
pancreatic acinar-to-ductal metaplasia
|
J:214846
|
Krastm4Tyj/Kras+ Tg(Cela1-cre/ERT)1Dam/0
(involves: 129S4/SvJae)
|
increased pancreas tumor incidence
|
J:197054
|
Krastm4Tyj/Kras+ Tg(Erbb2*)#Maed/0 Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
abnormal pancreatic acinar cell morphology
|
J:262746
|
increased pancreatic intraepithelial neoplasia incidence
|
J:262746
|
Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/?
(involves: 129S4/SvJae * FVB/N)
|
enlarged pancreas
|
J:87973
|
increased pancreatic ductal adenocarcinoma incidence
|
J:87973
|
Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal pancreatic duct morphology
|
J:214846
|
increased pancreatic intraepithelial neoplasia incidence
|
J:276349,
J:214846,
J:98936
|
Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0 Trp53tm1Gev/Trp53tm1Gev
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:220300
|
Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0 Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:276349
|
Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0 Trp53tm3Tyj/Trp53+
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:166678
|
Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0 Usp9xtm1Tuv/Y
(involves: 129S4/SvJae * FVB/N)
|
increased pancreas tumor incidence
|
J:186717
|
increased pancreatic intraepithelial neoplasia incidence
|
J:186717
|
Krastm4Tyj/Kras+ Tg(Pdx1-cre)6Tuv/0 Usp9xtm1Tuv/Usp9x+
(involves: 129S4/SvJae * FVB/N)
|
increased pancreas tumor incidence
|
J:186717
|
increased pancreatic intraepithelial neoplasia incidence
|
J:186717
|
Krastm4Tyj/Kras+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
enlarged pancreatic islets
|
J:87196
|
increased pancreatic ductal adenocarcinoma incidence
|
J:116130,
J:164210
|
increased pancreatic intraepithelial neoplasia incidence
|
J:87196,
J:164210
|
pancreatic acinar-to-ductal metaplasia
|
J:164210
|
Krastm4Tyj/Kras+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N)
|
increased pancreas tumor incidence
|
J:108298
|
Krastm4Tyj/Kras+ Tgfbr2tm1.2Hlm/Tgfbr2+ Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased pancreas tumor incidence
|
J:116129
|
increased pancreatic ductal adenocarcinoma incidence
|
J:116129
|
increased pancreatic intraepithelial neoplasia incidence
|
J:116129
|
Krastm4Tyj/Kras+ Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased pancreas tumor incidence
|
J:116129
|
increased pancreatic ductal adenocarcinoma incidence
|
J:116129
|
increased pancreatic intraepithelial neoplasia incidence
|
J:116129
|
Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N)
|
increased pancreas tumor incidence
|
J:108298
|
increased pancreatic ductal adenocarcinoma incidence
|
J:108298
|
Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53tm1Brn Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N)
|
increased pancreas tumor incidence
|
J:108298
|
increased pancreatic ductal adenocarcinoma incidence
|
J:108298
|
Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53tm2Tyj Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:197054
|
Krastm4Tyj/Kras+ Trp53tm2Tyj/Trp53+ Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:98936
|
increased pancreatic intraepithelial neoplasia incidence
|
J:98936
|
Krastm4Tyj/Krastm4Tyj Bhlha15tm3(cre/ERT2)Skz/Bhlha15+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:142189
|
Krastm4Tyj/Krastm4Tyj Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129S4/SvJae)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:162125
|
Krastm4Tyj/Krastm4Tyj Tg(Cela1-cre/ERT2)1Stof/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:142189
|
Krastm4Tyj/Krastm4Tyj Tg(Cela1-cre/ERT)1Dam/0
(involves: 129S4/SvJae)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:142188
|
Krastm4Tyj/Krastm4Tyj Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:151781
|
pancreas cyst
|
J:151781
|
Krastm4Tyj/Krastm4Tyj Tg(Pdx1-cre/Esr1*)35.10Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:142188
|
Krastm4Tyj/Krastm4Tyj Trim33tm1Los/Trim33tm1Los Tg(Pdx1-cre)89.1Dam/0
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal pancreas morphology
|
J:151781
|
dilated pancreatic duct
|
J:151781
|
disorganized pancreatic islets
|
J:151781
|
increased pancreas tumor incidence
|
J:151781
|
increased pancreatic intraepithelial neoplasia incidence
|
J:151781
|
pancreas cyst
|
J:151781
|
pancreas hyperplasia
|
J:151781
|
Krastm5Tyj/Kras+ Pdx1tm1.1(flpo)Most/Pdx1+ Trp53tm1.1Dgk/Trp53+
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * Black Swiss * C57BL/6)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:248550
|
increased pancreatic intraepithelial neoplasia incidence
|
J:248550
|
Krastm5Tyj/Kras+ Pdx1tm1.1(flpo)Most/Pdx1+ Trp53tm1.1Dgk/Trp53tm1.1Dgk
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * Black Swiss * C57BL/6)
|
increased pancreatic ductal adenocarcinoma incidence
|
J:248550
|
increased pancreatic intraepithelial neoplasia incidence
|
J:248550
|
Lamtor5tm1Lye/Lamtor5tm1Lye Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA)
|
abnormal pancreatic islet morphology
|
J:258406
|
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas)
|
pancreas fibrosis
|
J:262891
|
Lepob/Lepob
(involves: C57BL/6J)
|
enlarged pancreatic islets
|
J:219118
|
Lepob/Lepob
(B6.Cg-Lepob/J)
|
enlarged pancreatic islets
|
J:5400
|
Lepob/Lepob
(D2.Cg-Lepob/Chua)
|
abnormal pancreatic islet morphology
|
J:78850
|
decreased pancreatic beta cell number
|
J:78850
|
increased pancreatic beta cell number
|
J:78850
|
Lepob/Lepob
(involves: 129X1/SvJ * C57BL/6)
|
increased pancreas weight
|
J:107169
|
Lepob/Lepob
(involves: 129 * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:121534
|
enlarged pancreatic islets
|
J:121534
|
increased pancreatic islet number
|
J:121534
|
Lepob/Lepob
(BKS.Cg-Lepob/J)
|
small pancreatic islets
|
J:5400
|
Lepob/Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs)
|
abnormal pancreatic beta cell morphology
|
J:7702
|
increased pancreatic beta cell mass
|
J:7702
|
increased pancreatic beta cell number
|
J:7702
|
Lepob/Lepob
(involves: BTBR * C57BL/6 * V stock)
|
decreased pancreatic beta cell number
|
J:65486
|
disorganized pancreatic islets
|
J:65486
|
pancreatic islet hyperplasia
|
J:65486
|
Lepob/Lepob
(BTBR.Cg-Lepob/WiscJ)
|
abnormal pancreatic islet morphology
|
J:106121
|
decreased pancreatic beta cell mass
|
J:106121
|
small pancreatic islets
|
J:106121
|
Lepob/Lepob Mir375tm1Stf/Mir375tm1Stf
(B6.Cg-Mir375tm1Stf Lepob)
|
decreased pancreatic beta cell mass
|
J:147572
|
decreased pancreatic beta cell number
|
J:147572
|
increased pancreatic alpha cell number
|
J:147572
|
Lepob/Lepob Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
increased pancreas weight
|
J:107169
|
Lepob/Lepob Ppargtm2Avp/Ppargtm2Avp
(involves: 129 * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:121534
|
disorganized pancreatic islets
|
J:121534
|
Lepob/Lepob Tg(Ins2-Mir184)4Mnpy/0
(involves: C57BL/10J)
|
decreased pancreatic beta cell mass
|
J:210552
|
Leprdb-3J/Leprdb-3J
(129P3/J-Leprdb-3J/J)
|
abnormal exocrine pancreas morphology
|
J:6337
|
increased pancreatic alpha cell number
|
J:6337
|
increased pancreatic beta cell number
|
J:6337
|
pancreatic islet hyperplasia
|
J:6337
|
Leprdb-5J/Leprdb-5J
(NOD/ShiLtJ-Leprdb-5J/LtJ)
|
degranulated pancreatic beta cells
|
J:87061
|
pancreatic islet hyperplasia
|
J:87061
|
Leprdb-5J/Leprdb-5J
(NOD/ShiLt-Leprdb-5J)
|
abnormal pancreatic islet morphology
|
J:118305
|
degranulated pancreatic beta cells
|
J:118305
|
Leprdb-9J/Leprdb-9J
(involves: C57BL/6 * CBA * SWR)
|
abnormal pancreatic beta cell morphology
|
J:129982
|
degranulated pancreatic beta cells
|
J:129982
|
Leprdb-dmpg/Leprdb-dmpg
(involves: B10.D2-H8b/Sn * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:83762
|
Leprdb-rlpy/Leprdb-rlpy
(involves: NU/J)
|
abnormal pancreatic beta cell morphology
|
J:83762
|
Leprdb-rtnd/Leprdb-rtnd
(involves: C57BL/6 * CBA/J)
|
abnormal pancreatic beta cell morphology
|
J:83762
|
Leprdb/Lepr+ Tg(APPswe,PSEN1dE9)85Dbo/0
(involves: C3H * C57BL/6 * C57BLKS/J)
|
increased pancreatic beta cell mass
|
J:186924
|
Leprdb/Leprdb
(involves: C57BLKS/J)
|
abnormal pancreatic beta cell morphology
|
J:96047
|
abnormal pancreatic islet morphology
|
J:96047
|
Leprdb/Leprdb
(FVB.BKS-Leprdb)
|
increased pancreatic beta cell number
|
J:78850
|
pancreatic islet hyperplasia
|
J:78850
|
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/Jcl)
|
increased pancreatic beta cell mass
|
J:156725
|
Leprdb/Leprdb Ptentm1Hwu/Ptentm1Hwu Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * C57BLKS/J * DBA)
|
abnormal pancreatic islet morphology
|
J:170206
|
Leprm1Clo/Leprm1Clo
(STOCK Leprm1Clo/GrsrJ)
|
pancreatic islet hyperplasia
|
J:232775
|
Lipetm1Land/Lipetm1Land
(involves: 129 * C57BL/6J)
|
increased pancreatic beta cell mass
|
J:85540
|
pancreatic islet hyperplasia
|
J:85540
|
Lipetm2Rze/Lipetm2Rze Tg(Ins2-cre)25Mgn/?
(involves: 129 * C57BL/6 * DBA)
|
abnormal pancreatic beta cell morphology
|
J:144744
|
increased pancreatic beta cell mass
|
J:144744
|
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL)
|
abnormal pancreatic acinar cell morphology
|
J:307289
|
Ltatm1Dch/Ltatm1Dch Tg(Ins2-Cxcl13)1Cys/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:110548
|
Lztfl1tm1.2Zpl/Lztfl1tm1.2Zpl Tg(Camk2a-cre)#Stl/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL * C57BL/6 * C57BL/6N)
|
abnormal pancreas morphology
|
J:287261
|
pancreatic islet hyperplasia
|
J:287261
|
Lztfl1tm1.3Zpl/Lztfl1tm1.3Zpl
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N)
|
abnormal pancreas morphology
|
J:287261
|
pancreatic islet hyperplasia
|
J:287261
|
Maddtm1Bpra/Maddtm1Bpra Tg(Ins2-cre/ERT)1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pancreas morphology
|
J:225256
|
abnormal pancreatic beta cell morphology
|
J:225256
|
abnormal pancreatic islet morphology
|
J:225256
|
Mafatm1Staka/Mafatm1Staka
(involves: ICR)
|
abnormal pancreatic islet morphology
|
J:99126
|
Mafbm1Gsb/Mafbm1Gsb
(B6.Cg-Mafbm1Gsb)
|
abnormal endocrine pancreas development
|
J:132598
|
Man2b1tm1Psa/Man2b1tm1Psa
(involves: 129 * C57BL/6J)
|
abnormal pancreatic acinar cell morphology
|
J:56659
|
Manftm1a(KOMP)Wtsi/Manftm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N * ICR)
|
abnormal pancreatic beta cell differentiation
|
J:211812
|
decreased pancreatic beta cell mass
|
J:211812
|
decreased pancreatic beta cell number
|
J:211812
|
decreased pancreatic islet number
|
J:211812
|
Mapk8tm1Rjd/Mapk8tm1Rjd Mapk9tm2.1Rjd/Mapk9tm2.1Rjd Lyz2tm1(cre)Ifo/Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd)
|
small pancreatic islets
|
J:192551
|
Mapk8ip1tm1Rjd/Mapk8ip1tm1Rjd Mapk8ip2tm1Rjd/Mapk8ip2tm1Rjd
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal pancreatic beta cell morphology
|
J:152617
|
Mbd2tm1Bh/Mbd2tm1Bh
(NOD.129P2(B6)-Mbd2tm1Bh)
|
abnormal pancreatic islet morphology
|
J:323838
|
Men1tm1.1Ctre/Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N))
|
increased pancreas tumor incidence
|
J:67128
|
pancreatic islet hyperplasia
|
J:67128
|
Men1tm1.1Ctre/Men1+
(involves: 129S6/SvEvTac * FVB/N)
|
increased pancreatic islet cell adenoma incidence
|
J:133299
|
Men1tm1.1Ctre/Men1+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased pancreas tumor incidence
|
J:120835
|
Men1tm1.1Ctre/Men1+ Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
increased pancreas tumor incidence
|
J:133299
|
Men1tm1.1Gfk/Men1+
(involves: 129T2/SvEms * C57BL/6)
|
abnormal pancreas morphology
|
J:116086
|
increased glucagonoma incidence
|
J:116086
|
increased insulinoma incidence
|
J:116086
|
increased pancreas adenoma incidence
|
J:116086
|
pancreatic islet hyperplasia
|
J:116086
|
Men1tm1.2Ctre/Men1+ Tg(Ins2-cre)1Dh/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
increased insulinoma incidence
|
J:85042
|
Men1tm1.2Ctre/Men1+ Tg(Ins2-cre)1Heed/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
increased insulinoma incidence
|
J:85042
|
Men1tm1.2Ctre/Men1+ Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
increased insulinoma incidence
|
J:85042
|
Men1tm1.2Ctre/Men1tm1.2Ctre Tg(Ins2-cre)1Dh/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
increased insulinoma incidence
|
J:85042
|
pancreatic islet hyperplasia
|
J:85042
|
Men1tm1.2Ctre/Men1tm1.2Ctre Tg(Ins2-cre)1Heed/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
increased insulinoma incidence
|
J:85042
|
pancreatic islet hyperplasia
|
J:85042
|
Men1tm1.2Ctre/Men1tm1.2Ctre Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
increased insulinoma incidence
|
J:85042
|
pancreatic islet hyperplasia
|
J:85042
|
Men1tm1.2Zqw/Men1tm1.2Zqw Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
increased insulinoma incidence
|
J:85133
|
pancreatic islet hyperplasia
|
J:85133
|
Men1tm1Ctre/Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N))
|
abnormal pancreas morphology
|
J:67128
|
abnormal pancreatic acinar cell morphology
|
J:67128
|
increased pancreas tumor incidence
|
J:67128
|
pancreas cyst
|
J:67128
|
pancreas necrosis
|
J:67128
|
pancreatic islet hyperplasia
|
J:67128
|
Men1tm1Ctre/Men1tm1Ctre Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)
|
abnormal pancreatic islet morphology
|
J:146440
|
enlarged pancreatic islets
|
J:146440
|
increased insulinoma incidence
|
J:146440
|
pancreatic islet hyperplasia
|
J:146440
|
Men1tm1Gfk/Men1tm1Gfk Tg(Ins2-cre)25Mgn/0
(involves: 129T2/SvEms * C57BL/6 * C57BL/6J * DBA)
|
increased insulinoma incidence
|
J:89898
|
increased pancreas tumor incidence
|
J:89898
|
pancreatic islet hyperplasia
|
J:89898
|
Men1tm1Mmey/Men1+
(involves: 129S6/SvEvTac * FVB/N)
|
increased pancreatic beta cell number
|
J:102494
|
Men1tm1Rvt/Men1+
(involves: 129 * C57BL/6)
|
increased pancreatic islet cell adenoma incidence
|
J:191261
|
pancreatic islet hyperplasia
|
J:191261
|
Men1tm1Zqw/Men1+
(involves: 129/Sv * 129P2/OlaHsd)
|
increased glucagonoma incidence
|
J:85302
|
increased insulinoma incidence
|
J:85302
|
increased pancreas tumor incidence
|
J:85302
|
increased pancreatic islet cell adenoma incidence
|
J:85302
|
increased pancreatic islet cell carcinoma incidence
|
J:85302
|
Men1tm2.1Gfk/Men1+
(involves: 129T2/SvEms * C57BL/6)
|
increased insulinoma incidence
|
J:116086
|
increased pancreas adenoma incidence
|
J:116086
|
Men1tm2.1Mmey/Men1tm2.1Mmey Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA/J * FVB/N)
|
abnormal pancreatic islet morphology
|
J:175625
|
increased insulinoma incidence
|
J:175625
|
pancreatic islet hyperplasia
|
J:175625
|
Meox2tm1(cre)Sor/Meox2+ Ptrh2tm1Eruo/Ptrh2tm1.1Eruo
(B6.Cg-Ptrh2tm1Eruo Ptrh2tm1.1Eruo Meox2tm1(cre)Sor)
|
abnormal pancreatic acinar cell morphology
|
J:220518
|
Mettm1Sst/Mettm1Sst Tg(Pdx1-cre)89.1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pancreatic islet morphology
|
J:196854
|
decreased pancreatic beta cell mass
|
J:196854
|
Mgmttm1Lds/Mgmttm1Lds
(involves: 129P2/OlaHsd * C57BL/6)
|
small pancreatic islets
|
J:118148
|
Mgrn1em1(IMPC)Tcp/Mgrn1em1(IMPC)Tcp
(C57BL/6NCrl-Mgrn1em1(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Mib1tm2Kong/Mib1tm2Kong Foxa2tm3.1(icre)Heli/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal pancreas development
|
J:184814
|
abnormal pancreatic beta cell differentiation
|
J:184814
|
absent pancreatic duct
|
J:184814
|
Mir26a-1em1Xfu/Mir26a-1em1Xfu Mir26a-2em1Xfu/Mir26a-2em1Xfu
(involves: C57BL/6)
|
abnormal pancreatic alpha cell morphology
|
J:286108
|
decreased pancreatic islet number
|
J:286108
|
enlarged pancreatic islets
|
J:286108
|
pancreatic islet hyperplasia
|
J:286108
|
Mir184tm1Ics/Mir184tm1Ics
(Not Specified)
|
increased pancreatic beta cell mass
|
J:210552
|
Mir216aem1Uf/Mir216aem1Uf
(C57BL/6-Mir216aem1Uf)
|
pancreatic acinar-to-ductal metaplasia
|
J:278847
|
Mir216aem1Uf/Mir216aem1Uf Tg(Ela-KRAS*G12D)9Eps/0
(involves: C57BL/6N * FVB)
|
increased pancreas tumor incidence
|
J:278847
|
Mir216aem2Uf/Mir216aem2Uf
(C57BL/6-Mir216aem2Uf)
|
pancreatic acinar-to-ductal metaplasia
|
J:278847
|
Mir216aem2Uf/Mir216aem2Uf Tg(Ela-KRAS*G12D)9Eps/0
(involves: C57BL/6N * FVB)
|
increased pancreas tumor incidence
|
J:278847
|
Mir216bem1Uf/Mir216bem1Uf
(C57BL/6-Mir216bem1Uf)
|
pancreatic acinar-to-ductal metaplasia
|
J:278847
|
Mir216bem1Uf/Mir216bem1Uf Tg(Ela-KRAS*G12D)9Eps/0
(involves: C57BL/6N * FVB)
|
increased pancreas tumor incidence
|
J:278847
|
Mir217em1Uf/Mir217em1Uf
(C57BL/6-Mir217em1Uf)
|
pancreatic acinar-to-ductal metaplasia
|
J:278847
|
Mir217em1Uf/Mir217em1Uf Tg(Ela-KRAS*G12D)9Eps/0
(involves: C57BL/6N * FVB)
|
increased pancreas tumor incidence
|
J:278847
|
Mir217em2Uf/Mir217em2Uf
(C57BL/6-Mir217em2Uf)
|
pancreatic acinar-to-ductal metaplasia
|
J:278847
|
Mir217em2Uf/Mir217em2Uf Tg(Ela-KRAS*G12D)9Eps/0
(involves: C57BL/6N * FVB)
|
increased pancreas tumor incidence
|
J:278847
|
Mir375tm1Stf/Mir375tm1Stf
(B6.129-Mir375tm1Stf)
|
abnormal pancreatic islet morphology
|
J:147572
|
decreased pancreatic beta cell mass
|
J:147572
|
decreased pancreatic beta cell number
|
J:147572
|
disorganized pancreatic islets
|
J:147572
|
increased pancreatic alpha cell number
|
J:147572
|
Mir802em3Gpt/Mir802em3Gpt Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6JGpt * DBA)
|
abnormal pancreatic beta cell differentiation
|
J:287584
|
increased pancreatic beta cell number
|
J:287584
|
MitfTg(Tff3-Tmem207)2Tamo/Mitf+
(involves: C57BL/6)
|
pancreas cyst
|
J:244533
|
MitfTg(Tff3-Tmem207)2Tamo/MitfTg(Tff3-Tmem207)2Tamo
(involves: C57BL/6)
|
pancreas cyst
|
J:244533
|
Mmp15tm1b(KOMP)Wtsi/Mmp15tm1b(KOMP)Wtsi
(C57BL/6N-Mmp15tm1b(KOMP)Wtsi/Bay)
|
abnormal pancreas morphology
|
J:211773
|
Mmuttm1Cpv/Mmuttm1Cpv
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
abnormal exocrine pancreas morphology
|
J:147313
|
abnormal pancreas morphology
|
J:147313
|
abnormal pancreatic beta cell morphology
|
J:147313
|
Mnx1tm1Jhk/Mnx1tm1Jhk
(involves: 129P2/OlaHsd)
|
abnormal pancreas development
|
J:57314
|
abnormal pancreatic delta cell morphology
|
J:57314
|
abnormal pancreatic islet morphology
|
J:57314
|
decreased pancreatic beta cell number
|
J:57314
|
small pancreatic islets
|
J:57314
|
Mnx1tm1Tmj/Mnx1tm1Tmj
(involves: 129S1/Sv)
|
abnormal pancreas development
|
J:57317
|
abnormal pancreatic islet morphology
|
J:57317
|
decreased pancreatic beta cell number
|
J:57317
|
decreased pancreatic delta cell number
|
J:57317
|
Mogstm1(KOMP)Vlcg/Mogs+
(C57BL/6N-Mogstm1(KOMP)Vlcg/Bay)
|
abnormal pancreas morphology
|
J:211773
|
Morc2aem1(IMPC)Wtsi/Morc2aem1(IMPC)Wtsi
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu)
|
abnormal dorsal pancreas topology
|
J:239583
|
absent ventral pancreas
|
J:239583
|
small dorsal pancreas
|
J:239583
|
small pancreas
|
J:239583
|
small ventral pancreas
|
J:239583
|
Mpgtm1Lds/Mpgtm1Lds
(involves: 129P2/OlaHsd * C57BL/6)
|
small pancreatic islets
|
J:118148
|
Mplkiptm1.1(KOMP)Vlcg/Mplkiptm1.1(KOMP)Vlcg
(C57BL/6N-Mplkiptm1.1(KOMP)Vlcg/Ucd)
|
abnormal pancreas morphology
|
J:211773
|
Mpv17lem1Riida/Mpv17lem1Riida
(C57BL/6N-Mpv17lem1Riida)
|
enlarged pancreatic islets
|
J:319850
|
Mt1tm1Bri/Mt1tm1Bri Mt2tm1Bri/Mt2tm1Bri
(involves: 129S7/SvEvBrd)
|
abnormal pancreas morphology
|
J:34407
|
Myctm2.1Atp/Myctm2.1Atp Tg(Pdx1-cre)1Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
abnormal pancreas development
|
J:146087
|
abnormal pancreas morphology
|
J:146087
|
abnormal pancreas size
|
J:146087
|
abnormal pancreatic acinar cell morphology
|
J:146087
|
abnormal pancreatic acinus morphology
|
J:146087
|
abnormal pancreatic duct morphology
|
J:146087
|
absent pancreatic acinar cells
|
J:146087
|
decreased pancreas weight
|
J:146087
|
pancreas hypoplasia
|
J:146087
|
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal pancreatic beta cell morphology
|
J:148283
|
decreased pancreatic beta cell mass
|
J:148283
|
small pancreatic islets
|
J:148283
|
Myriptm1Tiz/Myriptm1Tiz
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal pancreatic beta cell morphology
|
J:258210
|
abnormal pancreatic islet morphology
|
J:258210
|
Myt1tm1Ggu/Myt1tm1.1Ggu Tg(Pdx1-cre)89.1Dam/?
(involves: 129 * C57BL/6 * CBA * CD-1 * SJL)
|
abnormal pancreas development
|
J:127471
|
Ncoa5tm1Hxia/Ncoa5+
(involves: 129 * C57BL/6)
|
decreased pancreatic islet number
|
J:207622
|
small pancreatic islets
|
J:207622
|
Ndrg2tm1Kmori/Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
increased pancreas tumor incidence
|
J:210264
|
Neurod1tm1Mjts/Neurod1tm1Mjts
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal pancreatic acinar cell morphology
|
J:43010
|
abnormal pancreatic beta cell morphology
|
J:43010
|
absent pancreatic islets
|
J:43010
|
decreased pancreatic alpha cell number
|
J:43010
|
decreased pancreatic beta cell number
|
J:43010
|
decreased pancreatic delta cell number
|
J:43010
|
pancreatic acinar cell zymogen granule accumulation
|
J:43010
|
Neurog3tm1(EGFP)Khk/Neurog3tm1(EGFP)Khk
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal pancreatic alpha cell morphology
|
J:77398
|
abnormal pancreatic beta cell morphology
|
J:77398
|
abnormal pancreatic delta cell morphology
|
J:77398
|
Neurog3tm1.1(cre/ERT)Ggu/Neurog3+ Pdx1tm1Macd/Pdx1+ Tg(tetO-Myt1)2Ggu/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
|
abnormal pancreatic islet morphology
|
J:136131
|
Neurog3tm1Fgu/Neurog3tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal pancreatic acinar cell morphology
|
J:60642
|
absent pancreatic alpha cells
|
J:60642
|
absent pancreatic beta cells
|
J:60642
|
absent pancreatic islets
|
J:60642
|
pancreatic acinar cell zymogen granule accumulation
|
J:60642
|
Neurog3tm1Fgu/Neurog3tm3.1Ggr Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL)
|
abnormal pancreatic islet morphology
|
J:161480
|
small pancreatic islets
|
J:161480
|
Neurog3tm1Heed/Neurog3tm1Heed
(Not Specified)
|
abnormal endocrine pancreas morphology
|
J:147764
|
Neurog3tm3.1Ggr/Neurog3tm3.1Ggr Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL)
|
abnormal pancreatic islet morphology
|
J:161480
|
small pancreatic islets
|
J:161480
|
Nfatc3tm1Glm/Nfatc3tm1Glm Nfatc4tm1Grc/Nfatc4tm1Grc
(involves: 129S2/SvPas)
|
annular pancreas
|
J:109139
|
Nfil3tm1.1(KOMP)Vlcg/Nfil3tm1.1(KOMP)Vlcg
(C57BL/6N-Nfil3tm1.1(KOMP)Vlcg/Ucd)
|
abnormal pancreas morphology
|
J:211773
|
Nidd5BALB/cA/Nidd5TSOD
(involves: BALB/cA * TSOD)
|
abnormal pancreatic beta cell morphology
|
J:55285
|
Nidd5TSOD/Nidd5TSOD
(involves: BALB/cA * TSOD)
|
abnormal pancreatic beta cell morphology
|
J:55285
|
NiddsSJL/NBom/?
(involves: NZO/HlBom * SJL/NBom)
|
abnormal pancreatic beta cell morphology
|
J:78920
|
Nkx2-2tm1Jlr/Nkx2-2tm1Jlr
(involves: 129X1/SvJ)
|
abnormal pancreatic beta cell differentiation
|
J:48576
|
abnormal pancreatic islet morphology
|
J:48576
|
absent pancreatic beta cells
|
J:48576
|
decreased pancreatic alpha cell number
|
J:48576
|
decreased PP cell number
|
J:48576
|
Nkx2-2tm1Jlr/Nkx2-2tm1Jlr Nkx6-1tm1Jlr/Nkx6-1tm1Jlr
(involves: 129 * 129X1/SvJ * C57BL/6J)
|
decreased pancreatic alpha cell number
|
J:65594
|
decreased pancreatic beta cell number
|
J:65594
|
decreased PP cell number
|
J:65594
|
disorganized pancreatic islets
|
J:65594
|
Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * C57BL/6J * SJL)
|
decreased pancreatic beta cell number
|
J:177838
|
disorganized pancreatic islets
|
J:177838
|
increased pancreatic alpha cell number
|
J:177838
|
increased pancreatic epsilon cell number
|
J:177838
|
small pancreatic islets
|
J:177838
|
Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+ Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA/J * SJL)
|
abnormal pancreatic beta cell differentiation
|
J:177838
|
Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+ Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA * SJL)
|
abnormal pancreatic beta cell differentiation
|
J:177838
|
Nkx2-2tm3Suss/Nkx2-2tm3Suss
(involves: 129S6/SvEvTac)
|
abnormal pancreas morphology
|
J:178173
|
Nkx2-2tm5.1Suss/Nkx2-2tm5.1Suss Tg(Pdx1-cre)6Tuv/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * NTac:NIHBS * SJL)
|
decreased pancreatic alpha cell number
|
J:204869
|
decreased pancreatic beta cell number
|
J:204869
|
increased pancreatic epsilon cell number
|
J:204869
|
Nkx3-2tm1Bobh/Nkx3-2tm1Bobh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreas development
|
J:93234
|
Nkx6-1tm1.1Msan/Nkx6-1+ Pdx1tm1Cvw/Pdx1+ Tg(Neurog3-cre)C1Able/0
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal pancreatic islet morphology
|
J:195153
|
decreased pancreatic beta cell number
|
J:195153
|
increased pancreatic alpha cell number
|
J:195153
|
Nkx6-1tm1Jlr/Nkx6-1tm1.1Msan Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Tg(Ins2-cre)25Mgn/0
(involves: 129 * C57BL/6 * DBA * SJL)
|
abnormal pancreatic beta cell differentiation
|
J:195153
|
decreased pancreatic beta cell number
|
J:195153
|
increased pancreatic delta cell number
|
J:195153
|
Nkx6-1tm1Jlr/Nkx6-1tm1.1Msan Tg(CAG-Bgeo/GFP)21Lbe/0 Tg(Neurog3-cre)C1Able/0
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal pancreatic beta cell differentiation
|
J:195153
|
decreased pancreatic beta cell number
|
J:195153
|
increased pancreatic alpha cell number
|
J:195153
|
increased pancreatic delta cell number
|
J:195153
|
increased pancreatic epsilon cell number
|
J:195153
|
Nkx6-1tm1Jlr/Nkx6-1tm1.2Msan
(involves: 129S6/SvEvTac * C57BL * DBA * SJL)
|
decreased pancreatic beta cell number
|
J:195153
|
Nkx6-1tm1Jlr/Nkx6-1tm1Jlr
(involves: 129 * C57BL/6J)
|
decreased pancreatic beta cell number
|
J:65594
|
small pancreatic islets
|
J:65594
|
Nmf15/Nmf15+
(C57BL/6J-Nmf15/J)
|
abnormal pancreas morphology
|
J:82238
|
enlarged pancreatic islets
|
J:82238
|
nmf356/nmf356
(C57BL/6J-nmf356/J)
|
pancreatic islet hyperplasia
|
J:87349
|
Nnattm1.2Geno/Nnat+
(either: 129S2(Cg)-Nnattm1.2Geno or B6.129S2(Cg)-Nnattm1.2Geno)
|
abnormal pancreatic beta cell morphology
|
J:265677
|
abnormal pancreatic islet morphology
|
J:265677
|
Nnmtem1(IMPC)Mbp/Nnmtem1(IMPC)Mbp
(C57BL/6NCrl-Nnmtem1(IMPC)Mbp/Mmucd)
|
abnormal pancreas morphology
|
J:211773
|
Nod2em1(IMPC)Mbp/Nod2em1(IMPC)Mbp
(C57BL/6N-Nod2em1(IMPC)Mbp/MbpMmucd)
|
abnormal pancreas morphology
|
J:211773
|
Notch1tm1Agt/Notch1tm1Agt Notch2tm1Frad/Notch2tm1Frad Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129 * BALB/cJ)
|
abnormal branching involved in pancreas development
|
J:139250
|
abnormal endocrine pancreas morphology
|
J:139250
|
abnormal pancreas development
|
J:139250
|
abnormal pancreatic acinus morphology
|
J:139250
|
abnormal pancreatic bud formation
|
J:139250
|
decreased pancreatic islet number
|
J:139250
|
small pancreas
|
J:139250
|
Nsmce2Gt(AA0032)Wtsi/Nsmce2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pancreas tumor incidence
|
J:227197
|
Ogtem1Dvaa/Y
(C57BL/6J-Ogtem1Dvaa)
|
increased pancreas weight
|
J:353384
|
Onecut1tm1.1Mga/Onecut1tm1.1Mga Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL)
|
abnormal branching involved in pancreas development
|
J:155058
|
abnormal pancreas morphology
|
J:155058
|
abnormal pancreatic acinus morphology
|
J:155058
|
abnormal pancreatic duct morphology
|
J:155058
|
abnormal pancreatic primary cilium morphology
|
J:155058
|
absent pancreatic islets
|
J:155058
|
calcified pancreas
|
J:155058
|
decreased pancreatic acinar cell number
|
J:155058
|
decreased pancreatic alpha cell number
|
J:155058
|
decreased pancreatic beta cell number
|
J:155058
|
decreased pancreatic primary cilium number
|
J:155058
|
dilated pancreatic duct
|
J:155058
|
exocrine pancreas atrophy
|
J:155058
|
pancreas cyst
|
J:155058
|
pancreas fibrosis
|
J:155058
|
pancreatic acinar-to-ductal metaplasia
|
J:155058
|
Onecut1tm1Flem/Onecut1tm1Flem
(involves: 129S1/Sv * 129X1/SvJ * Swiss)
|
abnormal endocrine pancreas development
|
J:121610
|
abnormal pancreas development
|
J:121610,
J:62595
|
abnormal pancreas morphology
|
J:121610
|
abnormal pancreatic islet morphology
|
J:62595
|
absent pancreatic alpha cells
|
J:121610
|
absent pancreatic beta cells
|
J:121610
|
decreased pancreatic alpha cell number
|
J:62595
|
decreased pancreatic beta cell number
|
J:62595
|
decreased pancreatic delta cell number
|
J:62595
|
disorganized pancreatic islets
|
J:62595
|
pancreas hypoplasia
|
J:121610
|
Onecut1tm1Flem/Onecut1tm1Flem
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreas development
|
J:83754
|
pancreas hypoplasia
|
J:83754
|
Onecut1tm1Flem/Onecut1tm1Flem Onecut2tm1Flem/Onecut2tm1Flem
(involves: 129S1/Sv * 129X1/SvJ * Swiss)
|
abnormal pancreas development
|
J:121610
|
Onecut1tm1Flem/Onecut1tm1Flem Onecut3tm1Jqmn/Onecut3tm1Jqmn
(involves: 129S1/Sv * 129X1/SvJ * Swiss)
|
abnormal pancreas development
|
J:121610
|
abnormal pancreas morphology
|
J:121610
|
pancreas hypoplasia
|
J:121610
|
Opa1tm1.1Hise/Opa1tm1.2Hise Tg(Ins2-cre)25Mgn/0
(involves: 129S/SvEv * C57BL/6 * DBA * SJL)
|
abnormal pancreatic beta cell morphology
|
J:183074
|
decreased pancreatic beta cell number
|
J:183074
|
small pancreatic islets
|
J:183074
|
Oprm1tm1Jep/Oprm1tm1Jep
(B6.129S-Oprm1tm1Jep)
|
enlarged pancreatic islets
|
J:147786
|
increased pancreas weight
|
J:147786
|
Or9g4em1(IMPC)Mbp/Or9g4em1(IMPC)Mbp
(C57BL/6N-Or9g4em1(IMPC)Mbp/MbpMmucd)
|
abnormal pancreas morphology
|
J:211773
|
Osmrtm1Mtan/Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan)
|
increased pancreatic beta cell number
|
J:214124
|
Pargtm1Zqw/Pargtm1Zqw
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:92244
|
Pax21Neu/Pax21Neu
(involves: 102)
|
increased pancreatic beta cell mass
|
J:89465
|
increased pancreatic islet number
|
J:89465
|
pancreatic islet hyperplasia
|
J:89465
|
Pax21Neu/Pax2+
(involves: 102)
|
increased pancreatic beta cell mass
|
J:89465
|
increased pancreatic islet number
|
J:89465
|
pancreatic islet hyperplasia
|
J:89465
|
Pax4tm1(cre/ERT2)Sosa/Pax4tm1(cre/ERT2)Sosa
(Not Specified)
|
abnormal pancreas morphology
|
J:130423
|
absent pancreatic beta cells
|
J:130423
|
absent pancreatic delta cells
|
J:130423
|
Pax4tm1Pgr/Pax4tm1.1Aman Tg(CMV-cre)1Cgn/0
(involves: 129S2/SvPas * BALB/cJ * C57BL/6 * SJL)
|
absent pancreatic beta cells
|
J:192683
|
absent pancreatic delta cells
|
J:192683
|
increased pancreatic alpha cell number
|
J:192683
|
Pax4tm1Pgr/Pax4tm1Pgr
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * NMRI))
|
abnormal pancreatic islet morphology
|
J:40439
|
absent pancreatic delta cells
|
J:39028
|
decreased pancreatic beta cell number
|
J:39208
|
Pax4tm1Pgr/Pax4tm1Pgr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreas morphology
|
J:130423
|
absent pancreatic beta cells
|
J:130423
|
absent pancreatic delta cells
|
J:130423
|
Pax6m1Lsli/Pax6+
(involves: C3H/HeJ * C57BL/6J)
|
abnormal pancreas morphology
|
J:146325
|
Pax6Sey-Neu/Pax6Sey-Neu
(involves: 102/El * C3H/Rl)
|
abnormal endocrine pancreas development
|
J:132598
|
Pax6Sey-Neu/Pax6Sey-Neu
(involves: 102 * C3H * CD-1)
|
absent pancreatic alpha cells
|
J:41624
|
absent pancreatic beta cells
|
J:41624
|
Pax6tm1Pgr/Pax6tm1Pgr
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
absent pancreatic alpha cells
|
J:40439
|
disorganized pancreatic islets
|
J:40439
|
Pax6tm1Pgr/Pax6tm2Pgr Tg(Pax6-cre,GFP)1Pgr/0
(involves: 129S1/Sv * 129X1/SvJ * FVB * NMRI)
|
decreased pancreatic alpha cell number
|
J:90642
|
decreased pancreatic beta cell number
|
J:90642
|
Pax6tm2Pgr/Pax6tm2Pgr Tg(Pax6-cre,GFP)1Pgr/0
(involves: FVB * NMRI)
|
decreased pancreatic alpha cell number
|
J:90642
|
decreased pancreatic beta cell number
|
J:90642
|
Pax6tm2Pgr/Pax6tm2Pgr Tg(Pdx1-cre)6Cvw/0
(involves: FVB * NMRI)
|
decreased pancreatic alpha cell number
|
J:90642
|
decreased pancreatic beta cell number
|
J:90642
|
Pbx1tm1Mlc/Pbx1+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:75811
|
Pbx1tm1Mlc/Pbx1tm1Mlc
(involves: 129S6/SvEvTac * C57BL/6)
|
absent pancreatic islets
|
J:75811
|
exocrine pancreas hypoplasia
|
J:75811
|
Pcsk1em2Irli/Pcsk1em2Irli
(C57BL/6J-Pcsk1em2Irli)
|
abnormal pancreatic islet morphology
|
J:324309
|
Pcsk2tm1Dfs/Pcsk2tm1Dfs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell differentiation
|
J:85590
|
abnormal pancreatic islet morphology
|
J:41505
|
decreased pancreatic beta cell number
|
J:41505
|
increased pancreatic alpha cell mass
|
J:41505
|
increased pancreatic delta cell number
|
J:41505
|
Pcsk2tm1Dfs/Pcsk2tm1Dfs
(B6;129-Pcsk2tm1Dfs/J)
|
abnormal pancreatic alpha cell differentiation
|
J:236905
|
abnormal pancreatic alpha cell morphology
|
J:236905
|
enlarged pancreatic islets
|
J:236905
|
increased glucagonoma incidence
|
J:236511
|
increased pancreas tumor incidence
|
J:236905
|
increased pancreatic alpha cell number
|
J:236905
|
increased pancreatic ductal adenocarcinoma incidence
|
J:236905
|
increased pancreatic islet cell adenoma incidence
|
J:236905
|
pancreatic islet hyperplasia
|
J:236905
|
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129S2/SvPas)
|
pancreas necrosis
|
J:222944
|
Pdcd1tm1Hon/Pdcd1tm1Hon Vsirtm1Lex/Vsirtm1Lex
(involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6)
|
pancreas necrosis
|
J:222944
|
Pdlim4em1(IMPC)Ics/Pdlim4em1(IMPC)Ics
(C57BL/6N-Pdlim4em2(IMPC)Ics/Ics)
|
abnormal pancreas morphology
|
J:211773
|
Pdpk1tm1Dral/Pdpk1tm1Dral
(B6.129P2-Pdpk1tm1Dral)
|
pancreatic islet hyperplasia
|
J:136089
|
pancreatic islet hypoplasia
|
J:136089
|
small pancreas
|
J:136089
|
Pdpk1tm1Maka/Pdpk1tm1Maka Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
abnormal pancreatic beta cell morphology
|
J:109010
|
small pancreatic islets
|
J:109010
|
Pdx1tm1.1Stof/Pdx1+
(involves: 129/Sv * C57BL/6)
|
decreased pancreatic beta cell mass
|
J:152582
|
pancreas hypoplasia
|
J:152582
|
Pdx1tm1.1Stof/Pdx1tm1.1Stof
(involves: 129/Sv * C57BL/6)
|
abnormal pancreas development
|
J:152582
|
abnormal pancreatic delta cell morphology
|
J:152582
|
abnormal pancreatic epsilon cell morphology
|
J:152582
|
abnormal PP cell morphology
|
J:152582
|
decreased pancreatic alpha cell mass
|
J:152582
|
decreased pancreatic beta cell mass
|
J:152582
|
pancreatic islet hypoplasia
|
J:152582
|
Pdx1tm1Cvw/Pdx1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic islet size
|
J:165268
|
decreased pancreatic beta cell number
|
J:165268
|
disorganized pancreatic islets
|
J:165268
|
small pancreatic islets
|
J:165268
|
Pdx1tm1Cvw/Pdx1+ Pbx1tm1Mlc/Pbx1+
(involves: 129S6/SvEvTac * C57BL/6)
|
disorganized pancreatic islets
|
J:75811
|
Pdx1tm1Cvw/Pdx1+ SpopGt(BGB118)Byg/Spop+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:165268
|
disorganized pancreatic islets
|
J:165268
|
Pdx1tm1Cvw/Pdx1tm1.1Stof
(involves: 129/Sv * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased pancreas weight
|
J:152582
|
small pancreas
|
J:152582
|
Pdx1tm1Cvw/Pdx1tm1Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal pancreatic acinar cell morphology
|
J:32017
|
abnormal pancreatic beta cell differentiation
|
J:32017
|
abnormal pancreatic duct morphology
|
J:32017
|
abnormal pancreatic islet morphology
|
J:32017
|
absent pancreas
|
J:32017
|
Pdx1tm1Cvw/Pdx1tm4Cvw Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * DBA)
|
abnormal pancreas morphology
|
J:130389
|
decreased pancreatic beta cell number
|
J:130389
|
disorganized pancreatic islets
|
J:130389
|
increased pancreatic alpha cell number
|
J:130389
|
increased pancreatic delta cell number
|
J:130389
|
Pdx1tm1Egs/Pdx1+ Stk11tm1.1Gne/Stk11tm1.1Gne
(involves: 129S1/Sv * C57BL/6N)
|
pancreas cyst
|
J:195229
|
Pdx1tm1Heed/Pdx1tm1Heed Tg(Ins2-cre)1Heed/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pancreatic islet morphology
|
J:48516
|
decreased pancreatic beta cell number
|
J:48516
|
disorganized pancreatic islets
|
J:48516
|
increased pancreatic alpha cell number
|
J:48516
|
Pdx1tm1Macd/Pdx1+ Tg(tetO-Myt1)2Ggu/0
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreas development
|
J:136131
|
Pdx1tm1Macd/Pdx1+ Tg(tetO-Neurog3)8Ggu/0
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreas development
|
J:136131
|
Pdx1tm1Macd/Pdx1+ Tg(tetO-Sox17,-EGFP)1Jaw/0
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal endocrine pancreas morphology
|
J:151981
|
abnormal pancreas development
|
J:151981
|
abnormal pancreas morphology
|
J:151981
|
exocrine pancreas hyperplasia
|
J:151981
|
pancreatic acinar hypoplasia
|
J:151981
|
small pancreas
|
J:151981
|
Pdx1tm1Macd/Pdx1tm1Macd Tg(tetO-Ipf1,EGFP)956.6Macd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal pancreas development
|
J:79206
|
abnormal pancreatic beta cell morphology
|
J:101742
|
small pancreatic islets
|
J:101742
|
Pdx1tm1Macd/Pdx1tm1Macd Tg(tetO-Ipf1,lacZ)958.1Macd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal pancreas development
|
J:103522
|
absent pancreas
|
J:103522
|
Pdx1tm1Ted/Pdx1+
(involves: 129P2/OlaHsd)
|
abnormal pancreatic islet morphology
|
J:82969
|
decreased pancreatic beta cell mass
|
J:82969
|
decreased pancreatic islet number
|
J:82969
|
small pancreatic islets
|
J:82969
|
Pdx1tm1Ted/Pdx1tm1Ted
(involves: 129P2/OlaHsd)
|
abnormal pancreas development
|
J:33133
|
absent pancreas
|
J:20779
|
Pdx1tm2Cvw/Pdx1+ Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * Black Swiss * C57BL/6 * SJL)
|
pancreatic islet hyperplasia
|
J:97234
|
Pdx1tm2Cvw/Pdx1tm2Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal pancreatic acinar cell morphology
|
J:32017
|
abnormal pancreatic beta cell differentiation
|
J:32017
|
abnormal pancreatic duct morphology
|
J:32017
|
abnormal pancreatic islet morphology
|
J:32017
|
absent pancreas
|
J:32017
|
Pdx1tm2Cvw/Pdx1tm3Cvw
(involves: 129/Sv * C57BL/6 * DBA * FVB/N)
|
abnormal pancreas development
|
J:104617
|
Pdx1tm3Cvw/Pdx1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)
|
disorganized pancreatic islets
|
J:104617
|
increased pancreatic alpha cell number
|
J:104617
|
increased PP cell number
|
J:104617
|
Pdx1tm3Cvw/Pdx1tm3Cvw
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)
|
abnormal pancreas development
|
J:104617
|
Pgbd1em1(IMPC)Tcp/Pgbd1em1(IMPC)Tcp
(C57BL/6NCrl-Pgbd1em1(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Pgm3Gt(W037B08)Wrst/Pgm3mld1
(involves: 129S1/Sv * C57BL/6)
|
abnormal pancreas morphology
|
J:125094
|
pancreatic acinar hypoplasia
|
J:125094
|
Pgm3mld1/Pgm3mld1
(C57BL/6-Pgm3mld1)
|
abnormal pancreas morphology
|
J:125094
|
abnormal pancreatic acinus morphology
|
J:125094
|
Pgrtm1Bwo/Pgrtm1Bwo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased pancreatic beta cell number
|
J:125584
|
pancreatic islet hyperplasia
|
J:125584
|
Phtf1tm1b(KOMP)Wtsi/Phtf1tm1b(KOMP)Wtsi
(C57BL/6N-Phtf1tm1b(KOMP)Wtsi/Ucd)
|
abnormal pancreas morphology
|
J:211773
|
Pik3catm1Bvan/Pik3ca+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pancreatic beta cell number
|
J:109024
|
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(B6.129P2-Pik3cbtm1.1Ehi)
|
pancreatic islet hyperplasia
|
J:152332
|
Pik3r1tm1.1Geno/Pik3r1+
(involves: C57BL/6 * C57BL/6J)
|
pancreatic islet hyperplasia
|
J:234657
|
PitpnaGt(OST1152)Lex/PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd)
|
abnormal pancreatic islet morphology
|
J:85204
|
decreased pancreatic islet number
|
J:85204
|
Pitpnatm1Vab/Pitpnatm1Vab
(involves: 129S7/SvEvBrd)
|
abnormal pancreatic islet morphology
|
J:85204
|
decreased pancreatic islet number
|
J:85204
|
Pitx2tm1Hmd/Pitx2tm1Hmd
(involves: C3H * C57BL/6 * C57BL/6J)
|
abnormal pancreas morphology
|
J:128475
|
Pkd1m1Bei/Pkd1m1Bei
(involves: A/J * FVB/N)
|
enlarged pancreas
|
J:75360
|
Pkd1tm1Bdgz/Pkd1+
(involves: 129S1/Sv * 129X1/SvJ)
|
pancreas cyst
|
J:130086
|
Pkd1tm1Bdgz/Pkd1tm1Bdgz
(involves: 129S1/Sv * 129X1/SvJ)
|
pancreas cyst
|
J:130086
|
Pkd1tm1Djmp/Pkd1tm1Djmp
(involves: 129P2/OlaHsd * C57BL/6)
|
pancreas cyst
|
J:94582
|
Pkd1tm1Ggg/Pkd1+ Pkhd1tm1.1Ggg/Pkhd1tm1.1Ggg
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
pancreas cyst
|
J:125113
|
Pkd1tm1Ggg/Pkd1tm1Ggg
(Not Specified)
|
pancreas cyst
|
J:76062
|
Pkd1tm1Hung/Pkd1tm1Hung
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB))
|
pancreas cyst
|
J:104361
|
Pkd1tm1Jzh/Pkd1+
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c))
|
abnormal exocrine pancreas morphology
|
J:72627
|
abnormal pancreatic acinus morphology
|
J:72627
|
decreased pancreatic islet number
|
J:72627
|
dilated pancreatic duct
|
J:72627
|
exocrine pancreas atrophy
|
J:72627
|
pancreas cyst
|
J:72627
|
pancreas fibrosis
|
J:72627
|
pancreas lipomatosis
|
J:72627
|
Pkd1tm1Jzh/Pkd1tm1Jzh
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c))
|
decreased pancreatic islet number
|
J:43193
|
dilated pancreatic duct
|
J:43193
|
pancreas cyst
|
J:43193
|
Pkd1tm1Maa/Pkd1tm1Maa
(involves: 129S4/SvJae * C57BL/6)
|
pancreas cyst
|
J:68331
|
Pkd1tm1Som/Pkd1tm1Som
(involves: 129/Sv * C57BL/6 * SJL)
|
pancreas cyst
|
J:78422
|
Pkd1tm2.1Ggg/Pkd1tm2.1Ggg
(involves: 129S4/SvJae * Black Swiss * C57BL/6)
|
pancreas cyst
|
J:103719
|
Pkd1tm2Ggg/Pkd1tm2Ggg Tg(Col1a1-cre)1Bek/0
(involves: 129S4/SvJae * CD-1)
|
abnormal exocrine pancreas morphology
|
J:191967
|
pancreas cyst
|
J:191967
|
Pkd1tm2Jzh/Pkd1+
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
pancreas cyst
|
J:72627
|
Pkd1tm2Jzh/Pkd1tm2Jzh
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
pancreas cyst
|
J:72627
|
Pkd2tm1.1Gwu/Pkd2tm1.1Gwu Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
pancreas cyst
|
J:265516
|
Pkd2tm1.1Tjwt/Pkd2tm1.2Tjwt Meox2tm1(cre)Sor/Meox2+
(involves: 129S/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
pancreas cyst
|
J:165114
|
Pkd2tm1Dwo/Pkd2tm1Dwo
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal pancreas morphology
|
J:77401
|
pancreas cyst
|
J:77401
|
Pkd2tm1Gwu/Pkd2tm1Gwu
(involves: C57BL/6)
|
dilated pancreatic duct
|
J:143124
|
pancreas cyst
|
J:143124
|
Pkd2tm1Som/Pkd2tm2Som
(involves: 129/Sv * C57BL/6J * SJL)
|
pancreas cyst
|
J:59314
|
Pkd2tm2Som/Pkd2tm2Som
(involves: 129/Sv * C57BL/6J * SJL)
|
pancreas cyst
|
J:59314
|
Pkhd1tm1.1Ggg/Pkhd1tm1.1Ggg
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
pancreas cyst
|
J:125113
|
Pkhd1tm1Cjwa/Pkhd1tm1Cjwa
(involves: 129S6/SvEvTac * FVB/N)
|
abnormal pancreatic duct morphology
|
J:140302
|
dilated pancreatic duct
|
J:140302
|
pancreas cyst
|
J:140302
|
Pkhd1tm1Gwu/Pkhd1tm1Gwu
(Not Specified)
|
dilated pancreatic duct
|
J:143124,
J:143394
|
pancreas cyst
|
J:143394
|
Pkhd1tm1Som/Pkhd1tm1Som
(involves: 129S/SvEv * C57BL/6)
|
dilated pancreatic duct
|
J:131370
|
pancreas cyst
|
J:131370
|
pancreas fibrosis
|
J:131370
|
Pkhd1tm1Sswi/Pkhd1tm1Sswi
(B6.Cg-Pkhd1tm1Sswi)
|
pancreas cyst
|
J:186064
|
Plvaptm1.1Rvst/Plvaptm1.1Rvst Tg(Cdh5-cre)1Spe/0
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6 * C57BL/6J)
|
small pancreas
|
J:191046
|
Plvaptm1.1Rvst/Plvaptm1.1Rvst Tg(Tek-cre)12Flv/0
(involves: 129S4/SvJae * C3H * C57BL/6)
|
small pancreas
|
J:191046
|
Plvaptm1.2Rvst/Plvaptm1.2Rvst
(involves: 129S4/SvJae * BALB/c * C57BL/6 * SJL)
|
small pancreas
|
J:191046
|
Plvaptm1e(EUCOMM)Hmgu/Plvaptm1e(EUCOMM)Hmgu Tg(TIE2GFP)287Sato/0
(involves: C57BL/6N * FVB/N)
|
abnormal pancreas morphology
|
J:203907
|
small pancreas
|
J:203907
|
Poc1btm1b(KOMP)Wtsi/Poc1btm1b(KOMP)Wtsi
(C57BL/6N-Poc1btm1b(KOMP)Wtsi/MbpMmucd)
|
abnormal pancreas morphology
|
J:211773
|
Ppargtm1.1Gonz/Ppargtm1.1Gonz Tg(Ins2-cre)25Mgn/0
(involves: 129 * C57 * FVB)
|
pancreatic islet hyperplasia
|
J:89959
|
Ppargtm1Mae/Pparg+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal endocrine pancreas morphology
|
J:91362
|
Ppargtm2(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6)
|
pancreas hyperplasia
|
J:125992
|
pancreatic islet hyperplasia
|
J:125992
|
Ppargtm2Avp/Ppargtm2Avp
(involves: 129/Sv * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:121534
|
Ppargc1atm1Brsp/Ppargc1atm2Brsp Tg(Myog-cre)1Eno/0
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal pancreatic beta cell morphology
|
J:127403
|
enlarged pancreatic islets
|
J:127403
|
increased pancreatic beta cell mass
|
J:127403
|
Ppp2r2aigt10/Ppp2r2a+
(involves: C3H/HeH * C57BL/6J)
|
increased pancreatic beta cell mass
|
J:246319
|
Ppt2tm1Hof/Ppt2tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal exocrine pancreas morphology
|
J:86202
|
abnormal pancreas morphology
|
J:86202
|
abnormal pancreatic acinar cell zymogen granule morphology
|
J:86202
|
enlarged pancreas
|
J:86202
|
Pramel12em1(IMPC)Mbp/Pramel12em1(IMPC)Mbp
(C57BL/6N-Pramel12em1(IMPC)Mbp/MbpMmucd)
|
abnormal pancreas morphology
|
J:211773
|
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6)
|
increased pancreatic islet cell adenoma incidence
|
J:84677
|
Prf1tm1Sdz/Prf1tm1Sdz
(NOD.B6-Prf1tm1Sdz)
|
decreased pancreatic beta cell number
|
J:43468
|
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:120293
|
Prkcitm1Rfar/Prkci+ Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
pancreatic islet hyperplasia
|
J:123964
|
Prkcitm1Rfar/Prkcitm1Rfar Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
pancreatic islet hyperplasia
|
J:123964
|
Prkdcscid/Prkdcscid Tg(INS-HBEGF*L148S*P149T)70Rin/0
(C.BKa-Prkdcscid Tg(INS-HBEGF*L148S*P149T)70Rin)
|
abnormal pancreatic islet morphology
|
J:204420
|
decreased pancreatic beta cell number
|
J:204420
|
Prlrtm1Cnp/Prlrtm1Cnp
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:106829
|
decreased pancreatic beta cell mass
|
J:106829
|
small pancreatic islets
|
J:106829
|
Prox1tm1Gco/Prox1tm1Gco
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
abnormal endocrine pancreas morphology
|
J:103538
|
increased pancreatic acinar cell number
|
J:103538
|
small pancreas
|
J:103538
|
Prss3btm1.1Satom/Prss3b+
(B6(FVB)-Prss3btm1.1Satom)
|
abnormal pancreas morphology
|
J:267764
|
decreased pancreas weight
|
J:267764
|
decreased pancreatic acinar cell number
|
J:267764
|
enlarged pancreatic islets
|
J:267764
|
increased pancreas weight
|
J:267764
|
pancreas atrophy
|
J:267764
|
small pancreas
|
J:267764
|
Psma8em1(IMPC)Tcp/Psma8em1(IMPC)Tcp
(C57BL/6N-Psma8em1(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Ptentm1Hwu/Ptentm1Hwu Rictortm1.1Mgn/Rictortm1.1Mgn Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
|
abnormal pancreatic beta cell morphology
|
J:170129
|
decreased pancreatic beta cell mass
|
J:170129
|
Ptentm1Hwu/Ptentm1Hwu Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
abnormal pancreatic beta cell morphology
|
J:170206
|
enlarged pancreatic islets
|
J:106937
|
increased pancreatic beta cell mass
|
J:170206
|
increased pancreatic beta cell number
|
J:106937
|
increased pancreatic islet number
|
J:106937
|
Ptentm1Hwu/Ptentm1Hwu Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA)
|
abnormal pancreatic beta cell morphology
|
J:170129
|
increased pancreatic beta cell mass
|
J:170129
|
Ptentm1Hwu/Ptentm1Hwu Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal centroacinar cell of Langerhans morphology
|
J:102226
|
abnormal exocrine pancreas morphology
|
J:102226
|
abnormal pancreatic acinar cell morphology
|
J:102226
|
abnormal pancreatic acinus morphology
|
J:102226
|
enlarged pancreatic islets
|
J:102226
|
increased pancreatic acinar cell number
|
J:102226
|
increased pancreatic ductal adenocarcinoma incidence
|
J:102226
|
increased pancreatic intraepithelial neoplasia incidence
|
J:102226
|
pancreatic islet hyperplasia
|
J:102226
|
Ptentm1Hwu/Ptentm1Hwu Tg(Pdx1-cre)89.1Dam/0 Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 * CBA)
|
increased pancreatic acinar cell carcinoma incidence
|
J:102226
|
increased pancreatic ductal adenocarcinoma incidence
|
J:102226
|
Ptentm1Hwu/Ptentm1Hwu Tg(Pdx1-cre/Esr1*)35.10Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
pancreatic islet hyperplasia
|
J:102226
|
Ptf1atm1(cre)Hnak/Ptf1a+ Rbpjtm1Rsch/Rbpjtm1Rsch
(involves: 129X1/SvJ)
|
abnormal pancreas development
|
J:139250
|
abnormal pancreas morphology
|
J:139250
|
abnormal pancreatic alpha cell differentiation
|
J:139250
|
decreased pancreatic acinar cell number
|
J:139250
|
decreased pancreatic islet number
|
J:139250
|
disorganized pancreatic islets
|
J:139250
|
increased pancreatic alpha cell number
|
J:139250
|
small pancreas
|
J:139250
|
Ptf1atm1.1(cre)Cvw/Ptf1a+ Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal pancreas development
|
J:116129
|
Ptf1atm1.1(cre)Cvw/Ptf1atm1.1(cre)Cvw
(involves: 129S1/Sv * 129X1/SvJ)
|
absent pancreas
|
J:130251
|
Ptf1atm1Pkwe/Ptf1atm1Pkwe
(involves: 129P2/OlaHsd * C57BL/6)
|
absent pancreas
|
J:51571
|
decreased pancreatic alpha cell number
|
J:51571
|
Ptf1atm1Pkwe/Ptf1atm1Pkwe
(involves: 129P2/OlaHsd)
|
absent pancreas
|
J:120017
|
Ptf1atm2Macd/Ptf1atm2Macd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreas development
|
J:125691
|
absent pancreas
|
J:130251
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
pancreas necrosis
|
J:108054
|
Ptpn1tm1Bbk/Ptpn1tm1Bbk
(involves: 129/Sv * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:87249
|
Ptprvtm1Kry/Ptprvtm1Kry Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
abnormal pancreatic islet morphology
|
J:126780
|
increased pancreatic beta cell mass
|
J:126780
|
increased pancreatic islet number
|
J:126780
|
pancreatic islet hyperplasia
|
J:126780
|
Pttg1tm1Sme/Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:82724
|
decreased pancreatic beta cell mass
|
J:82724
|
Pzptm1Vln/Pzptm1Vln
(B.129P2-Pzptm1Vln)
|
abnormal pancreatic acinar cell morphology
|
J:57485
|
abnormal pancreatic acinus morphology
|
J:57485
|
Rag1tm1Mom/Rag1tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
decreased pancreatic beta cell number
|
J:111874
|
Ralyem2(IMPC)Tcp/Ralyem2(IMPC)Tcp
(C57BL/6NCrl-Ralyem2(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Rapgef3tm1Skc/Rapgef3tm1Skc
(Not Specified)
|
enlarged pancreatic islets
|
J:201171
|
increased pancreatic alpha cell number
|
J:201171
|
pancreatic islet hyperplasia
|
J:201171
|
Rasgrf1tm1Esn/Rasgrf1tm1Esn
(involves: 129/Sv * C57BL/6N)
|
decreased pancreatic beta cell number
|
J:83950
|
small pancreatic islets
|
J:83950
|
Rb1tm1Tyj/Rb1+ Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased pancreatic islet cell carcinoma incidence
|
J:19542
|
Rb1tm2Brn/Rb1tm2Brn Trp53tm1Brn/Trp53tm1Brn Tg(Ren-cre)#Kwg/0
(involves: 129 * 129P2/OlaHsd)
|
increased glucagonoma incidence
|
J:216559
|
increased pancreatic islet cell carcinoma incidence
|
J:216559
|
Rbm4tm1Wtarn/Rbm4tm1Wtarn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
small pancreatic islets
|
J:192831
|
Rbm4btm1Wtarn/Rbm4btm1Wtarn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
small pancreatic islets
|
J:192831
|
Rbpjtm1Hon/Rbpjtm1.1Hon Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Hes1tm1(cre/ERT2)Lcm/Hes1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal centroacinar cell of Langerhans morphology
|
J:180310
|
increased pancreatic acinar cell number
|
J:180310
|
Rdh10tm1.1Ics/Rdh10tm1.1Ics
(involves: C57BL/6 * SJL)
|
pancreas hypoplasia
|
J:177362
|
Rdh10tm2Ics/Rdh10tm2Ics
(Not Specified)
|
pancreas hypoplasia
|
J:177362
|
Rdh10trex/Rdh10trex
(involves: 129S1/Sv * C57BL/6 * FVB/NJ)
|
absent pancreas
|
J:121229
|
Rfx6tm1.1(EGFP/cre)Mger/Rfx6tm1.1(EGFP/cre)Mger
(involves: 129P2/OlaHsd * C57BL/6)
|
small pancreas
|
J:156925
|
Rgcctm1.1(KOMP)Wtsi/Rgcctm1.1(KOMP)Wtsi
(C57BL/6N-Rgcctm1.1(KOMP)Wtsi/Ucd)
|
abnormal pancreas morphology
|
J:211773
|
Rgs5tm1.1Rgan/Rgs5tm1.1Rgan Tg(RIP1-Tag)5Dh/0
(C3.Cg-Rgs5tm1.1Rgan Tg(RIP1-Tag)5Dh)
|
increased insulinoma incidence
|
J:136259
|
Rhbdf1tm1.1Mfm/Rhbdf1tm1.1Mfm
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6J)
|
abnormal pancreatic acinus morphology
|
J:203951
|
absent pancreatic acinar cell zymogen granule
|
J:203951
|
pancreatic acinar hypoplasia
|
J:203951
|
Rictortm1.1Mgn/Rictortm1.1Mgn Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
|
decreased pancreatic beta cell mass
|
J:170129
|
Rictortm1.1Mnh/Rictortm1.1Mnh Tg(Fabp4-cre)1Rev/0
(B6.Cg-Rictortm1.1Mnh Tg(Fabp4-cre)1Rev)
|
enlarged pancreatic islets
|
J:150064
|
increased pancreas weight
|
J:150064
|
Rims2tm1Sse/Rims2tm1Sse
(B6.Cg-Rims2tm1Sse)
|
increased pancreatic alpha cell number
|
J:163080
|
pancreatic islet hyperplasia
|
J:163080
|
Ripply3tm1Sjt/Ripply3tm1Sjt
(involves: 129S1/Sv * C57BL/6)
|
increased pancreatic alpha cell mass
|
J:214095
|
increased pancreatic beta cell mass
|
J:214095
|
Rnd2em1(IMPC)Mbp/Rnd2em1(IMPC)Mbp
(C57BL/6NCrl-Rnd2em1(IMPC)Mbp/Mmucd)
|
abnormal pancreas morphology
|
J:211773
|
Rnf146tm1.1Rtpl/Rnf146tm1.1Rtpl Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6J * CD-1)
|
decreased pancreatic islet number
|
J:244583
|
small pancreatic islets
|
J:244583
|
Rpgrip1ltm1a(EUCOMM)Wtsi/Rpgrip1ltm1a(EUCOMM)Wtsi
(C57BL/6N-Rpgrip1ltm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal pancreas topology
|
J:239583
|
abnormal ventral pancreas morphology
|
J:239583
|
Rph3altm1Sse/Rph3altm1Sse
(B6.129-Rph3altm1Sse)
|
pancreatic acinar cell zymogen granule accumulation
|
J:90669
|
Rps6tm1Om/Rps6tm1Om
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
abnormal pancreatic beta cell morphology
|
J:100952
|
abnormal pancreatic islet morphology
|
J:100952
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased pancreatic beta cell mass
|
J:66406
|
small pancreatic islets
|
J:66406
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
(B6.129P2-Rps6kb1tm1Gtho)
|
abnormal pancreatic beta cell morphology
|
J:144599
|
decreased pancreatic beta cell mass
|
J:144599
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho Rps6kb2tm1Gtho/Rps6kb2tm1Gtho Tg(Ins2-Akt1*)3Mbb/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal pancreatic beta cell morphology
|
J:144599
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho Tg(Ins2-Akt1*)3Mbb/0
(B6.Cg-Rps6kb1tm1Gtho Tg(Ins2-Akt1*)3Mbb)
|
abnormal pancreatic beta cell morphology
|
J:144599
|
Rps6kb2tm1Gtho/Rps6kb2tm1Gtho Tg(Ins2-Akt1*)3Mbb/0
(B6.Cg-Rps6kb2tm1Gtho Tg(Ins2-Akt1*)3Mbb)
|
increased insulinoma incidence
|
J:144599
|
Rpsatm1Ells/Rpsa+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:138267
|
Rr344em1Jfer/Rr344em1Jfer
(B6.Cg-Rr344em1Jfer)
|
abnormal branching involved in pancreas development
|
J:328047
|
abnormal pancreatic bud formation
|
J:328047
|
decreased pancreatic alpha cell mass
|
J:328047
|
decreased pancreatic beta cell mass
|
J:328047
|
dilated pancreatic duct
|
J:328047
|
pancreas hypoplasia
|
J:328047
|
Sbdstm1Jrom/Sbdstm3.1Jrom Ptf1atm1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreatic islet size
|
J:189357
|
pancreas hypoplasia
|
J:189357
|
small pancreas
|
J:189357
|
Sbdstm2.1Jrom/Sbdstm3.1Jrom Ptf1atm1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreatic islet size
|
J:189357
|
pancreas lipomatosis
|
J:189357
|
pancreatic acinar hypoplasia
|
J:189357
|
small pancreas
|
J:189357
|
Sc5dtm1Fdp/Sc5dtm1Fdp
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreatic acinar cell zymogen granule morphology
|
J:84450
|
Scg5tm1Led/Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6))
|
abnormal pancreatic islet morphology
|
J:53349
|
increased pancreatic beta cell mass
|
J:53349
|
pancreatic islet hyperplasia
|
J:53349
|
Scgb1a1tm1Abm/Scgb1a1tm1Abm
(involves: 129S1/Sv * 129X1/SvJ)
|
pancreas necrosis
|
J:40748
|
Scribtm1.2Phum/Scrib+
(involves: FVB/N)
|
abnormal pancreas morphology
|
J:178461
|
Sdhbtm1c(EUCOMM)Hmgu/Sdhbtm1c(EUCOMM)Hmgu Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
abnormal pancreatic islet morphology
|
J:326592
|
decreased pancreatic beta cell mass
|
J:326592
|
Sec23bGt(AD0407)Wtsi/Sec23bGt(AD0407)Wtsi
(B6J.129P2-Sec23bGt(AD0407)Wtsi)
|
abnormal endocrine pancreas development
|
J:186391
|
abnormal endocrine pancreas morphology
|
J:186391
|
abnormal pancreas morphology
|
J:186391
|
abnormal pancreatic acinar cell morphology
|
J:186391,
J:237614
|
abnormal pancreatic acinus morphology
|
J:186391
|
absent pancreatic acinar cell zymogen granule
|
J:186391
|
decreased pancreatic acinar cell number
|
J:186391
|
decreased pancreatic alpha cell number
|
J:186391
|
decreased pancreatic beta cell number
|
J:186391
|
decreased pancreatic islet number
|
J:186391
|
pancreas degeneration
|
J:186391
|
pancreatic acinar hypoplasia
|
J:186391
|
small pancreas
|
J:186391
|
Sec23btm1a(EUCOMM)Wtsi/Sec23btm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
pancreas degeneration
|
J:186391
|
Sec23btm1b(EUCOMM)Wtsi/Sec23btm1b(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N * FVB/N)
|
pancreas degeneration
|
J:186391
|
Sec61a1m1Gek/Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek)
|
abnormal pancreatic beta cell morphology
|
J:164159
|
abnormal pancreatic delta cell morphology
|
J:164159
|
decreased pancreatic beta cell number
|
J:164159
|
increased pancreatic alpha cell number
|
J:164159
|
increased pancreatic delta cell number
|
J:164159
|
Sec61a1m1Gek/Sec61a1m1Gek Tg(Ins2-Sec61a1)#Gek/0
(C57BL/6-Sec61a1m1Gek Tg(Ins2-Sec61a1)#Gek)
|
abnormal pancreatic beta cell morphology
|
J:164159
|
Sel1lGt(CA0017)Wtsi/Sel1lGt(CA0017)Wtsi
(involves: 129P2/OlaHsd)
|
abnormal pancreas development
|
J:158780
|
abnormal pancreas morphology
|
J:158780
|
abnormal pancreatic alpha cell differentiation
|
J:158780
|
abnormal pancreatic beta cell differentiation
|
J:158780
|
Sel1ltm1c(KOMP)Wtsi/Sel1ltm1c(KOMP)Wtsi Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * C57BL/6N * CBA * SJL)
|
abnormal exocrine pancreas morphology
|
J:206568
|
exocrine pancreas atrophy
|
J:206568
|
Selenottm1.1Ics/Selenottm1.1Ics Tg(Ins2-cre)25Mgn/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * DBA)
|
increased pancreatic islet number
|
J:203279
|
small pancreatic islets
|
J:203279
|
Senp1tm1Wami/Senp1tm1Wami Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Senp1tm1Wami Tg(Adipoq-cre)1Evdr)
|
abnormal pancreatic islet morphology
|
J:228009
|
Senp1tm1Wami/Senp1tm1Wami Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel)
|
abnormal pancreatic islet morphology
|
J:228009
|
Senp1tm1Wami/Senp1tm1Wami Tg(Pdgfra-cre)1Clc/0
(B6.Cg-Senp1tm1Wami Tg(Pdgfra-cre)1Clc)
|
abnormal pancreatic islet morphology
|
J:228009
|
Serpinf1tm1Craw/Serpinf1tm1Craw
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal exocrine pancreas morphology
|
J:83748
|
abnormal pancreas morphology
|
J:83748
|
abnormal pancreatic acinar cell morphology
|
J:83748
|
enlarged pancreas
|
J:83748
|
exocrine pancreas hyperplasia
|
J:83748
|
Serpini2pq/Serpini2pq
(involves: C57BL/6J)
|
abnormal pancreatic acinar cell morphology
|
J:115744
|
abnormal pancreatic acinar cell zymogen granule morphology
|
J:115744
|
Sertad1tm1Srn/Sertad1tm1Srn
(B6.129-Sertad1tm1Srn)
|
decreased pancreatic beta cell mass
|
J:157231
|
decreased pancreatic islet number
|
J:157231
|
Setd3tm1.1(NCOM)Mfgc/Setd3tm1.1(NCOM)Mfgc
(C57BL/6N-Setd3tm1.1(NCOM)Mfgc/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Sgms1tm1Kenw/Sgms1tm1Kenw
(involves: 129S2/SvPas * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:168726
|
Sgpp2tm1Rlp/Sgpp2tm1Rlp
(B6.129S6-Sgpp2tm1Rlp)
|
decreased pancreatic beta cell mass
|
J:235035
|
small pancreatic islets
|
J:235035
|
Sh2b1tm1Lr/Sh2b1tm1Lr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
pancreatic islet hyperplasia
|
J:92794
|
Sh2b1tm2.1Lr/Sh2b1tm2.1Lr Tg(Pdx1-cre)89.1Dam/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
decreased pancreatic beta cell mass
|
J:209019
|
small pancreatic islets
|
J:209019
|
Shhtm1Amc/Shhtm1Amc
(involves: 129/Sv * C57BL/6J * CBA/J)
|
annular pancreas
|
J:62158
|
Sidt2tm1.1Hzha/Sidt2tm1.1Hzha
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal pancreatic beta cell morphology
|
J:204228
|
increased pancreatic beta cell number
|
J:204228
|
Sik3tm1Htake/Sik3tm1Htake
(involves: C57BL/6JJcl * C57BL/6N)
|
decreased pancreas weight
|
J:183827
|
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129)
|
exocrine pancreas atrophy
|
J:81010
|
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
exocrine pancreas atrophy
|
J:81010
|
Sirt1tm2.1Mcby/Sirt1tm2.1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
enlarged pancreas
|
J:180628
|
Sirt2tm1.1Cxd/Sirt2tm1.1Cxd
(either: (involves: C57BL/6 * FVB/N) or (involves: FVB/N * NIH Black Swiss))
|
increased pancreas tumor incidence
|
J:177486
|
Slc2a2tm1Thor/Slc2a2tm1Thor
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal pancreatic islet morphology
|
J:43839
|
decreased pancreas weight
|
J:43839
|
decreased pancreatic beta cell mass
|
J:43839
|
increased pancreatic alpha cell mass
|
J:43839
|
Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * C57BL/6 * SJL)
|
pancreatic islet hyperplasia
|
J:97234
|
Slc5a7tm1a(KOMP)Wtsi/Slc5a7tm1a(KOMP)Wtsi
(C57BL/6N-Slc5a7tm1a(KOMP)Wtsi/Wtsi)
|
dilated pancreatic duct
|
J:239583
|
Slc8a1tm1Herc/Slc8a1+
(involves: 129 * CD-1)
|
increased pancreatic beta cell mass
|
J:186743
|
Slc25a20tm1a(EUCOMM)Wtsi/Slc25a20tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc25a20tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal dorsal pancreas topology
|
J:239583
|
Slc30a8tm1.1Htwt/Slc30a8tm1.1Htwt Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * CBA/JNCrlj * DBA)
|
abnormal pancreatic beta cell morphology
|
J:204003
|
Slc38a5tm1(KOMP)Vlcg/Slc38a5tm1(KOMP)Vlcg
(C57BL/6-Slc38a5tm1(KOMP)Vlcg)
|
abnormal pancreatic alpha cell morphology
|
J:251829
|
Slc39a5tm1.1Gka/Slc39a5tm1.1Gka
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
pancreatic acinar cell atrophy
|
J:209760
|
Slc39a5tm1Gka/Slc39a5tm1Gka Tg(Cela1-cre/ERT)1Lgdn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
pancreatic acinar cell atrophy
|
J:209760
|
Slc40a1tm1.1Mmfe/Slc40a1+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pancreas iron level
|
J:215585
|
Slc40a1tm1.1Mmfe/Slc40a1tm1.1Mmfe
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreas morphology
|
J:215585
|
abnormal pancreatic acinar cell morphology
|
J:215585
|
increased pancreas iron level
|
J:215585
|
Smad4tm1.1Gsu/Smad4tm1.1Gsu Ptf1atm1.1(cre)Cvw/Ptf1a+ Tg(MtTGFA)Lmb/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal pancreas morphology
|
J:229184
|
abnormal pancreatic acinar cell morphology
|
J:229184
|
abnormal pancreatic duct morphology
|
J:229184
|
abnormal pancreatic islet morphology
|
J:229184
|
dilated pancreatic duct
|
J:229184
|
enlarged pancreas
|
J:229184
|
increased pancreatic intraepithelial neoplasia incidence
|
J:229184
|
pancreas cyst
|
J:229184
|
pancreas fibrosis
|
J:229184
|
pancreatic acinar-to-ductal metaplasia
|
J:229184
|
Smad7tm1Gkg/Smad7tm1Gkg Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: C57BL/6 * CBA)
|
abnormal pancreatic beta cell differentiation
|
J:198451
|
decreased pancreatic alpha cell number
|
J:198451
|
decreased pancreatic beta cell number
|
J:198451
|
Socs2tm1Wehi/Socs2tm1Wehi
(C57BL/6-Socs2tm1Wehi)
|
abnormal pancreatic duct morphology
|
J:63006
|
Socs7tm1Wsa/Socs7tm1Wsa
(involves: C57BL/6)
|
enlarged pancreatic islets
|
J:93449
|
Sox9tm1.1Gsr/Sox9+
(involves: 129S4/SvJae * CD-1)
|
decreased pancreatic alpha cell mass
|
J:141017
|
decreased pancreatic beta cell mass
|
J:141017
|
decreased pancreatic delta cell number
|
J:141017
|
decreased PP cell number
|
J:141017
|
pancreatic islet hyperplasia
|
J:141017
|
Sox9tm1Gsr/Sox9+ Tg(Pdx1-cre)6Cvw/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA * FVB/N)
|
abnormal pancreas development
|
J:141017
|
decreased pancreatic alpha cell mass
|
J:141017
|
decreased pancreatic beta cell mass
|
J:141017
|
decreased pancreatic delta cell number
|
J:141017
|
decreased PP cell number
|
J:141017
|
pancreatic islet hyperplasia
|
J:141017
|
Sox9tm2Gsr/Sox9tm2Gsr
(involves: 129P2/OlaHsd * CD-1)
|
pancreatic islet hyperplasia
|
J:141017
|
Sox11tm1Weg/Sox11tm1Weg
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreas morphology
|
J:92251
|
Sox17tm1Sjm/Sox17tm1Sjm
(involves: 129S1/Sv * 129X1/SvJ)
|
absent pancreas
|
J:151981
|
Spata22tm1b(KOMP)Wtsi/Spata22tm1b(KOMP)Wtsi
(C57BL/6N-Spata22tm1b(KOMP)Wtsi/Ucd)
|
abnormal pancreas morphology
|
J:211773
|
Spentm1Hon/Spentm1Hon
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal pancreas development
|
J:82332
|
Spink1tm1Kymm/Spink1tm1Kymm
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal pancreas morphology
|
J:104647
|
abnormal pancreatic acinar cell morphology
|
J:104647
|
SpopGt(BGB118)Byg/SpopGt(BGB118)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pancreatic beta cell mass
|
J:165268
|
Sptlc2tm1Yhir/Sptlc2tm1Yhir Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal pancreatic acinar cell zymogen granule morphology
|
J:202954
|
Sstr5tm1Fcb/Sstr5tm1Fcb
(involves: 129 * C57BL/6J)
|
decreased pancreatic beta cell number
|
J:91762
|
Sstr5tm1Fcb/Sstr5tm1Fcb
(involves: 129)
|
abnormal pancreatic alpha cell morphology
|
J:179577
|
Sstr5tm1Fcb/Sstr5tm2Fcb Tg(Ins2-cre)1Heed/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
decreased pancreatic delta cell number
|
J:99786
|
Stard13tm1.1Fms/Stard13tm1.1Fms Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA * SJL)
|
abnormal pancreas development
|
J:191071
|
pancreas hypoplasia
|
J:191071
|
Stard13tm1.2Fms/Stard13tm1.2Fms
(involves: BALB/cJ * C57BL/6 * SJL)
|
abnormal pancreas development
|
J:191071
|
Stat4tm1Gru/Stat4tm1Gru
(NOD.129S2-Stat4tm1Gru)
|
abnormal pancreatic beta cell morphology
|
J:90600
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
disorganized pancreatic islets
|
J:127051
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
disorganized pancreatic islets
|
J:127051
|
Stat5atm2Mam/Stat5atm2Mam Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell mass
|
J:284574
|
Stat5btm1Mam/Stat5btm1Mam Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
disorganized pancreatic islets
|
J:127051
|
Stat5btm1Mam/Stat5btm1Mam Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
disorganized pancreatic islets
|
J:127051
|
Stk11tm1.1Rdp/Stk11tm1.1Rdp Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N * ICR)
|
abnormal exocrine pancreas morphology
|
J:134078
|
abnormal pancreatic acinar cell morphology
|
J:134078
|
abnormal pancreatic acinus morphology
|
J:134078
|
abnormal pancreatic islet morphology
|
J:134078
|
decreased pancreatic alpha cell number
|
J:134078
|
decreased pancreatic beta cell number
|
J:134078
|
decreased pancreatic delta cell number
|
J:134078
|
pancreas fibrosis
|
J:134078
|
small pancreas
|
J:134078
|
small pancreatic islets
|
J:134078
|
Stk26tm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Stk26tm1b(EUCOMM)Hmgu/Ccpcz)
|
abnormal pancreas morphology
|
J:211773
|
enlarged pancreas
|
J:211773
|
Stoml1em1(IMPC)Tcp/Stoml1em1(IMPC)Tcp
(C57BL/6N-Stoml1em1(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Strip2em1(IMPC)Ccpcz/Strip2em1(IMPC)Ccpcz
(C57BL/6N-Strip2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal pancreas morphology
|
J:211773
|
enlarged pancreas
|
J:211773
|
Syt13tm1c(EUCOMM)Hmgu/Syt13tm1c(EUCOMM)Hmgu Tg(Neurog3-cre)C1Able/0
(involves: C57BL/6J * C57BL/6N)
|
abnormal endocrine pancreas development
|
J:327292
|
Syt13tm1d(EUCOMM)Hmgu/Syt13tm1d(EUCOMM)Hmgu
(involves: C57BL/6J * C57BL/6N)
|
abnormal endocrine pancreas development
|
J:327292
|
Sytl1tm1Mitf/Sytl1tm1Mitf
(involves: 129P2/OlaHsd)
|
pancreatic acinar cell zymogen granule accumulation
|
J:138210
|
Sytl1tm1Tiz/Sytl1tm1Tiz Sytl4tm1Tiz/Sytl4tm1Tiz
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NTac)
|
abnormal pancreatic beta cell morphology
|
J:200233
|
Sytl4tm1Tiz/Sytl4tm1Tiz
(involves: 129P2/OlaHsd * C3H/He)
|
abnormal pancreatic beta cell morphology
|
J:102610
|
Tbx1em1(IMPC)Mbp/Tbx1+
(C57BL/6NCrl-Tbx1em1(IMPC)Mbp/MbpMmucd)
|
abnormal pancreas morphology
|
J:211773
|
Tcf7l2tm1Geno/Tcf7l2tm1Geno Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA)
|
decreased pancreatic beta cell mass
|
J:189204
|
Tecrem1(IMPC)Rbrc/Tecr+
(C57BL/6NJcl-Tecrem1(IMPC)Rbrc/Rbrc)
|
abnormal pancreas morphology
|
J:211773
|
Teddm1aem1(IMPC)Tcp/Teddm1aem1(IMPC)Tcp
(C57BL/6N-Teddm1aem1(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Tet1tm1.1Gxu/Tet1tm1.1Gxu
(involves: 129 * 129P2/OlaHsd * C57BL/6J)
|
increased pancreas iron level
|
J:315675
|
Tfamtm1Lrsn/Tfamtm1Lrsn Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
absent pancreatic beta cells
|
J:65522
|
Tfb2mtm1a(KOMP)Wtsi/Tfb2m+ Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased pancreatic beta cell mass
|
J:256448
|
decreased pancreatic islet number
|
J:256448
|
Tfb2mtm1a(KOMP)Wtsi/Tfb2mtm1a(KOMP)Wtsi Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
abnormal pancreatic beta cell morphology
|
J:256448
|
decreased pancreatic beta cell mass
|
J:256448
|
decreased pancreatic islet number
|
J:256448
|
Tg(aP2-SREBF1c)9884Reh/0
(involves: C57BL/6J * SJL)
|
enlarged pancreas
|
J:50770
|
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6 * DBA/2)
|
small pancreatic islets
|
J:57075
|
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6J * FVB/N)
|
small pancreatic islets
|
J:69591
|
Tg(AZIP/F)1Vsn/0
(involves: FVB/N)
|
pancreatic islet hyperplasia
|
J:50807
|
Tg(AZIP/F)1Vsn/0
(FVB-Tg(AZIP/F)1Vsn/J)
|
increased pancreatic beta cell mass
|
J:145998
|
Tg(CAG-APP)0304Shoj/0
(involves: C3H * C57BL/6N)
|
abnormal pancreatic acinar cell morphology
|
J:100977
|
Tg(CAG-Bgeo,-Nkx6-1,-EGFP)#Msan/0 Tg(Neurog3-cre)C1Able/0
(involves: BALB/c * C57BL/6)
|
decreased pancreatic alpha cell number
|
J:195153
|
decreased pancreatic delta cell number
|
J:195153
|
decreased pancreatic epsilon cell number
|
J:195153
|
increased pancreatic beta cell number
|
J:195153
|
Tg(CAG-Bgeo,-tsA58T)T26Ichi/0 Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal pancreatic acinar cell morphology
|
J:214846
|
abnormal pancreatic duct morphology
|
J:214846
|
Tg(CAG-Bgeo,-tTA,-EGFP)2A11Kuw/0 Tg(Pdx1-cre)6Tuv/0 Tg(tetO-MYC)36Bop/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased pancreas tumor incidence
|
J:197052
|
increased pancreatic ductal adenocarcinoma incidence
|
J:197052
|
increased pancreatic intraepithelial neoplasia incidence
|
J:197052
|
Tg(CAG-Bgeo/ALPP)1Lbe/0 Tg(Ins2-cre/ERT)1Dam/0 Tg(Ins2-rtTA)2Efr/0 Tg(tetO-DTA)1Gfi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased pancreatic beta cell number
|
J:127412
|
Tg(CAG-Btc)2Ewo/0
(FVB/N-Tg(CAG-Btc)2Ewo)
|
decreased pancreas weight
|
J:103364
|
Tg(CAG-Btc)4Ewo/0
(FVB/N-Tg(CAG-Btc)4Ewo)
|
decreased pancreas weight
|
J:103364
|
Tg(CAG-lacZ,-SV40)#Bcv/0
(involves: FVB/N)
|
increased pancreas tumor incidence
|
J:158388
|
Tg(CAG-SPTLC1*C133W)8EAmcc/0
(involves: C3H * C57BL/6)
|
abnormal pancreas morphology
|
J:106812
|
exocrine pancreas atrophy
|
J:106812
|
Tg(Cela1-luc,Cela1-TAg)#Nzh/0
(involves: FVB/N)
|
increased pancreatic acinar cell carcinoma incidence
|
J:207960
|
Tg(Ckm-IGF1R*K1003R)1Dlr/0
(FVB/N-Tg(Ckm-IGF1R*K1003R)1Dlr)
|
pancreatic islet hyperplasia
|
J:71205
|
Tg(Col1a1-Ptprv)1Kry/?
(Not Specified)
|
decreased pancreatic beta cell mass
|
J:126780
|
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
(FVB(Cg)-Tg(Cryaa-Tag,Ins2-CALM1)26Ove/PneJ)
|
decreased pancreatic beta cell number
|
J:97926
|
Tg(Ela1-Bhlhb8)#Skz/?
(Not Specified)
|
abnormal pancreatic acinar cell morphology
|
J:89063
|
Tg(Ela1-Myc)158Bri/0
(involves: C57BL/6 * SJL)
|
exocrine pancreas atrophy
|
J:76992
|
increased pancreas tumor incidence
|
J:76992
|
increased pancreatic acinar cell carcinoma incidence
|
J:76992
|
small pancreas
|
J:76992
|
Tg(Ela1-Myc)159Bri/0
(involves: C57BL/6 * SJL)
|
exocrine pancreas atrophy
|
J:76992
|
increased pancreas tumor incidence
|
J:76992
|
increased pancreatic acinar cell carcinoma incidence
|
J:76992
|
small pancreas
|
J:76992
|
Tg(Ela1-Myc)160Bri/0
(involves: C57BL/6 * SJL)
|
exocrine pancreas atrophy
|
J:76992
|
increased pancreas tumor incidence
|
J:76992
|
increased pancreatic acinar cell carcinoma incidence
|
J:76992
|
small pancreas
|
J:76992
|
Tg(Ela1-TAg)18Bri/0
(involves: C57BL/6 * SJL)
|
abnormal pancreatic acinar cell morphology
|
J:76995
|
increased insulinoma incidence
|
J:76995
|
increased pancreas tumor incidence
|
J:76995
|
increased pancreatic acinar cell carcinoma incidence
|
J:76995
|
increased pancreatic islet cell adenoma incidence
|
J:76995
|
pancreatic islet hyperplasia
|
J:76995
|
Tg(Ela1-TAg)19Bri/0
(involves: C57BL/6 * SJL)
|
abnormal pancreatic acinar cell morphology
|
J:76995
|
increased insulinoma incidence
|
J:76995
|
increased pancreas tumor incidence
|
J:76995
|
increased pancreatic acinar cell carcinoma incidence
|
J:76995
|
pancreatic islet hyperplasia
|
J:76995
|
Tg(Ela1-TAg*)79Mjt/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreas morphology
|
J:78026
|
increased pancreas adenoma incidence
|
J:78026
|
increased pancreas tumor incidence
|
J:78026
|
increased pancreatic acinar cell carcinoma incidence
|
J:78026
|
Tg(Ela1-TAg*)79Mjt/0 Tg(MUC1)79.24Gend/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreas morphology
|
J:64570
|
increased pancreas adenoma incidence
|
J:64570
|
increased pancreas tumor incidence
|
J:64570
|
increased pancreatic acinar cell carcinoma incidence
|
J:64570
|
Tg(Ela1-TAg*)289Mjt/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreas morphology
|
J:78026
|
increased pancreas adenoma incidence
|
J:78026
|
increased pancreas tumor incidence
|
J:78026
|
increased pancreatic acinar cell carcinoma incidence
|
J:78026
|
Tg(Ela1-Tgfa)150Bri/0
(involves: C57BL/6 * SJL)
|
abnormal pancreas morphology
|
J:52757
|
abnormal pancreatic acinar cell morphology
|
J:52757
|
increased pancreas tumor incidence
|
J:52757,
J:67389
|
pancreas cyst
|
J:52757
|
pancreas fibrosis
|
J:52757
|
pancreatic acinar-to-ductal metaplasia
|
J:52757
|
Tg(Ela1-Tgfa)150Bri/0 Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
increased pancreas tumor incidence
|
J:67389
|
Tg(Ela1-Tgfa)150Bri/0 Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
increased pancreas tumor incidence
|
J:67389
|
increased pancreatic ductal adenocarcinoma incidence
|
J:67389
|
Tg(Ela2a-Prss1*,-GFP)1Dbs/0
(C57BL/6-Tg(Ela2a-Prss1*,-GFP)1Dbs)
|
abnormal pancreatic acinar cell morphology
|
J:144663
|
pancreas fibrosis
|
J:144663
|
pancreas necrosis
|
J:144663
|
Tg(Ela-KRAS*G12D)9Eps/0
(involves: C57BL/6 * FVB)
|
abnormal pancreas morphology
|
J:231759
|
abnormal pancreatic acinar cell morphology
|
J:231759
|
increased pancreas tumor incidence
|
J:231759
|
pancreas degeneration
|
J:231759
|
pancreatic acinar-to-ductal metaplasia
|
J:231759
|
Tg(Ela-KRAS*G12D)9Eps/0 Tg(Mt1-TGFBR2*)AM3Epb/0
(involves: C57BL/6 * FVB)
|
abnormal pancreas morphology
|
J:231759
|
increased pancreas tumor incidence
|
J:231759
|
pancreas fibrosis
|
J:231759
|
pancreatic acinar-to-ductal metaplasia
|
J:231759
|
Tg(Ela-KRAS*G12D)9Eps/0 Tgfbr1tm1Bopa/Tgfbr1+
(involves: 129S1/SvImJ * C57BL/6 * FVB)
|
increased pancreas tumor incidence
|
J:231759
|
Tg(Erbb2*)#Maed/0 Tg(Foxa3-cre)1Khk/0
(involves: C57BL/6 * C57BL/6J * DBA)
|
abnormal pancreas morphology
|
J:262746
|
abnormal pancreatic acinar cell morphology
|
J:262746
|
increased pancreas tumor incidence
|
J:262746
|
Tg(Gcg-TAg)25Ddr/?
(involves: CD-1)
|
abnormal pancreatic islet morphology
|
J:91490,
J:101537
|
enlarged pancreatic islets
|
J:101537
|
increased pancreas tumor incidence
|
J:91490,
J:101537
|
pancreatic islet hyperplasia
|
J:91490
|
Tg(GHRL-TAg)1-5Hiwa/0
(C57BL/6-Tg(GHRL-TAg)1-5Hiwa)
|
increased pancreas tumor incidence
|
J:152492
|
Tg(Gpbar1)1Auw/0
(involves: C57BL/6J)
|
abnormal pancreatic islet size
|
J:152388
|
Tg(HDexon1)62Gpb/0
(involves: C57BL/6J * CBA/J)
|
abnormal pancreatic alpha cell morphology
|
J:96353
|
abnormal pancreatic beta cell morphology
|
J:96353
|
abnormal pancreatic delta cell morphology
|
J:96353
|
decreased pancreatic beta cell number
|
J:96353
|
Tg(Ins1-Cat,Tyr)25Pne/0
(NOD.FVB-Tg(Ins1-Cat,Tyr)25Pne)
|
abnormal pancreatic islet morphology
|
J:108415
|
decreased pancreatic beta cell number
|
J:108415
|
Tg(Ins1-Cd80)378Psoh/0 Tg(Ins2-GP)#Psoh/0 Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2 * FVB/N)
|
absent pancreatic beta cells
|
J:209714
|
Tg(Ins1-EGFP/GH1)14Hara/0
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara)
|
decreased pancreatic beta cell number
|
J:127015
|
Tg(Ins1-EGFP/GH1)14Hara/Tg(Ins1-EGFP/GH1)14Hara
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara)
|
abnormal pancreatic beta cell morphology
|
J:127015
|
Tg(Ins1-Tag,-luc)1Gcr/0
(FVB/N-Tg(Ins1-Tag,-luc)1Gcr)
|
increased insulinoma incidence
|
J:162648
|
Tg(Ins1-Tag,-luc)1Gcr/0
(involves: C57BL/6 * FVB/N)
|
increased insulinoma incidence
|
J:162648
|
Tg(Ins2-Akt1*)3Mbb/0
(involves: C57BL/6 * SJL)
|
abnormal pancreatic beta cell morphology
|
J:72216
|
abnormal pancreatic islet morphology
|
J:72216
|
decreased pancreatic beta cell number
|
J:72216
|
enlarged pancreatic islets
|
J:72216
|
increased pancreatic beta cell mass
|
J:72216
|
increased pancreatic islet number
|
J:72216
|
Tg(Ins2-Akt1*)3Mbb/0
(B6.Cg-Tg(Ins2-Akt1*)3Mbb)
|
abnormal pancreatic beta cell morphology
|
J:144599
|
abnormal pancreatic islet morphology
|
J:144599
|
enlarged pancreatic islets
|
J:144599
|
increased insulinoma incidence
|
J:144599
|
increased pancreas tumor incidence
|
J:144599
|
increased pancreatic beta cell mass
|
J:144599
|
increased pancreatic islet cell carcinoma incidence
|
J:144599
|
pancreas fibrosis
|
J:144599
|
Tg(Ins2-Ccl19)2Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:77238
|
Tg(Ins2-Ccl19)2Cys/0 Tg(Ins2-Ccl21b)2Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:77238
|
Tg(Ins2-Ccl21b)2Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:77238
|
Tg(Ins2-CD80)3B7Flv/0 Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL)
|
abnormal pancreatic islet morphology
|
J:93555
|
Tg(Ins2-CD86)12B70Flv/0 Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL)
|
decreased pancreatic beta cell number
|
J:93555
|
Tg(Ins2-CDKN1B)1Maka/0
(involves: C57BL/6J)
|
abnormal pancreatic islet morphology
|
J:96047
|
decreased pancreatic beta cell number
|
J:96047
|
Tg(Ins2-Cebpb)2Maka/0
(involves: C57BL/6)
|
decreased pancreatic beta cell mass
|
J:156725
|
Tg(Ins2-cre)23Herr/0 Tsc2tm1Kido/Tsc2tm1Kido
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA/J)
|
abnormal pancreatic islet morphology
|
J:135811
|
decreased pancreatic beta cell number
|
J:135811
|
increased pancreatic beta cell mass
|
J:135811
|
pancreatic islet hyperplasia
|
J:135811
|
Tg(Ins2-Cxcl12)2Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:77238
|
Tg(Ins2-Cxcl13)1Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:77238,
J:110548
|
Tg(Ins2-Fasl)24Ach/0
(NOD-Tg(Ins2-Fasl)24Ach/J)
|
abnormal pancreatic islet morphology
|
J:78679
|
Tg(Ins2-GP)34-20Olds/0
(involves: BALB/c * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:81287
|
absent pancreatic beta cells
|
J:81287
|
Tg(Ins2-HA)165Bri/0 Tg(TcraCl4,TcrbCl4)1Shrm/0
(involves: BALB/c * C57BL/6 * C57BL/10 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:99756
|
Tg(Ins2-HBEGF)5Rin/?
(C57BL/6-Tg(Ins2-HBEGF)5Rin)
|
abnormal pancreatic islet morphology
|
J:204420
|
decreased pancreatic beta cell number
|
J:204420
|
Tg(Ins2-Hnf1a)#Cbw/0
(involves: C57BL/6 * CBA/J)
|
abnormal pancreatic beta cell morphology
|
J:134757
|
decreased pancreatic beta cell number
|
J:134757
|
disorganized pancreatic islets
|
J:134757
|
increased pancreatic alpha cell number
|
J:134757
|
Tg(Ins2-Iapp)6Soel/Tg(Ins2-Iapp)6Soel
(involves: FVB/N)
|
abnormal pancreatic islet morphology
|
J:130022
|
Tg(Ins2-IAPP)L13Gjsc/0
(FVB/N-Tg(Ins2-IAPP)L13Gjsc)
|
abnormal pancreatic islet morphology
|
J:142009
|
decreased pancreatic beta cell mass
|
J:142009
|
decreased pancreatic beta cell number
|
J:142009
|
Tg(Ins2-IAPP)RHFSoel/Tg(Ins2-IAPP)RHFSoel
(involves: FVB/N)
|
abnormal pancreatic islet morphology
|
J:130022
|
decreased pancreatic beta cell mass
|
J:130022
|
Tg(Ins2-IGF1R)1Dh/0 Tg(RIP1-Tag)2Dh/0
(involves: C3H * C57BL/6 * C57BL/6J * DBA/2J)
|
increased insulinoma incidence
|
J:205389
|
increased pancreatic islet cell carcinoma incidence
|
J:205389
|
Tg(Ins2-Irs2)13Mfw/0
(involves: C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:94000
|
Tg(Ins2-Lta)#Flv/0
(involves: NOD)
|
abnormal pancreatic islet morphology
|
J:91820
|
Tg(Ins2-Lta)#Flv/0
(involves: C57BL/6)
|
abnormal pancreatic islet morphology
|
J:91820
|
Tg(Ins2-Mir184)4Mnpy/0
(Not Specified)
|
decreased pancreatic beta cell mass
|
J:210552
|
Tg(Ins2-Mirc13)E4Biat/0
(C57BL/6N-Tg(Ins2-Mirc13)E4Biat)
|
decreased pancreatic beta cell mass
|
J:314874
|
Tg(Ins2-Nos2)31Okam/0
(involves: C57BL/6 * CD-1 * DBA/2)
|
abnormal pancreas morphology
|
J:45520
|
abnormal pancreatic islet morphology
|
J:45520
|
decreased pancreatic beta cell mass
|
J:45520
|
Tg(Ins2-Nos2)40Okam/0
(involves: C57BL/6 * CD-1 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:45520
|
decreased pancreatic beta cell mass
|
J:45520
|
Tg(Ins2-NP)25-3Olds/0
(involves: BALB/c * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:81284,
J:81287
|
Tg(Ins2-OVA)307Wehi/0 Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * C57BL/6JWehi)
|
decreased pancreatic beta cell number
|
J:99451
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Ago2)30Mnpy/0
(involves: C57BL/6 * CBA)
|
increased pancreatic beta cell mass
|
J:210552
|
increased pancreatic beta cell number
|
J:210552
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-DTA)1Gfi/0
(involves: C57BL/6 * CBA)
|
abnormal pancreas morphology
|
J:127412
|
abnormal pancreatic beta cell morphology
|
J:127412
|
decreased pancreatic beta cell number
|
J:127412
|
disorganized pancreatic islets
|
J:127412
|
increased pancreatic beta cell number
|
J:127412
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Mir184)#Mnpy/0
(involves: C57BL/6 * CBA)
|
decreased pancreatic beta cell mass
|
J:210552
|
decreased pancreatic beta cell number
|
J:210552
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Sri)10Hhv/0
(involves: C57BL/6 * CBA)
|
abnormal pancreatic islet morphology
|
J:246708
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-TAg)1Efr/0
(involves: C3HeB/FeJ * C57BL/6 * CBA)
|
increased insulinoma incidence
|
J:130049
|
Tg(Ins2-TAg)1Lt/0
(NOD/ShiLt-Tg(Ins2-TAg)1Lt)
|
increased insulinoma incidence
|
J:92449
|
Tg(Ins2-Tag*,-flpe)#Gne/0
(involves: C57BL/6J)
|
abnormal pancreas morphology
|
J:187012
|
increased insulinoma incidence
|
J:187012
|
increased pancreas tumor incidence
|
J:187012
|
increased pancreatic islet cell carcinoma incidence
|
J:187012
|
Tg(Ins2-Tag*,-flpe)#Gne/0
(Not Specified)
|
increased pancreatic islet cell carcinoma incidence
|
J:188693
|
Tg(Ins2-TCF1*P291)2Kya/0
(involves: C57BL/6 * SJL)
|
abnormal pancreatic islet morphology
|
J:73760
|
decreased pancreatic beta cell number
|
J:73760
|
disorganized pancreatic islets
|
J:73760
|
small pancreatic islets
|
J:73760
|
Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA * NOD)
|
abnormal pancreatic islet morphology
|
J:91820
|
Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA)
|
abnormal pancreatic islet morphology
|
J:91820
|
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * SJL)
|
disorganized pancreatic islets
|
J:141527
|
increased pancreas weight
|
J:141527
|
increased pancreatic beta cell mass
|
J:141527
|
pancreatic islet hyperplasia
|
J:141527
|
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * C57BLKs/J * SJL)
|
disorganized pancreatic islets
|
J:141527
|
pancreatic islet hyperplasia
|
J:141527
|
Tg(INS-Il10)#Sar/0
(involves: BALB/c)
|
abnormal exocrine pancreas morphology
|
J:107927
|
Tg(INS-MT2A,Tyr)1Pne/0
(FVB-Tg(INS-MT2A,Tyr)1Pne)
|
abnormal pancreatic islet morphology
|
J:95089
|
Tg(INS-MT2A,Tyr)1Pne/0
(NOD.FVB-Tg(INS-MT2A,Tyr)1Pne)
|
abnormal pancreatic islet morphology
|
J:108415
|
decreased pancreatic beta cell number
|
J:108415
|
Tg(Mafg-Nfe2l1)1Mym/0
(involves: C57BL/6J * DBA/2)
|
abnormal pancreatic beta cell morphology
|
J:230118
|
enlarged pancreatic islets
|
J:230118
|
Tg(Mafg-Nfe2l1)6Mym/0
(involves: C57BL/6J * DBA/2)
|
abnormal pancreatic beta cell morphology
|
J:230118
|
enlarged pancreatic islets
|
J:230118
|
Tg(Mt1-Tgfa)149Bri/0
(involves: C57BL/6 * SJL)
|
increased pancreatic intraepithelial neoplasia incidence
|
J:162125
|
Tg(Mt1-TGFBR2*)AM3Epb/0
(involves: FVB/N)
|
abnormal exocrine pancreas morphology
|
J:76993
|
abnormal pancreas morphology
|
J:76993
|
abnormal pancreatic acinus morphology
|
J:76993
|
abnormal pancreatic duct morphology
|
J:76993
|
decreased pancreas weight
|
J:76993
|
pancreas fibrosis
|
J:76993
|
pancreatic acinar hyperplasia
|
J:76993
|
pancreatic acinar-to-ductal metaplasia
|
J:76993
|
Tg(MtTGFA)42Lmb/Tg(MtTGFA)42Lmb
(involves: CD-1)
|
abnormal pancreas morphology
|
J:28452
|
pancreas fibrosis
|
J:28452
|
Tg(MtTGFA)100Lmb/Tg(MtTGFA)100Lmb
(involves: FVB/N)
|
pancreas fibrosis
|
J:28452
|
Tg(MtTGFA)Lmb/0
(involves: CD-1)
|
abnormal pancreas morphology
|
J:229184
|
abnormal pancreatic acinar cell morphology
|
J:229184
|
abnormal pancreatic islet morphology
|
J:229184
|
increased pancreatic intraepithelial neoplasia incidence
|
J:229184
|
pancreas fibrosis
|
J:229184
|
pancreatic acinar-to-ductal metaplasia
|
J:229184
|
Tg(Pdx1-Ffar1)AHeed/0
(Not Specified)
|
disorganized pancreatic islets
|
J:129843
|
Tg(Pdx1-Myt1)2Ggu/0
(Not Specified)
|
abnormal pancreatic islet morphology
|
J:136131
|
Tg(Pdx1-Neurog3)1Heed/?
(involves: C57BL/6 * CBA)
|
abnormal pancreas development
|
J:57072
|
Tg(Pdx1-Notch3)1Heed/?
(involves: C57BL/6 * CBA)
|
abnormal pancreas development
|
J:57072
|
Tg(Pklr-Myc)73Ak/0
(involves: C57BL/6 * DBA)
|
pancreatic islet hyperplasia
|
J:185488
|
Tg(Pklr-SV40)1Ak/0
(involves: C57BL/6 * DBA)
|
increased insulinoma incidence
|
J:185488
|
increased pancreas tumor incidence
|
J:185488
|
pancreatic islet hyperplasia
|
J:185488
|
Tg(Pklr-SV40)1Ak/Tg(Pklr-SV40)1Ak
(involves: C57BL/6 * DBA)
|
increased pancreas tumor incidence
|
J:185488
|
Tg(PRSS1/lacZ)#Gwzh/0
(Not Specified)
|
abnormal pancreatic acinus morphology
|
J:345508
|
Tg(RIP1-Tag)2Dh/?
(C3.Cg-Tg(RIP1-Tag)2Dh/Nci)
|
increased insulinoma incidence
|
J:80168
|
Tg(RIP1-Tag)2Dh/0
(involves: C57BL/6)
|
increased insulinoma incidence
|
J:162648
|
Tg(RIP1-Tag)2Dh/0
(involves: C57BL/6J * DBA/2J)
|
abnormal pancreatic islet morphology
|
J:50695
|
decreased pancreatic alpha cell number
|
J:50695
|
decreased pancreatic delta cell number
|
J:50695
|
increased insulinoma incidence
|
J:205389
|
increased pancreas tumor incidence
|
J:50695
|
increased pancreatic beta cell number
|
J:50695
|
increased pancreatic islet cell carcinoma incidence
|
J:205389
|
Tg(RIP1-Tag)5Dh/?
(C3HeB/FeJ-Tg(RIP1-Tag)5Dh)
|
abnormal pancreatic islet morphology
|
J:80168
|
increased insulinoma incidence
|
J:80168
|
Tg(RIP1-Tag)5Dh/0
(C3.Cg-Rgs5tm1.1Rgan Tg(RIP1-Tag)5Dh)
|
increased insulinoma incidence
|
J:136259
|
Tg(RIR-Tag)87Dh/0
(involves: C57BL/6J * DBA/2J)
|
abnormal pancreatic islet morphology
|
J:50695
|
decreased pancreatic alpha cell number
|
J:50695
|
decreased pancreatic delta cell number
|
J:50695
|
increased pancreas tumor incidence
|
J:50695
|
increased pancreatic beta cell number
|
J:50695
|
Tg(RP3-340H11)29Kel/0
(involves: C57BL/6J * CBA/Ca)
|
abnormal pancreas development
|
J:91709
|
decreased pancreatic alpha cell number
|
J:91709
|
decreased pancreatic beta cell mass
|
J:91709
|
decreased pancreatic beta cell number
|
J:91709
|
decreased pancreatic delta cell number
|
J:91709
|
decreased PP cell number
|
J:91709
|
increased pancreatic alpha cell number
|
J:91709
|
increased pancreatic beta cell number
|
J:91709
|
Tg(SREBP1a)7343Reh/0
(B6.Cg-Tg(SREBP1a)7343Reh)
|
increased pancreatic beta cell mass
|
J:100328
|
pancreatic islet hyperplasia
|
J:100328
|
Tg(Ttr-Foxo1)305Dac/0
(involves: FVB * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:79560
|
Tg(Ttr-Foxo1)307Dac/0
(involves: FVB * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:79560
|
Tgfbitm1Jwu/Tgfbitm1Jwu
(B6.129-Tgfbitm1Jwu)
|
abnormal pancreatic islet morphology
|
J:213611
|
Thbs1tm1Hyn/Thbs1tm1Hyn
(either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal pancreas morphology
|
J:48446
|
exocrine pancreas hypoplasia
|
J:48446
|
pancreatic islet hyperplasia
|
J:48446
|
Thbs1tm1Hyn/Thbs1tm1Hyn Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased pancreas tumor incidence
|
J:72391
|
Thbs1tm1Hyn/Thbs1tm1Hyn Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased pancreas tumor incidence
|
J:72391
|
Thratm1.1Fcas/Thratm1.1Fcas
(B6.Cg-Thratm1.1Fcas)
|
abnormal pancreatic islet morphology
|
J:179839
|
small pancreatic islets
|
J:179839
|
Tk1tm1Vnd/Tk1tm1Vnd
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased pancreatic islet number
|
J:101669
|
pancreatic acinar cell zymogen granule accumulation
|
J:101669
|
small pancreas
|
J:101669
|
Tle3tm1Jcc/Tle3tm1Jcc
(involves: 129P2/OlaHsd)
|
abnormal pancreas development
|
J:183486
|
abnormal pancreatic alpha cell differentiation
|
J:183486
|
abnormal pancreatic alpha cell morphology
|
J:183486
|
abnormal pancreatic beta cell differentiation
|
J:183486
|
abnormal pancreatic beta cell morphology
|
J:183486
|
abnormal pancreatic delta cell differentiation
|
J:183486
|
abnormal pancreatic epsilon cell differentiation
|
J:183486
|
abnormal pancreatic epsilon cell morphology
|
J:183486
|
abnormal PP cell differentiation
|
J:183486
|
small pancreas
|
J:183486
|
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki)
|
abnormal pancreatic beta cell morphology
|
J:148283
|
small pancreatic islets
|
J:148283
|
Tlr3tm1Flv/Tlr3tm1Flv
(involves: 129S1/Sv)
|
abnormal pancreatic islet morphology
|
J:148283
|
decreased pancreatic beta cell mass
|
J:148283
|
increased pancreatic islet number
|
J:148283
|
Tlr7em2Anu/Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu)
|
abnormal exocrine pancreas morphology
|
J:324448
|
Tmed6em1(IMPC)Rbrc/Tmed6em1(IMPC)Rbrc
(C57BL/6NJcl-Tmed6em1(IMPC)Rbrc/Rbrc)
|
abnormal pancreas morphology
|
J:211773
|
small pancreas
|
J:211773
|
Tmem248tm1.1(KOMP)Vlcg/Tmem248tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem248tm1.1(KOMP)Vlcg/Ucd)
|
abnormal pancreas morphology
|
J:211773
|
absent pancreas
|
J:211773
|
Tmprss6tm1Dgen/Tmprss6tm1Dgen
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
decreased pancreas iron level
|
J:160248
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx Tg(Ins2-Cxcl13)1Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:110548
|
Tnk1tm1Sksuf/Tnk1+
(involves: 129X1/SvJ * C57BL/6)
|
increased pancreas tumor incidence
|
J:140639
|
pancreatic islet hyperplasia
|
J:140639
|
Top3btm1Jcw/Top3btm1Jcw
(involves: 129S6/SvEvTac * C57BL/6)
|
pancreatic islet hyperplasia
|
J:69405
|
Tph1tm1c(KOMP)Wtsi/Tph1tm1c(KOMP)Wtsi Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell mass
|
J:284574
|
Trap1Gt(E150H04)Wrst/Trap1Gt(E150H04)Wrst
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreas morphology
|
J:226880
|
Trappc8em1(IMPC)Tcp/Trappc8+
(C57BL/6NCrl-Trappc8em1(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Trim37Gt(RRO307)Byg/Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg)
|
abnormal pancreas morphology
|
J:232482
|
enlarged pancreas
|
J:232482
|
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased pancreas tumor incidence
|
J:72391
|
Trp53tm1Tyj/Trp53+ Trp73tm1Fmc/Trp73+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased pancreatic acinar cell carcinoma incidence
|
J:98958
|
Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ)
|
increased pancreatic alpha cell number
|
J:223992
|
Tsnaxem1(IMPC)Mbp/Tsnaxem1(IMPC)Mbp
(C57BL/6NCrl-Tsnaxem1(IMPC)Mbp/MbpMmucd)
|
abnormal pancreas morphology
|
J:211773
|
Tspan32em1(IMPC)Mbp/Tspan32em1(IMPC)Mbp
(C57BL/6N-Tspan32em1(IMPC)Mbp/MbpMmucd)
|
abnormal pancreas morphology
|
J:211773
|
Tubtub/Tubtub
(C57BL/6J-Tubtub)
|
enlarged pancreatic islets
|
J:13772
|
Tyk2tm2b(EUCOMM)Hmgu/Tyk2tm2b(EUCOMM)Hmgu
(C57BL/6N-Tyk2tm2b(EUCOMM)Hmgu/Ieg)
|
abnormal pancreas morphology
|
J:211773
|
Ubl7em1(IMPC)Tcp/Ubl7em1(IMPC)Tcp
(C57BL/6N-Ubl7em1(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Ucp2tm1Lowl/Ucp2tm1Lowl
(B6.129S4-Ucp2tm1Lowl)
|
pancreas cyst
|
J:272325
|
Unc13atm1Bros/Unc13a+
(involves: 129)
|
abnormal pancreatic islet morphology
|
J:108689
|
Unc13atm2Bros/Unc13a+
(Not Specified)
|
abnormal pancreatic islet morphology
|
J:108689
|
Uoxem1(IMPC)Ccpcz/Uox+
(C57BL/6NCrl-Uoxem1(IMPC)Ccpcz/Ccpcz)
|
abnormal pancreas morphology
|
J:211773
|
enlarged pancreas
|
J:211773
|
small pancreas
|
J:211773
|
Uoxem1Cli/Uoxem1Cli
(C57BL/6J-Uoxem1Cli)
|
decreased pancreatic beta cell mass
|
J:271949
|
Uqcrhtm1b(EUCOMM)Wtsi/Uqcrh+
(C57BL/6NCrl-Uqcrhtm1b(EUCOMM)Wtsi/Ieg)
|
abnormal pancreas morphology
|
J:211773
|
Vamp4em1Tax/Vamp4em1Tax
(involves: C57BL/6J)
|
abnormal pancreatic beta cell morphology
|
J:352764
|
Vamp8tm1Hong/Vamp8tm1Hong
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreatic acinar cell morphology
|
J:93035
|
abnormal pancreatic acinar cell zymogen granule morphology
|
J:137704
|
pancreatic acinar cell zymogen granule accumulation
|
J:93035
|
Vhltm1Lss/Vhltm1Lss Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal exocrine pancreas morphology
|
J:148174
|
abnormal pancreatic islet morphology
|
J:148174
|
increased pancreas adenoma incidence
|
J:148174
|
pancreas cyst
|
J:148174
|
Vipr1tm1Msod/Vipr1tm1Msod
(B6.129-Vipr1tm1Msod)
|
abnormal exocrine pancreas morphology
|
J:177616
|
disorganized pancreatic islets
|
J:177616
|
Vrk3em1(IMPC)Mbp/Vrk3em1(IMPC)Mbp
(C57BL/6NCrl-Vrk3em1(IMPC)Mbp/Mmucd)
|
abnormal pancreas morphology
|
J:211773
|
Vsirtm1Lex/Vsirtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
pancreas necrosis
|
J:222944
|
Wdr13tm1Kuma/Y
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased pancreas weight
|
J:225111
|
pancreatic islet hyperplasia
|
J:225111
|
Wdr13tm1Kuma/Wdr13tm1Kuma
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased pancreas weight
|
J:225111
|
Wfs1tm1Perm/Wfs1tm1Perm Tg(Ins2-cre)23Herr/0
(involves: 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal pancreatic islet morphology
|
J:104712
|
decreased pancreatic beta cell mass
|
J:104712
|
decreased pancreatic beta cell number
|
J:104712
|
disorganized pancreatic islets
|
J:104712
|
Wfs1tm1Yoka/Wfs1tm1Yoka
(involves: 129/Sv * C57BL/6)
|
decreased pancreatic beta cell number
|
J:90420
|
Wfs1tm1Yoka/Wfs1tm1Yoka
(B6.Cg-Wfs1tm1Yoka)
|
decreased pancreatic beta cell number
|
J:90420
|
Wlstm1.1Lan/Wlstm1.1Lan Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * FVB/N * SJL)
|
pancreas hypoplasia
|
J:164701
|
Yipf6M1Btlr/Y
(C57BL/6J-Yipf6M1Btlr/Mmucd)
|
abnormal pancreatic acinar cell morphology
|
J:187584
|
Yipf6M1Btlr/Yipf6M1Btlr
(C57BL/6J-Yipf6M1Btlr/Mmucd)
|
abnormal pancreatic acinar cell morphology
|
J:187584
|
Zcwpw1em1(IMPC)Tcp/Zcwpw1em1(IMPC)Tcp
(C57BL/6N-Zcwpw1em1(IMPC)Tcp/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Zfp451tm1b(EUCOMM)Hmgu/Zfp451tm1b(EUCOMM)Hmgu
(C57BL/6N-Zfp451tm1b(EUCOMM)Hmgu/Tcp)
|
abnormal pancreas morphology
|
J:211773
|
Zfp800em1Mgn/Zfp800em1Mgn
(B6.Cg-Zfp800em1Mgn)
|
abnormal endocrine pancreas development
|
J:306470
|
abnormal pancreatic acinar cell morphology
|
J:306470
|
decreased pancreatic alpha cell number
|
J:306470
|
decreased pancreatic beta cell number
|
J:306470
|
decreased pancreatic delta cell number
|
J:306470
|
decreased PP cell number
|
J:306470
|
Zic2iso/Zic2iso
(involves: C3H/HeH * C57BL/6)
|
abnormal pancreas morphology
|
J:268103
|